<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><?DTDIdentifier.IdentifierValue -//ACS//DTD ACS Journal DTD v1.02 20061031//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName ACSJournal-v102.dtd?><?SourceDTD.Version 1.02?><?ConverterInfo.XSLTName acs2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Org Chem</journal-id><journal-id journal-id-type="iso-abbrev">J. Org. Chem</journal-id><journal-id journal-id-type="publisher-id">jo</journal-id><journal-id journal-id-type="coden">joceah</journal-id><journal-title-group><journal-title>The Journal of Organic Chemistry</journal-title></journal-title-group><issn pub-type="ppub">0022-3263</issn><issn pub-type="epub">1520-6904</issn><publisher><publisher-name>American Chemical
Society</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1021/jo5019848</article-id><article-categories><subj-group><subject>Article</subject></subj-group></article-categories><title-group><article-title>Photoassisted Diversity-Oriented
Synthesis: Accessing 2,6-Epoxyazocane (Oxamorphan) Cores</article-title></title-group><contrib-group><contrib contrib-type="author" id="ath1"><name><surname>Mukhina</surname><given-names>Olga A.</given-names></name></contrib><contrib contrib-type="author" id="ath2"><name><surname>Kumar</surname><given-names>N. N.
Bhuvan</given-names></name></contrib><contrib contrib-type="author" id="ath3"><name><surname>Cowger</surname><given-names>Teresa M.</given-names></name></contrib><contrib contrib-type="author" corresp="yes" id="ath4"><name><surname>Kutateladze</surname><given-names>Andrei G.</given-names></name><xref rid="cor1" ref-type="other">*</xref></contrib><aff id="aff1">Department of Chemistry and Biochemistry, <institution>University of Denver</institution>, Denver, Colorado 80208, <country>United States</country></aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>E-mail for A.G.K.: <email>akutatel@du.edu</email>.</corresp></author-notes><pub-date pub-type="pmc-release"><day>05</day><month>11</month><year>2015</year></pub-date><pub-date pub-type="epub"><day>05</day><month>11</month><year>2014</year></pub-date><pub-date pub-type="ppub"><day>21</day><month>11</month><year>2014</year></pub-date><volume>79</volume><issue>22</issue><fpage>10956</fpage><lpage>10971</lpage><history><date date-type="received"><day>27</day><month>08</month><year>2014</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2014 American Chemical Society</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>American Chemical Society</copyright-holder><license><license-p>This is an open access article published under an ACS AuthorChoice <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/page/policy/authorchoice_termsofuse.html">License</ext-link>, which permits copying and redistribution of the article or any adaptations for non-commercial purposes.</license-p></license></permissions><abstract><p content-type="toc-graphic"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jo-2014-019848_0007" id="ab-tgr1"/></p><p>The
modular synthesis of photoprecursors and their photoinduced cyclization
into substituted 1-benzazocanes of two distinct topologies is described.
The key step producing an extended polyheterocyclic system involves
the photogeneration of azaxylylenes and their subsequent intramolecular
cycloaddition with furan-containing pendants tethered either via the
aniline nitrogen or through the carbonyl group containing arm. The
primary photoproducts&#x02014;secondary or tertiary anilines which
are not acylated at the nitrogen atom&#x02014;undergo facile acid-catalyzed
or spontaneous ring-opening&#x02013;ring-closing rearrangement to yield
fused polyheterocyclic structures possessing a 2,6-epoxyazocane (or
oxamorphan) core.</p></abstract><funding-group><funding-statement><funding-source>National Institutes of Health, United States</funding-source></funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>document-id-old-9</meta-name><meta-value>jo5019848</meta-value></custom-meta><custom-meta><meta-name>document-id-new-14</meta-name><meta-value>jo-2014-019848</meta-value></custom-meta><custom-meta><meta-name>ccc-price</meta-name><meta-value/></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="sec1"><title>Introduction</title><p>Nitrogen heterocycles are ubiquitous in
nature: a large number of biochemical pathways involve N-heterocycles
as substrates, products, or coenzymes.<sup><xref ref-type="bibr" rid="ref1">1</xref></sup> This ensures their prominence among top pharmaceuticals, with 23
out of the 50 top-selling drugs in the US in 2012 containing N-heterocycles.<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> It is not surprising that their methods of synthesis
and properties have long been a focus of sustained research efforts.<sup><xref ref-type="bibr" rid="ref3">3</xref></sup> As a result, the methods for five- and six-membered
N-containing heterocycle preparation are countless and also diverse.<sup><xref ref-type="bibr" rid="ref4">4</xref></sup> However, access to seven- and especially eight-membered
heterocycles remains challenging, mostly because these medium-sized
rings are less entropically favored. Such structures, their properties,
and methods of synthesis deserve closer examination and further development.
They either can be found in a number of bioactive molecules, for example
nakadomarin A and manzamine A, or are intermediates in their biosynthesis
(Figure <xref rid="fig1" ref-type="fig">1</xref>).<sup><xref ref-type="bibr" rid="ref5">5</xref></sup></p><fig id="fig1" position="float"><label>Figure 1</label><caption><p>Some members
of mitomycinoid alkaloids and their congeners.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jo-2014-019848_0009" id="gr14" position="float"/></fig><p>The 1-benzazocine core is of particular interest: it can
serve as an important intermediate in the synthesis of mitomycinoid
alkaloids,<sup><xref ref-type="bibr" rid="ref6">6</xref></sup> which are potent cytotoxins
as they can cross-link DNA, and exhibits a broad range of biological
activity, including potent anticancer activity.<sup><xref ref-type="bibr" rid="ref7">7</xref></sup> Moreover, it has been suggested that the biochemistry of
several alkaloids of the mitomycine family, FR-66979 and FR-900482,
as well as their semisynthetic analogues, FK-973 and FK-317, can be
rationalized by invoking <italic>in vivo</italic> formation of the benzazocane intermediate
that starts a biochemical cascade.<sup><xref ref-type="bibr" rid="ref8">8</xref></sup> Several
approaches to the synthesis of the benzazocine/benzazocane moiety
have been described, including ingenious examples of olefin metathesis,<sup><xref ref-type="bibr" rid="ref9">9</xref></sup> Mizoroki&#x02013;Heck reaction,<sup><xref ref-type="bibr" rid="ref10">10</xref></sup> ring expansion,<sup><xref ref-type="bibr" rid="ref11">11</xref></sup> cycloaddition,<sup><xref ref-type="bibr" rid="ref12">12</xref></sup> and condensation<sup><xref ref-type="bibr" rid="ref13">13</xref></sup> strategies. Most of these approaches, however, imply multistep synthesis;
therefore, the development of new short synthetic pathways to the
benzazocane scaffold is well justified.</p><p>The route to 1-benzazocanes
that is being developed in our laboratory is based on [4 + 4] cycloaddition
reactions of azaxylylenes&#x02014;short-lived species generated via
excited-state intramolecular proton transfer, ESIPT,<sup><xref ref-type="bibr" rid="ref14">14</xref></sup> in aromatic <italic>o-</italic>amino ketones and aldehydes.
Transient <italic>C</italic>-hydroxyazaxylylenes generated via ESIPT
have been observed in the past and characterized by time-resolved
photophysical methods.<sup><xref ref-type="bibr" rid="ref14">14</xref></sup> However, they
were not trapped chemically, as any addition reaction would have to
compete with very fast back proton transfer. Alternative (i.e., non-ESIPT)
approaches to azaxylylenes require exotic precursors such as benzosultams
and benzoazetines and often occur under the harsh conditions of flash
vacuum pyrolysis;<sup><xref ref-type="bibr" rid="ref15">15</xref></sup> thus, their utilization
in the synthesis of delicate complex organic architectures remains
very limited. An exception is Corey&#x02019;s mild generation of azaxylylenes
via 1,4-dehydrochlorination of <italic>o</italic>-aminobenzyl chlorides.<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> However, azaxylylenes generated via nonphotochemical
methods exclusively undergo [4 + 2] cycloadditions, limiting the structural
scaffolds accessible via these reactions to quinolines. The [4 + 4]
cycloaddition path is not available for these ground-state reactions.</p><p>Another option&#x02014;<italic>intra</italic>molecular reactions
of the ESIPT-generated azaxylylenes in their excited state which could
successfully compete with the wasteful back proton transfer&#x02014;has
not been explored before our work. Recently we found that photogenerated
azaxylylenes can indeed react <italic>intra</italic>molecularly with
the appropriately tethered unsaturated pendants (Scheme <xref rid="sch1" ref-type="scheme">1</xref>).<sup><xref ref-type="bibr" rid="ref17">17</xref></sup></p><fig id="sch1" position="float"><label>Scheme 1</label><caption><title>Photogeneration of
Azaxylylenes and Their Intramolecular Cycloadditions</title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jo-2014-019848_0013" id="gr1" position="float"/></fig><p>In this context, furans and other five-membered
heterocycles are particularly suitable as unsaturated pendants, because
they can participate in the cycloaddition reaction not only as an
alkene component, leading to the products of [4 + 2] cycloadditions,
but also as a diene component, furnishing azacanes as the products
of [4 + 4] cycloadditions. Our initial studies with azaxylylenes and
furan as a pendant demonstrated predominant formation of the [4 +
4] products in a 3:1 or lower ratio to the [4 + 2] products in the
majority of cases. This scaffold diversity and complexity arising
in one step from the same photoprecursor is appealing from a diversity-oriented
synthesis (DOS) standpoint.</p><p>Although furan derivatives have
been employed in Diels&#x02013;Alder reactions<sup><xref ref-type="bibr" rid="ref18">18</xref></sup> both as 4&#x003c0; and less commonly as 2&#x003c0;<sup><xref ref-type="bibr" rid="ref19">19</xref></sup> components, to the best of our knowledge there have not
been observations of the borderline behavior where <italic>both</italic> [4 + 4] and [4 + 2] reaction pathways are realized from the same
starting material under the same reaction conditions.<sup><xref ref-type="bibr" rid="ref20">20</xref></sup> According to our recent experimental and theoretical mechanistic
study,<sup><xref ref-type="bibr" rid="ref21">21</xref></sup> it is likely that the intramolecular
cycloaddition of azaxylylenes photogenerated via ESIPT occurs in a
stepwise manner in the triplet manifold, thus offering a rationale
for the formation of both [4 + 4] and [4 + 2] cycloadducts. From our
prior work we infer that the ratio of [4 + 4] to [4 + 2] products
is affected by the length of the tether between the azaxylylene precursor
and the nature of unsaturated pendants, with longer linkers often
favoring [4 + 4] products. The same bias toward [4 + 4] cycloaddition
was observed when the azaxylylenophile, i.e. a furan-based pendant,
was tethered via a carbonyl group, as in furanoyls. Also, in the past
we utilized ubiquitous amide bond forming coupling reactions to tether
unsaturated pendants to the photoactive <italic>o-</italic>amino ketone
core of the azaxylylene precursor.</p><p>In the current study we extend
the scope to azaxylylenes derived <italic>from o-amines,</italic> i.e. <italic>not amides</italic>, and also explore topological variations related
to the nature and the attachment point of the tether linking the photoactive
core with the unsaturated, mostly dienic, pendant. For cycloadditions
of ESIPT-generated azaxylylenes&#x02014;in the context of DOS&#x02014;it
is desirable not only to modulate the topology resulting from the
competing [4 + 2] and [4 + 4] photoinduced processes but also to take
advantage of the fact that a variety of additional (poly)cyclic moieties
can be installed in the photoproducts utilizing strategically chosen
linking groups and their attachment points. Our original topology
of tethering the furan-containing unsaturated pendant via the aniline
moiety of the photoprecursor was predicated on the simplicity of the
coupling reaction: i.e., the amide bond formation (Figure <xref rid="fig2" ref-type="fig">2</xref>, top; the &#x0201c;south-bridged&#x0201d; topology).
In this paper we report an alternative approach to the assembly of
photoprecursors&#x02014;via the ketone arm of the aromatic amino ketone
(Figure <xref rid="fig2" ref-type="fig">2</xref>, bottom; the &#x0201c;north-bridged&#x0201d;
topology). This alternative linking offers access to new topologically
unique polyheterocyclic core structures.</p><fig id="fig2" position="float"><label>Figure 2</label><caption><p>Original &#x0201c;south-bridged&#x0201d;
and new &#x0201c;north-bridged&#x0201d; topology.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jo-2014-019848_0010" id="gr15" position="float"/></fig></sec><sec id="sec2"><title>Results and Discussion</title><p>The departure from the original south-bridged
topology is realized by linking the unsaturated pendant and the azaxylylene
precursor through the &#x003b1; carbon of the carbonyl group (Figure <xref rid="fig2" ref-type="fig">2</xref>, north-bridged topology). Thus, this new scaffold
consists of a primary aromatic amine and an unsaturated pendant joined
through the &#x003b1; substitution in aminoacetophenone, which entails
differences in both stereo and electronic properties of the photoprecursors.
The synthetic route and the nature of the linker between the azaxylylene
precursor and the unsaturated pendant were deliberately chosen to
be attuned with a modular approach within the framework of diversity-oriented
synthesis.<sup><xref ref-type="bibr" rid="ref22">22</xref></sup> The implemented pathway to
the photoprecursors comprises two simple steps: aldol condensation
of the <italic>o-</italic>furyl aromatic (or &#x003b1;-furyl vinyl)
carboxaldehyde followed by the conjugate (Michael) addition of a nucleophile
to the obtained &#x003b1;,&#x003b2;-unsaturated ketone. The starting aldehyde
can be prepared by the Suzuki reaction of 2-furanboronic acid with
the corresponding <italic>o-</italic> or &#x003b2;-halogen-substituted
aromatic or vinyl aldehyde. Thus, a diverse library of compounds can
be accessed through the variation of the following building blocks
and pendants: the polycyclic aldehyde obtained via the Suzuki reaction,
the Michael nucleophile, and aromatic or &#x003b1; substitution in <italic>o</italic>-aminoacetophenone.</p><p>The initial synthetic studies
were conducted using <italic>o</italic>-bromobenzaldehyde (<bold>1</bold>) as a starting material (Scheme <xref rid="sch2" ref-type="scheme">2</xref>). The Suzuki
coupling with furanboronic acid <bold>2</bold>, catalyzed by 5 mol
% of PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, yielded aldehyde <bold>3</bold>(<xref ref-type="bibr" rid="ref23">23</xref>) (89%), which serves as the
carbonyl component in the subsequent aldol condensation<sup><xref ref-type="bibr" rid="ref24">24</xref></sup> with <italic>o</italic>-aminoacetophenone (<bold>4</bold>), giving chalcone <bold>5</bold>, a reactive Michael acceptor
for a variety of nucleophiles, including nitromethane,<sup><xref ref-type="bibr" rid="ref25">25</xref></sup> diethyl malonic ester,<sup><xref ref-type="bibr" rid="ref26">26</xref></sup> and phenylboronic acid,<sup><xref ref-type="bibr" rid="ref27">27</xref></sup> in a Pd<sup>0</sup>-catalyzed reaction. Thus, the photoprecursors <bold>6</bold>&#x02013;<bold>8</bold> are readily available in three simple steps
in moderate to good yields.</p><fig id="sch2" position="float"><label>Scheme 2</label><caption><title>Synthesis of the Initial Batch of
Photoprecursors</title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jo-2014-019848_0014" id="gr2" position="float"/></fig><p>Similarly, heterocyclic
analogues <bold>15</bold> and <bold>16</bold> were prepared, starting
the sequence with 2-bromonicotinaldehyde (<bold>9</bold>) or 2-formyl-3-bromothiophene
(<bold>10</bold>) (Scheme <xref rid="sch3" ref-type="scheme">3</xref>). In both of these
cases, nitromethane was used as a Michael nucleophile.</p><fig id="sch3" position="float"><label>Scheme 3</label><caption><title>Access
to Photoprecursors Containing Heterocyclic Moieties</title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jo-2014-019848_0015" id="gr3" position="float"/></fig><p>Further diversification of photoprecursors was
achieved by making use of vinyl carboxaldehydes <bold>20</bold>&#x02013;<bold>22</bold> as starting materials. These aldehydes are readily obtained
via a variation of the Vilsmeier&#x02013;Haack reaction<sup><xref ref-type="bibr" rid="ref28">28</xref></sup> from commercially available cyclic ketones on
a multigram scale, using DMF and PBr<sub>3</sub>. In these cases,
the developed synthetic sequence of Suzuki coupling, followed by aldol
condensation and conjugate addition to chalcone, gives the photoprecursors <bold>29</bold>&#x02013;<bold>31</bold> in good yields (Scheme <xref rid="sch4" ref-type="scheme">4</xref>).</p><fig id="sch4" position="float"><label>Scheme 4</label><caption><title>Synthesis of Alicyclic Derivatives</title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jo-2014-019848_0016" id="gr4" position="float"/></fig><p>The photoprecursors, obtained
as described above, have an (n,&#x003c0;*) UV absorption maximum around
350 nm. Methanol was the solvent of choice for irradiation after a
few solvent optimization runs. Irradiations were carried out with
a Rayonet broad-band 300&#x02013;400 nm UV source (RPR-3500 lamps).
Curiously, irradiation of the photoprecursors possessing the north-bridged
topology yielded exclusively the products of [4 + 4] addition: i.e.,
no [4 + 2] products were detected (Scheme <xref rid="sch5" ref-type="scheme">5</xref> and Table <xref rid="tbl1" ref-type="other">1</xref>).</p><fig id="sch5" position="float"><label>Scheme 5</label><caption><title>Intramolecular Cycloadditions of Photogenerated Azaxylylenes</title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jo-2014-019848_0017" id="gr5" position="float"/></fig><table-wrap id="tbl1" position="float"><label>Table 1</label><caption><title>Primary
Photoproducts from the &#x0201c;North-Bridged&#x0201d; Photoprecursors
and Their Acid-Catalyzed Rearrangement</title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jo-2014-019848_0005" id="fx1" position="float"/></table-wrap><p>The stereochemistry of the primary [4 + 4] photoproducts
was assigned on the basis of their NMR spectra and the X-ray structure
of <bold>34</bold>. We hypothesize that the [4 + 4] intramolecular
cycloaddition of the ESIPT-generated azaxylylene occurs via a transition
state (Figure <xref rid="fig3" ref-type="fig">3</xref>), in which the stereochemistry
of folding of the &#x003b1;-(nitromethyl)ethylphenyl tether to form
a six-membered ring is biased by the nitromethyl group assuming the
shown pseudoequatorial conformation. The alternative folding, with
the nitromethyl assuming a pseudoaxial conformation, leads to a severe
steric clash and therefore is not expected to be a feasible reaction
channel.</p><fig id="fig3" position="float"><label>Figure 3</label><caption><p>Nitromethyl moiety biasing the folding of the furanyl tether in the
transition state, leading to the [4 + 4] intramolecular cycloadducts.
The ORTEP structure of <bold>34</bold> is shown with 50% thermal ellipsoids.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jo-2014-019848_0011" id="gr16" position="float"/></fig><p>Another observation was that in
some cases primary photoproducts underwent a partial rearrangement,
similar to a carbohydrate transformation from a furanose to a pyranose
form. Further probing the stability of the primary photoproducts,
we subjected compound <bold>34</bold> to acidic conditions (1 vol
% of TFA in DCM), which resulted in a 100% conversion into the &#x0201c;pyranose&#x0201d;
form (Scheme <xref rid="sch6" ref-type="scheme">6</xref>). Presumably, such a rearrangement
is facilitated by the amino stabilization of the cation formed upon
the opening of the 2,5-dihydrofuran moiety. The initial step of it
is somewhat reminiscent of the rearrangement reported by Padwa and
co-workers,<sup><xref ref-type="bibr" rid="ref29">29</xref></sup> except that in our case the
transient cation is captured by the benzylic hydroxy group, leading
to the formation of the unprecedented oxazobicyclo[3.3.1]nonadiene
or oxamorphan substructure.</p><fig id="sch6" position="float"><label>Scheme 6</label><caption><title>Bicyclo[4.2.1] to [3.3.1] Rearrangement
and the ORTEP Structure of <bold>42</bold></title><p id="sch6-fn1">Shown with 50% thermal ellipsoids.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jo-2014-019848_0018" id="gr6" position="float"/></fig><p>This rearrangement
appears to be general for all the photoproducts in Table <xref rid="tbl1" ref-type="other">1</xref>. It proceeds smoothly upon the addition of a catalytic
amount of acid or simply upon heating of the reaction mixture in DMSO.
The structures of the rearranged products were supported by NMR data.
Additionally the structures of photoproduct <bold>34</bold> and rearranged
product <bold>40</bold> were unambiguously determined by X-ray analysis. <sup>1</sup>H NMR spectra of the rearranged products differ considerably
from the NMR spectra of nonrearranged compounds (Figure <xref rid="fig4" ref-type="fig">4</xref>). In compound <bold>34</bold> the vinyl protons appear as
a doublet and a doublet of doublets with a common spin&#x02013;spin
coupling constant of 5.6 Hz. After the rearrangement the vicinal coupling
constant of vinyl protons increases to 10.0 Hz, which is in keeping
with the proposed change in the molecule&#x02019;s geometry. The experimental
NMR data were supported by our <italic>relativistic force field</italic> computations of proton spin&#x02013;spin coupling constants,<sup><xref ref-type="bibr" rid="ref30">30</xref></sup> with the predicted constants, shown in Figure <xref rid="fig4" ref-type="fig">4</xref>, matching the experimental values very well.</p><fig id="fig4" position="float"><label>Figure 4</label><caption><p>Experimental
and calculated (in parentheses) proton spin&#x02013;spin coupling constants
(in Hz) for primary and rearranged products exemplified by compounds <bold>34</bold> and <bold>42</bold>.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jo-2014-019848_0012" id="gr17" position="float"/></fig><p>The only exception in this series was the rearrangement of
photoproduct <bold>49</bold>, derived from tetralone-based precursor <bold>48</bold>. The photoprecursor <bold>48</bold> was obtained as a mixture
of diastereomers. However, only one diastereomer of the photoproduct <bold>49</bold> is formed with an isolated yield of 27%. We hypothesize
that one of the diastereomers <bold>48</bold> is photoinactive due
to unfavorable folding of the tether in the transition state. We were
unable to obtain an X-ray structure of the photoproduct and could
not assign its stereochemistry on the basis of NMR data.</p><p>During
column chromatography compound <bold>49</bold> isomerized on silica
gel into the [4 + 2] product <bold>50</bold>. The structure of the
product was established on the basis of its <sup>1</sup>H NMR and
COSY spectra. Protons H<sub>a</sub>, H<sub>b</sub>, and H<sub>c</sub> (Scheme <xref rid="sch7" ref-type="scheme">7</xref>) of the primary photoproduct <bold>49</bold> are characterized by the set of spin&#x02013;spin coupling
constants typical of the series: 5.6 Hz for the vinylic H<sub>a</sub> and H<sub>b</sub> protons and 1.3 Hz for H<sub>b</sub> and H<sub>c</sub> (bridge). In contrast to both these experimental observations
and the spin&#x02013;spin coupling constants observed for other compounds
possessing the [4.2.1] scaffold, the rearranged product <bold>50</bold> exhibited a set of much smaller constants: vinyl <italic>J</italic><sub>ab</sub> = 2.4 Hz and <italic>J</italic><sub>ac</sub> = 0.9
Hz. Such a distinctive set of values has been observed earlier for
[4 + 2] azaxylylene cycloaddition products and is supported by our
calculations. A plausible mechanism for such 1,3-allylic migration
is presented in Scheme <xref rid="sch7" ref-type="scheme">7</xref> and involves protonation
of the amine, scission of the aminal C&#x02013;N bond (i.e., not C&#x02013;O
bond), and subsequent nucleophilic attack by aniline at C-3 of the
furan ring.</p><fig id="sch7" position="float"><label>Scheme 7</label><caption><title>Rearrangement of Tetralone-Derived <bold>49</bold></title><p id="sch7-fn1">Computed <italic>J</italic> values
are given in parentheses.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jo-2014-019848_0019" id="gr7" position="float"/></fig><p>This outlier notwithstanding,
the north-bridged anilines, lacking acyl substitution at the nitrogen
atom, exclusively undergo a photoinduced intramolecular [4 + 4] cycloaddition,
with subsequent heat- or acid-catalyzed [4.2.1] &#x02192; [3.3.1] rearrangement
yielding a polycyclic aminal possessing an oxamorphan core. We identified
a case in which this rearrangement occurs spontaneously during the
photolysis. Sulfide <bold>52,</bold> which is readily synthesized
via the substitution in &#x003b1;-bromo-2&#x02032;-nitroacetophenone <bold>51</bold> and a subsequent reduction of the nitro group with tin
chloride (Scheme <xref rid="sch8" ref-type="scheme">8</xref>) undergoes irradiation in
wet acetonitrile, yielding only the rearranged compound <bold>54</bold> as a single product. The [4 + 4] cycloadduct <bold>53</bold>, which
is a presumed intermediate, could not be isolated. While we do not
have an X-ray structure for <bold>54</bold>, the predicted NMR spectra
better match the syn stereochemical configuration of the hydroxy group.
The spontaneous [4.2.1] &#x02192; [3.3.1] rearrangement without added
acid also provides circumstantial evidence for the syn configuration.
As we show below, the anti photoproducts do not undergo this rearrangement
in the absence of acids.</p><fig id="sch8" position="float"><label>Scheme 8</label><caption><title>Spontaneous Post-Photochemical Rearrangement
in Sulfide <bold>52</bold></title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jo-2014-019848_0020" id="gr8" position="float"/></fig><p>The observed rearrangement into the pyranose form is clearly
facilitated by the fact that the aniline moiety is not acylated, resulting
in a more stable iminium ion (Scheme <xref rid="sch6" ref-type="scheme">6</xref>) as
the key intermediate in this rearrangement. Additional questions are
whether this lack of N-acylation (or further electron-donating alkyl
substitution on the nitrogen) possibly affects the [4 + 4] vs [4 +
2] partitioning of the primary photoproducts and also whether the
[4.2.1] &#x02192; [3.3.1] transformation is unique to the north-bridged
architecture of the photoprecursors.</p><p>We therefore revisited
the south-bridged structures, but instead of amide-forming coupling
of the furan pendant we explored reductive amination to furnish alkylated <italic>anilines</italic>, not <italic>anilides</italic>. First, we synthesized
the secondary amine <bold>57</bold>, through the sequence of reductive
amination of 3-furylpropanal (<bold>56</bold>) with 2-aminophenylmethanol
(<bold>55</bold>) and the oxidation of the benzylic alcohol with MnO<sub>2</sub> (Scheme <xref rid="sch9" ref-type="scheme">9</xref>).</p><fig id="sch9" position="float"><label>Scheme 9</label><caption><title>Typical Synthesis
of South-Bridged Alkylamines via Reductive Amination</title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jo-2014-019848_0021" id="gr9" position="float"/></fig><p>Similar to the case for the previously studied
amides, photoprecursor <bold>57</bold> has a UV absorption band in
the range 320&#x02013;350 nm. After screening the solvents methanol,
methanol&#x02013;water, acetonitrile, acetonitrile&#x02013;water, benzene,
and <italic>tert</italic>-butyl alcohol, we arrived at methanol as
the optimal medium for the initial photoinduced cycloaddition. Irradiation
of <bold>57</bold> with a Rayonet broad-band 300&#x02013;400 nm UV
source is accompanied by a spontaneous [4.2.1] &#x02192; [3.3.1] rearrangement,
yielding diastereomeric oxamorphans <bold>65a</bold> (OH is syn to
the bridge oxygen) and <bold>65b</bold> (anti) (Scheme <xref rid="sch10" ref-type="scheme">10</xref>). The structural assignment of the products was guided by
calculations of their proton spin&#x02013;spin coupling constants.
Both syn and anti products have a large vicinal coupling constant
between vinylic protons, <italic>J</italic><sub>cd</sub> = 9.8 Hz
(calculated 9.6 Hz) for the syn isomer and 10.0 Hz (calculated 9.9
Hz) for the anti isomer, indicative of oxabicyclo[3.3.1] scaffold
formation. There is, however, a significant difference in spin&#x02013;spin
coupling for the &#x003b1;-hydroxy proton H<sub>b</sub>: the syn isomer
has the large constant <italic>J</italic><sub>bc</sub><italic>=</italic> 5.2 Hz (calculated 5.1 Hz) and a small constant <italic>J</italic><sub>ab</sub> = 1.3 Hz (calculated 1.5 Hz); in contrast, the anti
isomer has a small constant <italic>J</italic><sub>bc</sub> = 1.7
Hz (calculated 2.0 Hz) and a large constant <italic>J</italic><sub>ab</sub> = 5.9 Hz (calculated 5.9 Hz). The near-perfect match of
the experimental and calculated spin&#x02013;spin coupling constants
leaves no doubt that the conversion of the primary photoproducts into
the 9-oxabicyclo[3.3.1]nonadiene compounds <bold>65a</bold>,<bold>b</bold> occurs spontaneously at room temperature in these amines.</p><fig id="sch10" position="float"><label>Scheme 10</label><caption><title>Irradiation of Alkylamine <bold>57</bold></title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jo-2014-019848_0001" id="gr10" position="float"/></fig><p>To test the scope of the reaction, additional secondary
amines were similarly synthesized. The reductive amination approach
is again amenable to the modular synthesis of photoprecursors, allowing
for access to diverse structures from various aldehydes and amines
used for the reductive amination. A heterocyclic (pyridine) moiety
was readily incorporated into photoprecursors <bold>60</bold> and <bold>63</bold>, synthesized with 2-amino-3-pyridinylmethanol. Upon irradiation
both produced the desired photoproducts, which is, to the best of
our knowledge, the first example of azaxylylene generation from heterocyclic
precursors.</p><p>The modular synthesis of photoprecursors benefits
from the fact that the aldehydes obtained via Suzuki coupling (Schemes <xref rid="sch2" ref-type="scheme">2</xref>&#x02013;<xref rid="sch4" ref-type="scheme">4</xref>) and utilized to
assemble the north-bridged precursors via aldol condensation can also
be used in the reductive amination synthetic sequence, as exemplified
by the south-bridged photoprecursors <bold>63</bold> and <bold>64</bold>. The matrix of synthesized photoprecursors and their respective
photoproducts is presented in Table <xref rid="tbl2" ref-type="other">2</xref>.</p><table-wrap id="tbl2" position="float"><label>Table 2</label><caption><title>South-Bridged Alkylamines<xref rid="t2fn1" ref-type="table-fn">a</xref></title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jo-2014-019848_0006" id="fx2" position="float"/><table-wrap-foot><fn id="t2fn1"><label>a</label><p>The asterisk indicates that the yields for synthesis
of photoprecursors <bold>57</bold>&#x02013;<bold>61</bold> and <bold>63</bold> are given over two steps: reductive amination and benzylic
alcohol oxidation.</p></fn></table-wrap-foot></table-wrap><p>As it
is evident from Table <xref rid="tbl2" ref-type="other">2</xref>, upon irradiation all
photoprecursors produced the rearranged oxabicyclo[3.3.1]nonadiene
core, supporting the mechanistic rationale that additional alkyl stabilization
of the transient iminium cation is needed for the spontaneous [4.2.1]
to [3.3.1] rearrangement. It should also be noted that, with the exception
of <bold>65</bold>, the only isolated stereoisomer was that with the
OH group syn to the bridge oxygen. In the case of the tetralone-derived
photoproduct <bold>70</bold>, the NMR-based structural assignment
was also supported by X-ray data. Introduction of halogen substitution
into the aromatic ring (<bold>58</bold>, <bold>59</bold>) accelerates
the photochemical step, which is in keeping with our prior observations.<sup><xref ref-type="bibr" rid="ref21">21</xref></sup> It also sets the product up for a subsequent
Suzuki coupling,<sup><xref ref-type="bibr" rid="ref31">31</xref></sup> allowing for another
diversity input in the resulting [3.3.1] scaffold. The presence of
the Me&#x02013;C* stereogenic center in the tether of photoprecursor <bold>61</bold> expectedly does not impose any diastereoselection in the
transition state of the primary photoinduced cycloaddition step and
leads to the formation of a 1:1 mixture of diastereomers (<bold>69a</bold>,<bold>b</bold>), which can be separated via column chromatography.
Diastereomers <bold>69a</bold>,<bold>b</bold> both have the same syn
configuration of the hydroxy group but differ in the stereoconfiguration
of the methyl group in the pyrroline moiety.</p><p>Indanone-derived <bold>73</bold> was the only photoprecursor which did not undergo spontaneous
[4.2.1] to [3.3.1] rearrangement. Instead, we observed dehydration
in the primary photoproduct <bold>74</bold> to yield indene <bold>75</bold> (Scheme <xref rid="sch11" ref-type="scheme">11</xref>). A plausible explanation
for this is that the [4.2.1] &#x02192; [3.3.1] rearrangement in this
case is less energetically favorable. This hypothesis is corroborated
by our DFT calculations, which predict that generally the rearranged
bicyclo[3.3.1]nonadienes are 7&#x02013;12 kcal/mol more stable than
the primary photoproducts possessing the bicyclo[4.2.1]nonadiene structure.
Even the tetralone-based <bold>70</bold> is 6.9 kcal/mol more stable
than its [4.2.1] precursor. However, in the indanone case the [4.2.1]
and the [3.3.1] structures are nearly (within 0.6 kcal/mol) energy
degenerate. An analysis of the experimental and predicted NMR spectra
of <bold>75</bold> does not leave any doubt of the correct structural
assignment. In the 5.0&#x02013;6.0 ppm region of the NMR spectrum of
the photoproduct, in addition to the two expected alkenyl protons
(<italic>J</italic><sub>exp</sub> = 5.6 Hz, <italic>J</italic><sub>calc</sub> = 5.5 Hz) and the allylic bridgehead proton (<italic>J</italic><sub>exp</sub> = 2.0, 1.2 Hz, <italic>J</italic><sub>calc</sub> =
2.0, 1.3 Hz), there is an additional triplet with <italic>J</italic><sub>exp</sub> = 2.2 Hz (calculated dd, <italic>J</italic><sub>calc</sub> = 2.4, 2.3 Hz), corresponding to the new vinyl proton of the indene
moiety.</p><fig id="sch11" position="float"><label>Scheme 11</label><caption><title>Spontaneous Dehydration of the Primary Photoproduct <bold>74</bold></title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jo-2014-019848_0002" id="gr11" position="float"/></fig><p>In the majority of
the cases, as follows from Table <xref rid="tbl2" ref-type="other">2</xref>, the photoinduced
cycloaddition is always followed by the spontaneous [4.2.1] &#x02192;
[3.3.1] rearrangement, which is clearly accelerated by the lack of
acyl substitution on nitrogen. While the acyl linker explored in our
previous work should indeed retard the rate of this rearrangement,
we hypothesized that such acyl substitution should not necessarily
affect the position of the equilibrium between [4.2.1] and [3.3.1].
Our DFT B3LYP/6-311+G(d,p) calculations indeed revealed that this
equilibrium has a very similar 7&#x02013;12 kcal/mol energy bias toward
the rearranged [3.3.1] products <italic>in the amido series</italic>. We therefore revisited the amide-derived photoproducts synthesized
earlier to test whether this rearrangement can be induced in the structures
with an electron-withdrawing acyl substituent on the nitrogen atom.
Indeed, we found that the heat- or acid-promoted [4.2.1] &#x02192;
[3.3.1] rearrangement in this series is possible as well (Scheme <xref rid="sch12" ref-type="scheme">12</xref>). Moreover, as is illustrated by the rearrangement
of the ketopiperazine <bold>82</bold>, the rearrangement is not limited
to three-atom tethers but occurs in photoproducts with four-atom linkers
as well.</p><fig id="sch12" position="float"><label>Scheme 12</label><caption><title>[4.2.1] &#x02192; [3.3.1] Rearrangement in Amides</title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jo-2014-019848_0003" id="gr12" position="float"/></fig><p>It is instructive that the
barrier for the [4.2.1] &#x02192; [3.3.1] transformation in the absence
of acid catalysis is much higher for anti photoproducts to a point
that, while <italic>syn</italic>-<bold>76</bold> photoproduct rearranges
in DMSO at 150 &#x000b0;C, there is no thermal reaction at all for the
anti photoproduct (Scheme <xref rid="sch13" ref-type="scheme">13</xref>).</p><fig id="sch13" position="float"><label>Scheme 13</label><caption><title>Thermal
Rearrangement: Anti vs Syn Reactivity</title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jo-2014-019848_0004" id="gr13" position="float"/></fig><p>The versatility of the [4.2.1] &#x02192; [3.3.1] transformation
in the syn photoproducts of the amido series is hard to underestimate.
On one hand, the initial photoproducts are very stable at temperatures
varying from ambient to 70&#x02013;80 &#x000b0;C. On the other, they undergo
a clean transformation in DMSO when heated to 140 &#x000b0;C, furnishing
the rearranged products with the oxamorphan core.</p></sec><sec sec-type="conclusions" id="sec3"><title>Conclusions</title><p>We have developed a versatile approach to the synthesis of bicyclic
1-benzoazocine structures of two distinct topologies. The method is
amenable to a straightforward modular synthesis of both south- and
north-bridged photoprecursors in three to four simple steps. Irradiation
of photoprecursors results in a significant growth of complexity,
giving a single primary photoproduct of the [4.2.1] oxabicyclic core
structure in the case of north-bridged primary amines and the [3.3.1]
oxabicyclic core structure as a result of spontaneous [4.2.1] &#x02192;
[3.3.1] rearrangement in the case of secondary amines. The [4.2.1]
&#x02192; [3.3.1] transformation can be achieved either by heat or
under acid catalysis. The generality of this rearrangement was demonstrated
using the <italic>amides</italic> of the same topology as secondary <italic>amines</italic>.</p></sec><sec id="sec4"><title>Experimental Section</title><p>Commercial solvents were used as is, except for THF, which was
refluxed over and distilled from potassium benzophenone ketyl prior
to use. Common reagents were purchased from commercial sources and
used without additional purification, unless indicated otherwise.
NMR spectra were recorded at 25 &#x000b0;C on a 500 MHz spectrometer
in CDCl<sub>3</sub> with TMS as an internal standard (unless noted
otherwise). Flash column chromatography was performed using 230&#x02013;400
mesh silica gel.</p><sec id="sec4.1"><title>Synthesis of Photoprecursors</title></sec><sec id="sec4.1.1"><title>General Procedure
for Vilsmeier&#x02013;Haack Reaction</title><p>To a solution of <italic>N</italic>,<italic>N</italic>-dimethylformamide (2.40 mL, 30.6 mmol)
in chloroform (20 mL) at 0 &#x000b0;C was added phosphorus tribromide
(2.60 mL, 27.5 mmol). After 30 min the reaction mixture was warmed
to room temperature and a solution of ketone (10.2 mmol) in chloroform
(10 mL) added. The reaction mixture was heated to reflux for 3 h then
cooled to room temperature and poured onto ice&#x02013;water (50 mL).
Solid sodium bicarbonate was added to neutralize the aqueous phase,
which was then separated and extracted with ether (3 &#x000d7; 75 mL).
The combined organic phases were washed with saturated NaHCO<sub>3</sub> (100 mL) and brine (100 mL), dried over MgSO<sub>4</sub>, and concentrated
in vacuo.<sup><xref ref-type="bibr" rid="ref28">28</xref></sup></p><sec id="sec4.1.1.1"><title>1-Bromo-2-formyl-1-cyclopentene<sup><xref ref-type="bibr" rid="ref32">32</xref></sup> (<bold>20</bold>)</title><p>Following the general
procedure for the Vilsmeier&#x02013;Haack reaction from 0.86 g (10.2
mmol) of cyclopentanone, 1.20 g (67%) of the title compound was obtained,
which was used without further purification. <sup>1</sup>H NMR (500
MHz, CDCl<sub>3</sub>): &#x003b4; 9.93 (s, 1H), 2.93 (m, 2H), 2.56 (m,
2H), 2.04 (m, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>):
&#x003b4; 189.3, 141.5, 140.0, 42.6, 29.3, 21.4.</p></sec><sec id="sec4.1.1.2"><title>1-Bromo-2-formyl-1-cyclohexene<sup><xref ref-type="bibr" rid="ref32">32</xref></sup> (<bold>21</bold>)</title><p>Following the general
procedure for the Vilsmeier&#x02013;Haack reaction from 1.00 g (10.2
mmol) of cyclohexanone, 1.08 g (56%) of the title compound was obtained,
which was used without further purification. <sup>1</sup>H NMR (500
MHz, CDCl<sub>3</sub>): &#x003b4; 10.05 (s, 1H), 2.77 (m, 2H), 2.30
(m, 2H), 1.79 (m, 2H), 1.71 (m, 2H). <sup>13</sup>C NMR (126 MHz,
CDCl<sub>3</sub>): &#x003b4; 193.8, 143.6, 135.3, 38.8, 25.0, 24.3,
21.1.</p></sec><sec id="sec4.1.1.3"><title>1-Bromo-2-formyl-1-cycloheptene<sup><xref ref-type="bibr" rid="ref33">33</xref></sup> (<bold>22</bold>)</title><p>Following the general procedure for the
Vilsmeier&#x02013;Haack reaction reaction from 1.34 g (10.2 mmol) of
cycloheptanone, 0.87 g (42%) of the title compound was obtained, which
was used without further purification. <sup>1</sup>H NMR (500 MHz,
CDCl<sub>3</sub>): &#x003b4; 9.95 (s, 1H), 3.04 (m, 2H), 2.52 (m, 2H),
1.82 (m, 2H), 1.69 (m, 2H), 1.48 (m, 2H). <sup>13</sup>C NMR (126
MHz, CDCl<sub>3</sub>): &#x003b4; 193.3, 148.3, 140.5, 44.3, 31.4, 25.7,
25.2, 24.8.</p></sec></sec><sec id="sec4.1.2"><title>General Procedure for Suzuki Coupling</title><p>Under a nitrogen atmosphere, &#x003b1;-formyl aryl (or cycloalkyl)
halide (10 mmol), arylboronic acid (12 mmol), K<sub>2</sub>CO<sub>3</sub> (30 mmol), and PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, (5 mol %, 350 mg) were suspended in DMF/H<sub>2</sub>O (15 mL/1.5
mL). The resulting solution was stirred at 110 &#x000b0;C until the completion
of the reaction. After it was cooled to room temperature, the resulting
mixture was filtered through a short path of silica gel. The filtrate
was then extracted several times with EtOAc/Et<sub>2</sub>O (1/1).
The combined organic layer was washed with brine (3 &#x000d7; 10 mL)
and dried over MgSO<sub>4</sub>. The reaction mixture was then concentrated
in vacuo, and the crude residue was purified by silica gel column
chromatography if necessary (petroleum ether/EtOAc) to afford the
coupling products.<sup><xref ref-type="bibr" rid="ref23">23</xref></sup></p><sec id="sec4.1.2.1"><title>2-(Furan-2-yl)cyclopent-1-enecarbaldehyde<sup><xref ref-type="bibr" rid="ref34">34</xref></sup> (<bold>23</bold>)</title><p>Following the general
procedure for Suzuki coupling from 2.40 g (13.71 mmol) of <bold>20</bold>, 1.20 g (54%) of the title compound was obtained. <sup>1</sup>H
NMR (500 MHz, CDCl<sub>3</sub>): &#x003b4; 10.61 (s, 1H), 7.60 (d, <italic>J</italic> = 1.6 Hz, 1H), 6.63 (d, <italic>J</italic> = 3.4 Hz, 1H),
6.53 (dd, <italic>J</italic> = 3.4, 1.8 Hz, 1H), 2.94 (m, 2H), 2.77
(m, 2H), 1.99 (p, <italic>J</italic> = 7.6 Hz, 2H). <sup>13</sup>C
NMR (126 MHz, CDCl<sub>3</sub>): &#x003b4; 191.2, 151.0, 145.3, 144.8,
137.4, 114.0, 111.8, 36.0, 31.1, 21.7.</p></sec><sec id="sec4.1.2.2"><title>2-(Furan-2-yl)cyclohex-1-enecarbaldehyde<sup><xref ref-type="bibr" rid="ref34">34</xref></sup> (<bold>24</bold>)</title><p>Following the general
procedure for Suzuki coupling from 1.20 g (6.34 mmol) of <bold>21</bold>, 0.83 g (74%) of the title compound was obtained. <sup>1</sup>H
NMR (500 MHz, CDCl<sub>3</sub>): &#x003b4; 10.14 (s, 1H), 7.55 (s, br,
1H), 6.54 (d, <italic>J</italic> = 3.3 Hz, 1H), 6.50 (m, 1H), 2.63
(m, 2H), 2.41 (m, 2H), 1.77 (m, 2H), 1.69 (m, 2H). <sup>13</sup>C
NMR (126 MHz, CDCl<sub>3</sub>): &#x003b4; 193.5, 151.9, 144.1, 143.8,
135.8, 113.1, 111.5, 29.19, 23.0, 22.1, 21.4.</p></sec><sec id="sec4.1.2.3"><title>2-(Furan-2-yl)cyclohept-1-enecarbaldehyde
(<bold>25</bold>)</title><p>Following the general procedure for Suzuki
coupling from 2.10 g (10.3 mmol) of <bold>22</bold>, 1.08 g (55%)
of the title compound was obtained. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): &#x003b4; 9.97 (s, 1H), 7.57 (dd, <italic>J</italic> = 1.8,
0.6 Hz, 1H), 6.55 (d, <italic>J</italic> = 3.4 Hz, 1H), 6.51 (dd, <italic>J</italic> = 3.4, 1.8 Hz, 1H), 2.81 (m, 2H), 2.65 (m, 2H), 1.85 (m,
2H), 1.70 (dt, <italic>J</italic> = 11.6, 6.1 Hz, 2H), 1.52 (p, <italic>J</italic> = 6.0 Hz, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): &#x003b4; 192.6, 151.9, 150.5, 144.7, 141.8, 114.8, 111.7, 33.9,
32.2, 26.0, 25.9, 25.3.</p></sec><sec id="sec4.1.2.4"><title>2-(Furan-2-yl)benzaldehyde<sup><xref ref-type="bibr" rid="ref35">35</xref></sup> (<bold>3</bold>)</title><p>Following the general procedure
for Suzuki coupling from 0.92 g (4.97 mmol) of 2-bromobenzaldehyde
(<bold>1</bold>), 0.76 g (89%) of the title compound was obtained. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): &#x003b4; 10.41 (s, 1H),
8.00 (m, 1H), 7.71 (m, 1H), 7.65 (m, 2H), 7.47 (m, 1H), 6.66 (m, 1H),
6.59 (dd, <italic>J</italic> = 3.4, 1.8 Hz, 1H). <sup>13</sup>C NMR
(126 MHz, CDCl<sub>3</sub>): &#x003b4; 192.4, 151.1, 144.0, 133.6, 133.4,
133.1, 128.4, 128.1, 128.0, 111.9, 111.3.</p></sec><sec id="sec4.1.2.5"><title>2-(Furan-2-yl)nicotinaldehyde<sup><xref ref-type="bibr" rid="ref36">36</xref></sup> (<bold>11</bold>)</title><p>Following the general
procedure for Suzuki coupling from 0.92 g (4.97 mmol) of nicontinaldehyde
(<bold>9</bold>), 0.52 g (60%) of the title compound was obtained. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): &#x003b4; 10.72 (d, <italic>J</italic> = 0.8 Hz, 1H), 8.82 (dd, <italic>J</italic> = 4.6, 1.8
Hz, 1H), 8.28 (dd, <italic>J</italic> = 7.9, 1.8 Hz, 1H), 7.71 (dd, <italic>J</italic> = 1.7, 0.8 Hz, 1H), 7.35 (m, 1H), 7.23 (dd, <italic>J</italic> = 3.5, 0.7 Hz, 1H), 6.66 (dd, <italic>J</italic> = 3.5, 1.8 Hz,
1H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): &#x003b4; 191.9,
153.4, 150.0, 152.6, 145.3, 136.2, 128.2, 122.3, 113.8, 112.4.</p></sec><sec id="sec4.1.2.6"><title>3-(Furan-2-yl)thiophene-2-carbaldehyde<sup><xref ref-type="bibr" rid="ref37">37</xref></sup> (<bold>12</bold>)</title><p>Following the general
procedure for Suzuki coupling from 1.00 g (5.23 mmol) of 3-bromo-thiophene-2-carbaldehyde
(<bold>10</bold>), 0.84 g (90%) of the title compound was obtained. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): &#x003b4; 10.50 (d, <italic>J</italic> = 1.2 Hz, 1H), 7.68 (dd, <italic>J</italic> = 5.1, 1.2
Hz, 1H), 7.60 (dd, <italic>J</italic> = 1.8, 0.7 Hz, 1H), 7.36 (m,
1H), 6.80 (dd, <italic>J</italic> = 3.4, 0.6 Hz, 1H), 6.57 (dd, <italic>J</italic> = 3.4, 1.8 Hz, 1H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): &#x003b4; 184.6, 149.7, 143.9, 137.4, 134.2, 128.5, 127.5,
112.0, 110.8.</p></sec></sec><sec id="sec4.1.3"><title>General Procedure for Aldol Condensation</title><sec id="sec50"><title>Procedure A.<sup><xref ref-type="bibr" rid="ref24">24</xref></sup></title><p>2&#x02032;-Aminoacetophenone (10 mmol, 1 equiv) was added to a solution
of the corresponding aldehyde (10 mmol, 1 equiv) in EtOH (10 mL) containing
NaOH (0.3 of a pellet), and the mixture was stirred at 5 &#x000b0;C for
8 h. The precipitate was filtered, washed with EtOH and then with
water, and finally dried under vacuum to yield a product pure enough
for subsequent transformations.</p></sec><sec id="sec4.1.4"><title>Procedure B.<sup><xref ref-type="bibr" rid="ref38">38</xref></sup></title><p>Ethanolic solutions (10 mL) of equimolar
amounts of 2&#x02032;-aminoacetophenone (2.8 mmol), the corresponding
aldehyde, and 20% aqueous NaOH (0.5 mL, 2.5 mmol) were heated to reflux
for 10&#x02013;20 min. After the mixture was cooled, the precipitate
was filtered off, washed with EtOH and then with water, and finally
dried under vacuum.</p></sec><sec id="sec4.1.4.1"><title>(<italic>E</italic>)-1-(2-Aminophenyl)-3-(2-(furan-2-yl)pyridin-3-yl)prop-2-en-1-one
(<bold>13</bold>)</title><p>Following the general procedure A for aldol
condensation from 0.35 g (2.02 mmol) of <bold>11</bold>, 0.38 g (65%)
of the title compound was obtained. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): &#x003b4; 8.70 (dd, <italic>J</italic> = 4.7, 1.6 Hz, 1H),
8.29 (d, <italic>J</italic> = 15.5 Hz, 1H), 8.01 (dd, <italic>J</italic> = 7.9, 1.3 Hz, 1H), 7.91 (d, <italic>J</italic> = 8.1 Hz, 1H), 7.69
(d, <italic>J</italic> = 1.1 Hz, 1H), 7.57 (d, <italic>J</italic> =
15.4 Hz, 1H), 7.34 (m, 1H), 7.30 (m, 1H), 6.97 (dd, <italic>J</italic> = 3.4, 0.6 Hz, 1H), 6.74 (m, 2H), 6.60 (dd, <italic>J</italic> =
3.4, 1.8 Hz, 1H), 6.42 (s, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): &#x003b4; 191.2, 152.2, 151.2, 150.1, 144.3, 140.2, 135.6,
134.6, 132.1, 131.1, 128.5, 126.7, 122.0, 118.6, 117.4, 115.9, 113.5,
112.0.</p></sec><sec id="sec4.1.4.2"><title>(<italic>E</italic>)-1-(2-Aminophenyl)-3-(3-(furan-2-yl)thiophen-2-yl)prop-2-en-1-one
(<bold>14</bold>)</title><p>Following the general procedure B for aldol
condensation from 0.36 g (2.02 mmol) of <bold>12</bold>, 0.40 g (67%)
of the title compound was obtained. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): &#x003b4; 8.48 (dd, <italic>J</italic> = 15.1, 0.8, 1H),
7.88 (dd, <italic>J</italic> = 8.1, 1.3 Hz, 1H), 7.58 (dd, <italic>J</italic> = 1.8, 0.7 Hz, 1H), 7.49 (d, <italic>J</italic> = 15.2
Hz, 1H), 7.35 (dd, <italic>J</italic> = 5.3, 0.7 Hz, 1H), 7.31 (m,
1H), 7.30 (d, <italic>J</italic> = 5.3 Hz, 1H), 6.73 (m, 2H), 6.65
(dd, <italic>J</italic> = 3.4, 0.6 Hz, 1H), 6.53 (dd, <italic>J</italic> = 3.4, 1.8 Hz, 1H), 6.37 (s, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): &#x003b4; 190.9, 151.0, 150.2, 142.8, 135.1, 134.4, 134.3,
133.8, 130.9, 127.8, 126.9, 123.0, 119.1, 117.3, 115.9, 111.6, 109.3.</p></sec><sec id="sec4.1.4.3"><title>(<italic>E</italic>)-1-(2-Aminophenyl)-3-(2-(furan-2-yl)phenyl)prop-2-en-1-one
(<bold>5</bold>)</title><p>Following the general procedure A for aldol
condensation from 0.24 g (1.39 mmol) of <bold>3</bold>, 0.29 g (72%)
of the title compound was obtained. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): &#x003b4; 8.19 (d, <italic>J</italic> = 15.4 Hz, 1H), 7.92
(dd, <italic>J</italic> = 8.4, 1.4 Hz, 1H), 7.76 (dd, <italic>J</italic> = 7.9, 1.1 Hz, 1H), 7.74 (d, <italic>J</italic> = 7.8 Hz, 1H), 7.59
(m, 1H), 7.57 (d, <italic>J</italic> = 15.5 Hz, 1H), 7.48 (td, <italic>J</italic> = 7.6, 1.3 Hz, 1H), 7.39 (m, 1H), 7.31 (m, 1H), 6.73 (m,
2H), 6.56 (m, 2H), 6.39 (s, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): &#x003b4; 191.6, 152.0, 151.1, 142.9, 142.2, 134.4, 133.0,
131.1, 131.1, 129.6, 127.8, 127.7, 127.6, 125.1, 119.0, 117.3, 115.9,
111.9, 111.0.</p></sec><sec id="sec4.1.4.4"><title>(<italic>E</italic>)-1-(2-Aminophenyl)-3-(2-(furan-2-yl)cyclohex-1-en-1-yl)prop-2-en-1-one
(<bold>27</bold>)</title><p>Following the general procedure A for aldol
condensation from 0.80 g (4.54 mmol) of <bold>24</bold>, 0.45 g (34%)
of the title compound was obtained. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): &#x003b4; 8.24 (d, <italic>J</italic> = 15.3 Hz, 1H), 7.84
(m, 1H), 7.52 (dd, <italic>J</italic> = 1.7, 0.6 Hz, 1H), 7.28 (m,
1H), 7.14 (d, <italic>J</italic> = 15.3 Hz, 1H), 6.70 (m, 2H), 6.47
(dd, <italic>J</italic> = 3.4, 1.8 Hz, 1H), 6.44 (d, <italic>J</italic> = 3.3 Hz, 1H), 6.30 (m, 2H), 2.61 (m, 2H), 2.50 (m, 2H), 1.78 (m,
4H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): &#x003b4; 192.6,
153.8, 150.7, 143.2, 142.7, 134.7, 133.9, 131.0, 130.9, 121.8, 119.6,
117.2, 115.7, 111.5, 111.3, 29.1, 26.5, 22.3, 22.2.</p></sec><sec id="sec4.1.4.5"><title>(<italic>E</italic>)-1-(2-Aminophenyl)-3-(2-(furan-2-yl)cyclopent-1-en-1-yl)prop-2-en-1-one
(<bold>26</bold>)</title><p>Following the general procedure B for aldol
condensation from 1.20 g (7.39 mmol) of <bold>23</bold>, 0.75 g (37%)
of the title compound was obtained. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): &#x003b4; 8.53 (d, <italic>J</italic> = 15.2 Hz, 1H), 7.84
(dd, <italic>J</italic> = 8.4, 1.4 Hz, 1H), 7.59 (d, <italic>J</italic> = 1.3 Hz, 1H), 7.29 (m, 1H), 7.04 (d, <italic>J</italic> = 15.2
Hz, 1H), 6.70 (m, 2H), 6.48 (d, <italic>J</italic> = 3.3 Hz, 1H),
6.47 (dd, <italic>J</italic> = 3.4, 1.8 Hz, 1H), 6.34 (s, 2H), 2.88
(m, 2H), 2.82 (m, 2H), 2.06 (m, 2H). <sup>13</sup>C NMR (126 MHz,
CDCl<sub>3</sub>): &#x003b4; 192.3, 152.3, 150.8, 143.7, 138.5, 136.3,
134.2, 133.9, 131.0, 124.5, 119.5, 117.2, 115.8, 111.3, 111.2, 35.6,
33.7, 21.9.</p></sec><sec id="sec4.1.4.6"><title>(<italic>E</italic>)-1-(2-Aminophenyl)-3-(2-(furan-2-yl)cyclohept-1-en-1-yl)prop-2-en-1-one
(<bold>28</bold>)</title><p>Following the general procedure A for aldol
condensation from 0.76 g (3.99 mmol) of <bold>25</bold>, 0.47 g (38%)
of the title compound was obtained. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): &#x003b4; 8.16 (d, <italic>J</italic> = 15.2 Hz, 1H), 7.84
(m, 1H), 7.52 (dd, <italic>J</italic> = 1.8, 0.6 Hz, 1H), 7.28 (m,
1H), 7.17 (d, <italic>J</italic> = 15.2 Hz, 1H), 6.71 (m, 2H), 6.48
(dd, <italic>J</italic> = 3.4, 1.8 Hz, 1H), 6.42 (m, 1H), 6.28 (s,
2H), 2.79 (m, 2H), 2.68 (m, 2H), 1.86 (h, <italic>J</italic> = 7.5,
6.7 Hz, 2H), 1.65 (dq, <italic>J</italic> = 17.1, 5.8 Hz, 4H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): &#x003b4; 192.7, 154.0,
150.7, 143.7, 142.8, 140.6, 137.8, 133.9, 130.9, 122.0, 119.7, 117.2,
115.8, 112.6, 111.5, 32.8, 32.0, 29.9, 26.3, 25.9.</p></sec><sec id="sec4.1.4.7"><title>(<italic>E</italic>)-8-Amino-2-(2-(furan-2-yl)benzylidene)-3,4-dihydronaphthalen-1(2<italic>H</italic>)-one</title><p>Following the general procedure A for aldol
condensation from 0.34 g (1.97 mmol) of <bold>3</bold>, 0.26 g (42%)
of the title compound was obtained. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): &#x003b4; 7.89 (m, 2H), 7.53 (dd, <italic>J</italic> = 1.8,
0.7 Hz, 1H), 7.44 (m, 1H), 7.33 (m, 2H), 7.22 (dd, <italic>J</italic> = 8.3, 7.3 Hz, 1H), 6.63 (s, 2H), 6.58 (d, <italic>J</italic> =
8.3 Hz, 1H), 6.54 (dd, <italic>J</italic> = 3.4, 0.7 Hz, 1H), 6.49
(m, 2H), 2.92 (m, 2H), 2.87 (m, 2H). <sup>13</sup>C NMR (126 MHz,
CDCl<sub>3</sub>): &#x003b4; 190.2, 152.1, 151.8, 145.0, 142.3, 137.1,
135.3, 134.5, 132.7, 130.6, 129.7, 128.3, 126.8, 126.4, 115.9, 115.6,
115.0, 111.9, 110.8, 30.4, 27.1.</p></sec></sec><sec id="sec4.1.5"><title>Procedure for Addition
of Phenyl Boronic Acid to Enones.<sup><xref ref-type="bibr" rid="ref27">27</xref></sup></title><p>Enone (1.0 mmol), arylboronic acid (2.0 mmol), Pd<sub>2</sub>(dba)<sub>3</sub> (5 mol %, 0.05 mmol), PPh<sub>3</sub> (10 mol %, 0.10 mmol),
Cs<sub>2</sub>CO<sub>3</sub> (1.0 mmol, 0.32 g), and CHCl<sub>3</sub> (0.01 mL) in toluene (2 mL) were heated to 80 &#x000b0;C for 24 h.
The mixture was concentrated and purified via chromatography.</p><sec id="sec4.1.5.1"><title>1-(2-Aminophenyl)-3-(2-(furan-2-yl)phenyl)-3-phenylpropan-1-one
(<bold>6</bold>)</title><p>Following the procedure for addition of
boronic acids from 0.27 g (0.93 mmol) of <bold>5</bold>, 0.18 g (53%)
of the title compound was obtained. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): &#x003b4; 7.81 (dd, <italic>J</italic> = 8.4, 1.4 Hz, 1H),
7.61&#x02013;7.55 (m, 1H), 7.54&#x02013;7.49 (m, 1H), 7.31&#x02013;7.23
(m, 6H), 7.18 (dd, <italic>J</italic> = 13.1, 7.1 Hz, 3H), 6.69&#x02013;6.61
(m, 2H), 6.52&#x02013;6.43 (m, 2H), 6.19 (s, 2H), 5.42 (dd, <italic>J</italic> = 8.2, 6.4 Hz, 1H), 3.82 (dd, <italic>J</italic> = 17.1,
8.4 Hz, 1H), 3.65 (dd, <italic>J</italic> = 17.1, 6.2 Hz, 1H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): &#x003b4; 199.7, 153.4,
150.4, 144.0, 142.2, 142.1, 134.2, 130.9, 130.5, 129.4, 128.4, 128.3,
128.3, 127.9, 126.3, 126.1, 118.0, 117.3, 115.7, 111.2, 108.8, 45.3,
41.8. HRMS (ESI): calcd for C<sub>25</sub>H<sub>22</sub>NO<sub>2</sub><sup>+</sup> (MH<sup>+</sup>) 368.1645, found 368.1650.</p></sec></sec><sec id="sec4.1.6"><title>Procedure
for Addition of Diethyl Malonate.<sup><xref ref-type="bibr" rid="ref26">26</xref></sup></title><p>To a solution of 1 mmol of chalcone and 5 mL of diethyl malonate
in 25 mL of ethanol was added 0.25 g of sodium in 2.5 mL of ethanol,
the mixture was refluxed for 2 h, quenched with NH<sub>4</sub>Cl,
and extracted with ether, and the extract was dried over Na<sub>2</sub>SO<sub>4</sub>, concentrated, and chromatographed.</p><sec id="sec4.1.6.1"><title>Diethyl
2-(3-(2-Aminophenyl)-1-(2-(furan-2-yl)phenyl)-3-oxopropyl)malonate
(<bold>7</bold>)</title><p>Following the procedure for addition of
diethyl malonate from 0.30 g (1.03 mmol) of <bold>5</bold>, 0.27 g
(58%) of the title compound was obtained. <sup>1</sup>H NMR (500 MHz,
CDCl<sub>3</sub>): &#x003b4; 7.80 (dd, <italic>J</italic> = 8.1, 1.2
Hz, 1H), 7.51 (dd, <italic>J</italic> = 7.4, 1.7 Hz, 1H), 7.45 (m,
1H), 7.40 (m, 1H), 7.25 (m, 3H), 6.69 (d, <italic>J</italic> = 3.3
Hz, 1H), 6.62 (m, 1H), 6.59 (d, <italic>J</italic> = 8.3 Hz, 1H),
6.47 (dd, <italic>J</italic> = 3.3, 1.8 Hz, 1H), 6.13 (s, 2H), 4.83
(td, <italic>J</italic> = 8.6, 5.2 Hz, 1H), 4.18 (dq, <italic>J</italic> = 10.7, 7.1 Hz, 1H), 4.13 (dq, <italic>J</italic> = 10.8, 7.5, 7.0
Hz, 1H), 4.00 (m, 2H), 3.94 (d, <italic>J</italic> = 8.6 Hz, 1H),
3.60 (dd, <italic>J</italic> = 16.2, 5.2 Hz, 1H), 3.48 (dd, <italic>J</italic> = 16.2, 8.6 Hz, 1H), 1.20 (t, <italic>J</italic> = 7.1
Hz, 3H), 1.04 (t, <italic>J</italic> = 7.1 Hz, 3H). <sup>13</sup>C
NMR (126 MHz, CDCl<sub>3</sub>): &#x003b4; 199.7, 168.5, 168.0, 153.1,
150.3, 142.1, 138.5, 134.1, 131.2, 130.9, 129.4, 128.1, 127.5, 126.9,
117.9, 117.1, 115.7, 111.3, 108.9, 61.4, 61.3, 57.0, 42.7, 36.7, 13.9,
13.7. HRMS (ESI): calcd for C<sub>26</sub>H<sub>27</sub>LiNO<sub>6</sub><sup>+</sup> (MLi<sup>+</sup>) 456.1993, found 456.2001.</p></sec></sec><sec id="sec4.1.7"><title>Procedure for Addition of Nitromethane</title><sec id="sec60"><title>Procedure C.<sup><xref ref-type="bibr" rid="cit25a">25a</xref></sup></title><p>A mixture of
chalcone (0.3 mmol) and nitromethane (1.5 mmol) in DMSO (1 mL) in
the presence of MS 4 &#x000c5; (100 mg) was stirred at room temperature
under an argon atmosphere. After 12 h, the reaction mixture was quenched
with a phosphate buffer (pH 7, 20 mL). The organic materials were
extracted with ethyl acetate and dried over anhydrous MgSO<sub>4</sub>. If necessary, the product was purified with flash chromatography.</p></sec><sec id="sec4.1.8"><title>Procedure D.<sup><xref ref-type="bibr" rid="cit25b">25b</xref></sup></title><p>To a mixture
of chalcone (0.3 mmol) and nitromethane (1 mL) in DMSO (5 mL) was
added 0.3 mmol of tBuOK. After 12 h at room temperature the reaction
mixture was quenched with saturated aqueous NH<sub>4</sub>Cl. The
organic materials were extracted with ethyl acetate and dried over
anhydrous MgSO<sub>4</sub>. If necessary, the product was purified
with flash chromatography.</p></sec><sec id="sec4.1.8.1"><title>1-(2-Aminophenyl)-3-(2-(furan-2-yl)phenyl)-4-nitrobutan-1-one
(<bold>8</bold>)</title><p>Following general procedure C for addition
of nitromethane from 0.10 g (0.35 mmol) of <bold>5</bold>, 0.05 g
(43%) of the title compound was obtained. <sup>1</sup>H NMR (500 MHz,
CDCl<sub>3</sub>): &#x003b4; 7.69 (dd, <italic>J</italic> = 8.1, 1.3
Hz, 1H), 7.56 (m, 2H), 7.36 (m, 4H), 6.65 (m, 3H), 6.55 (dd, <italic>J</italic> = 3.3, 1.9 Hz, 1H), 6.25 (s, 2H), 4.81 (m, 3H), 3.51 (dd, <italic>J</italic> = 17.3, 5.1 Hz, 1H), 3.39 (dd, <italic>J</italic> = 17.3,
8.0 Hz, 1H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): &#x003b4;
198.8, 153.1, 150.5, 142.6, 137.1, 134.7, 130.8, 130.8, 130.1, 128.8,
127.6, 126.7, 117.4, 117.4, 115.9, 111.5, 109.0, 79.0, 42.0, 35.8.
HRMS (ESI): calcd for C<sub>20</sub>H<sub>19</sub>N<sub>2</sub>O<sub>4</sub><sup>+</sup> (MH<sup>+</sup>) 351.1339, found 351.1343.</p></sec><sec id="sec4.1.8.2"><title>1-(2-Aminophenyl)-3-(2-(furan-2-yl)cyclopent-1-en-1-yl)-4-nitrobutan-1-one
(<bold>29</bold>)</title><p>Following general procedure D for addition
of nitromethane from 0.74 g (2.65 mmol) of <bold>26</bold>, 0.70 g
(77%) of the title compound was obtained. <sup>1</sup>H NMR (500 MHz,
CDCl<sub>3</sub>): &#x003b4; 7.73 (m, 1H), 7.42 (m, 1H), 7.28 (m, 1H),
6.66 (m, 2H), 6.41 (dd, <italic>J</italic> = 3.3, 1.8 Hz, 1H), 6.29
(m, 3H), 4.79 (m, 1H), 4.73 (dd, <italic>J</italic> = 11.7, 6.2 Hz,
1H), 4.62 (dd, <italic>J</italic> = 11.7, 8.1 Hz, 1H), 3.28 (dd, <italic>J</italic> = 16.5, 6.1 Hz, 1H), 3.22 (dd, <italic>J</italic> = 16.5,
7.8 Hz, 1H), 2.70 (m, 2H), 2.56 (m, 2H), 1.93 (m, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): &#x003b4; 199.5, 151.8, 150.5, 141.9,
134.8, 134.6, 131.0, 128.4, 117.5, 117.4, 115.8, 110.9, 108.5, 78.0,
40.0, 34.7, 34.4, 33.8, 22.0. HRMS (ESI): calcd for C<sub>19</sub>H<sub>21</sub>N<sub>2</sub>O<sub>4</sub><sup>+</sup> (MH<sup>+</sup>) 341.1496, found 341.1497.</p></sec><sec id="sec4.1.8.3"><title>1-(2-Aminophenyl)-3-(2-(furan-2-yl)cyclohex-1-en-1-yl)-4-nitrobutan-1-one
(<bold>30</bold>)</title><p>Following general procedure D for addition
of nitromethane from 0.43 g (1.47 mmol) of <bold>27</bold>, 0.42 g
(81%) of the title compound was obtained. <sup>1</sup>H NMR (500 MHz,
CDCl<sub>3</sub>): &#x003b4; 7.69 (dd, <italic>J</italic> = 8.2, 1.3
Hz, 1H), 7.35 (m, 1H), 7.27 (m, 1H), 6.65 (m, 2H), 6.38 (dd, <italic>J</italic> = 3.3, 1.8 Hz, 1H), 6.29 (m, 3H), 4.61 (m, 3H), 3.24 (dd, <italic>J</italic> = 16.3, 4.9 Hz, 1H), 3.11 (dd, <italic>J</italic> = 16.2,
7.8 Hz, 1H), 2.35 (m, 2H), 2.17 (m, 2H), 1.67 (m, 4H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): &#x003b4; 199.5, 154.2, 150.5, 141.2,
134.6, 132.5, 131.0, 126.4, 117.5, 117.4, 115.8, 110.7, 107.8, 77.5,
40.0, 37.8, 29.3, 25.6, 22.4, 22.4. HRMS (ESI): calcd for C<sub>20</sub>H<sub>23</sub>N<sub>2</sub>O<sub>4</sub><sup>+</sup> (MH<sup>+</sup>) 355.1652, found 355.1653.</p></sec><sec id="sec4.1.8.4"><title>1-(2-Aminophenyl)-3-(2-(furan-2-yl)cyclohept-1-en-1-yl)-4-nitrobutan-1-one
(<bold>31</bold>)</title><p>Following the general procedure D for nitromethane
addition from 0.20 g (0.65 mmol) of <bold>28</bold>, 0.18 g (75%)
of the title compound was obtained. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): &#x003b4; 7.66 (dd, <italic>J</italic> = 8.2, 1.4, 1H), 7.34
(dd, <italic>J</italic> = 1.8, 0.7, 1H), 7.29 (m, 1H), 6.66 (dd, <italic>J</italic> = 8.3, 0.9 Hz, 1H), 6.63 (ddd, <italic>J</italic> = 8.2,
7.1, 1.1 Hz, 1H), 6.38 (dd, <italic>J</italic> = 3.3, 1.8, Hz 1H),
6.27 (s, 2H), 6.24 (dd, <italic>J</italic> = 3.3, 0.7 Hz, 1H), 4.57
(m, 3H), 3.18 (dd, <italic>J</italic> = 16.0, 4.9 Hz, 1H), 3.06 (dd, <italic>J</italic> = 16.0, 8.3 Hz, 1H), 2.51 (m, 2H), 2.37 (m, 2H), 1.81
(m, 2H), 1.57 (m, 4H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): &#x003b4; 199.4, 154.6, 150.6, 141.3, 138.3, 134.6, 133.5, 130.9,
117.4, 117.4, 115.8, 110.7, 107.9, 77.5, 39.9, 38.8, 33.7, 32.2, 29.2,
26.6, 26.1. HRMS (ESI): calcd for C<sub>21</sub>H<sub>25</sub>N<sub>2</sub>O<sub>4</sub><sup>+</sup> (MH<sup>+</sup>) 369.1809, found
369.1811.</p></sec><sec id="sec4.1.8.5"><title>1-(2-Aminophenyl)-3-(3-(furan-2-yl)thiophen-2-yl)-4-nitrobutan-1-one
(<bold>16</bold>)</title><p>Following general procedure C for nitromethane
addition from 0.35 g (1.19 mmol) of <bold>14</bold>, 0.28 g (66%)
of the title compound was obtained. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): &#x003b4; 7.73 (dd, <italic>J</italic> = 8.4, 1.4 Hz, 1H),
7.51 (dd, <italic>J</italic> = 1.8, 0.6 Hz, 1H), 7.31 (m, 1H), 7.23
(m, 2H), 6.67 (m, 2H), 6.61 (dd, <italic>J</italic> = 3.4, 0.6 Hz,
1H), 6.52 (dd, <italic>J</italic> = 3.4, 1.8 Hz, 1H), 6.28 (s, 2H),
5.16 (m, 1H), 4.88 (dd, <italic>J</italic> = 12.7, 6.8 Hz, 1H), 4.80
(dd, <italic>J</italic> = 12.7, 6.9 Hz, 1H), 3.59 (dd, <italic>J</italic> = 17.4, 6.2 Hz, 1H), 3.52 (dd, <italic>J</italic> = 17.4, 7.6 Hz,
1H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): &#x003b4; 198.1,
150.6, 150.2, 141.9, 136.7, 134.8, 130.8, 129.2, 127.5, 123.7, 117.5,
117.4, 115.9, 111.4, 107.3, 79.5, 42.6, 33.9. HRMS (ESI): calcd for
C<sub>18</sub>H<sub>17</sub>N<sub>2</sub>O<sub>4</sub>S<sup>+</sup> (MH<sup>+</sup>) 357.0904, found 357.0903.</p></sec><sec id="sec4.1.8.6"><title>1-(2-Aminophenyl)-3-(2-(furan-2-yl)pyridin-3-yl)-4-nitrobutan-1-one
(<bold>15</bold>)</title><p>Following general procedure C for addition
of nitromethane from 0.35 g (1.21 mmol) of <bold>13</bold>, 0.16 g
(38%) of the title compound was obtained. <sup>1</sup>H NMR (500 MHz,
CDCl<sub>3</sub>): &#x003b4; 8.59 (dd, <italic>J</italic> = 4.6, 1.5
Hz, 1H), 7.70 (m, 2H), 7.60 (m, 1H), 7.31 (m, 1H), 7.23 (dd, <italic>J</italic> = 8.0, 4.6 Hz, 1H), 7.14 (d, <italic>J</italic> = 3.4
Hz, 1H), 6.66 (m, 2H), 6.61 (dd, <italic>J</italic> = 3.4, 1.8 Hz,
1H), 6.26 (s, 2H), 5.09 (m, 1H), 4.91 (dd, <italic>J</italic> = 12.9,
6.4 Hz, 1H), 4.87 (dd, <italic>J</italic> = 12.9, 7.1 Hz, 1H), 3.54
(dd, <italic>J</italic> = 17.4, 6.1 Hz, 1H), 3.49 (dd, <italic>J</italic> = 17.4, 7.9 Hz, 1H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): &#x003b4; 198.3, 153.5, 150.6, 148.4, 148.0, 143.6, 135.2, 134.8,
131.6, 130.7, 122.4, 117.5, 117.3, 115.9, 112.0, 111.9, 78.6, 41.2,
34.7. HRMS (ESI): calcd for C<sub>19</sub>H<sub>18</sub>N<sub>3</sub>O<sub>4</sub><sup>+</sup> (MH<sup>+</sup>) 352.1297, found 352.1299.</p></sec><sec id="sec4.1.8.7"><title>8-Amino-2-(1-(2-(furan-2-yl)phenyl)-2-nitroethyl)-3,4-dihydronaphthalen-1(2H)-one
(<bold>48</bold>)</title><p>Following general procedure D for addition
of nitromethane from 0.24 g (0.76 mmol) of (<italic>E</italic>)-1-(2-aminophenyl)-3-(2-(furan-2-yl)phenyl)prop-2-en-1-one,
0.11 g (38%) of the title compound was obtained as a mixture of diastereomers
that could not be separated. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): &#x003b4; 7.52 (m, 2H), 7.43 (d, <italic>J</italic> = 3.8
Hz, 2H), 7.36 (m, 1H), 7.17 (m, 1H), 6.59 (d, <italic>J</italic> =
3.3 Hz, 1H), 6.51 (m, 2H), 6.40 (m, 3H), 5.23 (m, 1H), 4.88 (dd, <italic>J</italic> = 13.1, 9.4 Hz, 1H), 4.56 (td, <italic>J</italic> = 9.7,
4.6 Hz, 1H), 2.76 (m, 1H), 2.69 (m, 2H), 1.80 (m, 1H), 1.64 (dtd, <italic>J</italic> = 13.6, 8.2, 5.1 Hz, 1H). HRMS (ESI): calcd for C<sub>22</sub>H<sub>21</sub>N<sub>2</sub>O<sub>4</sub><sup>+</sup> (MH<sup>+</sup>) 377.1496, found 377.1494.</p></sec></sec><sec id="sec4.1.9"><title>General Procedure for Reductive
Amination</title><p>To a solution of substituted aniline (1 mmol) in
MeOH (10 mL) at 0 &#x000b0;C was added NaOAc (2 equiv), glacial acetic
acid (4 equiv), the corresponding aldehyde (1.5 equiv), and NaCNBH<sub>3</sub> (1.1 equiv). The solution was warmed slowly to room temperature
over 1 h. The mixture was then filtered through a plug of silica gel
and washed with 1% glacial acetic acid in ethyl acetate. The solution
was then washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>),
and concentrated to afford the crude material, which was then purified
with flash chromatography.</p></sec><sec id="sec4.1.10"><title>General Procedure for Oxidation
with MnO<sub>2</sub></title><p>Benzylic alcohol (1 equiv) was dissolved
in DCM, 7 equiv of MnO<sub>2</sub> was added, and the mixture was
stirred overnight and then filtered through a plug of Celite, concentrated,
and purified using flash chromatography.</p><sec id="sec4.1.10.1"><title>2-((3-(Furan-2-yl)propyl)amino)benzaldehyde
(<bold>57</bold>)</title><p>(1) (2-((3-(Furan-2-yl)propyl)amino)phenyl)methanol
was prepared following the general procedure for reductive amination
from 0.60 g (4.46 mmol) of 2-aminophenylmethanol with a yield of 0.78
g (73%) and used without further purification in the next step. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): &#x003b4; 7.35 (dd, <italic>J</italic> = 1.8, 0.8 Hz, 1H), 7.25 (td, <italic>J</italic> = 7.9,
1.6 Hz, 1H), 7.09 (dd, <italic>J</italic> = 7.6, 1.6 Hz, 1H), 6.68
(m, 2H), 6.32 (dd, <italic>J</italic> = 3.1, 1.9 Hz, 1H), 6.05 (m,
1H), 4.68 (s, 2H), 3.24 (t, <italic>J</italic> = 7.0 Hz, 2H), 2.80
(t, <italic>J</italic> = 7.4 Hz, 2H), 2.04 (p, <italic>J</italic> =
7.2 Hz, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): &#x003b4;
155.4, 147.6, 141.0, 129.7, 129.2, 124.2, 116.3, 110.6, 110.2, 105.1,
64.9, 42.8, 27.7, 25.6.</p><p>(2) Following the general procedure
for benzylic alcohol oxidation from 0.78 g (3.37 mmol) of (2-((3-(furan-2-yl)propyl)amino)phenyl)methanol,
0.51 g (66%) of the title compound was obtained. <sup>1</sup>H NMR
(500 MHz, CDCl<sub>3</sub>): &#x003b4; 9.84 (s, 1H), 8.40 (s, 1H), 7.49
(d, <italic>J</italic> = 7.6 Hz, 1H), 7.41 (t, <italic>J</italic> =
7.8 Hz, 1H), 7.35 (s, 1H), 6.70 (m, 2H), 6.32 (s, 1H), 6.06 (m, 1H),
3.31 (m, 2H), 2.79 (t, <italic>J</italic> = 7.4 Hz, 2H), 2.06 (p, <italic>J</italic> = 7.2 Hz, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): &#x003b4; 193.9, 155.0, 150.7, 141.1, 136.7, 135.8, 118.4, 114.8,
110.8, 110.2, 105.4, 41.6, 27.4, 25.4. HRMS (ESI): calcd for C<sub>14</sub>H<sub>16</sub>NO<sub>2</sub><sup>+</sup> (MH<sup>+</sup>)
230.1176, found 230.1176.</p></sec><sec id="sec4.1.10.2"><title>5-Chloro-2-((3-(furan-2-yl)propyl)amino)benzaldehyde
(<bold>58</bold>)</title><p>(1) (5-Chloro-2-((3-(furan-2-yl)propyl)amino)phenyl)methanol
was prepared following the general procedure for reductive amination
from 0.50 g (3.18 mmol) of 5-chloro-2-aminophenylmethanol with a yield
of 0.48 g (57%) and used without further purification in the next
step. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): &#x003b4; 7.34
(dd, <italic>J</italic> = 1.8, 0.8 Hz, 1H), 7.18 (dd, <italic>J</italic> = 8.6, 2.5 Hz, 1H), 7.06 (d, <italic>J</italic> = 2.5 Hz, 1H), 6.58
(d, <italic>J</italic> = 8.7 Hz, 1H), 6.32 (dd, <italic>J</italic> = 3.1, 1.9 Hz, 1H), 6.05 (m, 1H), 4.77 (s, br, 1H), 4.63 (s, 2H),
3.20 (t, <italic>J</italic> = 7.0 Hz, 2H), 2.79 (t, <italic>J</italic> = 7.4 Hz, 2H), 2.03 (p, <italic>J</italic> = 7.2 Hz, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): &#x003b4; 155.2, 146.1, 141.0, 129.1,
128.7, 125.5, 120.8, 111.6, 110.2, 105.2, 64.3, 42.9, 27.6, 25.6.</p><p>(2) Following the general procedure for benzylic alcohol oxidation
from 0.48 g (1.80 mmol) of (5-chloro-2-((3-(furan-2-yl)propyl)amino)phenyl)methanol,
0.31 g (65%) of the title compound was obtained. <sup>1</sup>H NMR
(500 MHz, CDCl<sub>3</sub>): &#x003b4; 9.77 (s, 1H), 8.37 (s, 1H), 7.44
(d, <italic>J</italic> = 2.6 Hz, 1H), 7.34 (m, 2H), 6.64 (d, <italic>J</italic> = 9.1 Hz, 1H), 6.32 (dd, <italic>J</italic> = 3.1, 1.9
Hz, 1H), 6.06 (m, 1H), 3.28 (m, 2H), 2.78 (t, <italic>J</italic> =
7.3 Hz, 2H), 2.04 (p, <italic>J</italic> = 7.3 Hz, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): &#x003b4; 192.8, 154.7, 149.2, 141.2,
135.8, 135.2, 119.3, 118.9, 112.6, 110.2, 105.5, 41.8, 27.3, 25.3.</p></sec><sec id="sec4.1.10.3"><title>5-Bromo-2-((3-(furan-2-yl)propyl)amino)benzaldehyde (<bold>59</bold>)</title><p>(1) (5-Bromo-2-((3-(furan-2-yl)propyl)amino)phenyl)methanol
was prepared following the general procedure for reductive amination
from 0.5 g (2.48 mmol) of 5-bromo-2-aminophenylmethanol with a yield
of 0.34 g (44%) and used without further purification in the next
step. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): &#x003b4; 7.34
(dd, <italic>J</italic> = 1.8, 0.8 Hz, 1H), 7.31 (dd, <italic>J</italic> = 8.7, 2.4 Hz, 1H), 7.19 (d, <italic>J</italic> = 2.4 Hz, 1H), 6.54
(d, <italic>J</italic> = 8.7 Hz, 1H), 6.32 (dd, <italic>J</italic> = 3.1, 1.9 Hz, 1H), 6.05 (m, 1H), 4.77 (s, br, 1H), 4.62 (s, 2H),
3.19 (t, <italic>J</italic> = 7.0 Hz, 2H), 2.78 (t, <italic>J</italic> = 7.3 Hz, 2H), 2.02 (p, <italic>J</italic> = 7.2 Hz, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): &#x003b4; 155.2, 146.6, 141.0, 132.1,
131.5, 126.0, 112.1, 110.2, 107.7, 105.2, 64.3, 42.8, 27.5, 25.6.</p><p>(2) Following the general procedure for benzylic alcohol oxidation
from 0.34 g (1.10 mmol) of (5-bromo-2-((3-(furan-2-yl)propyl)amino)phenyl)methanol,
0.14 g (41%) of the title compound was obtained. <sup>1</sup>H NMR
(500 MHz, CDCl<sub>3</sub>): &#x003b4; 9.76 (s, 1H), 8.38 (s, 1H), 7.58
(d, <italic>J</italic> = 2.4 Hz, 1H), 7.45 (dd, <italic>J</italic> = 9.0, 2.4 Hz, 1H), 7.35 (d, <italic>J</italic> = 1.7 Hz, 1H), 6.60
(d, <italic>J</italic> = 9.0 Hz, 1H), 6.32 (dd, <italic>J</italic> = 3.1, 1.9 Hz, 1H), 6.06 (d, <italic>J</italic> = 3.0 Hz, 1H), 3.28
(m, 2H), 2.78 (t, <italic>J</italic> = 7.3 Hz, 2H), 2.04 (p, <italic>J</italic> = 7.2 Hz, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): &#x003b4; 192.7, 154.7, 149.5, 141.2, 138.4, 138.3, 119.5, 113.0,
110.2, 105.7, 105.5, 41.7, 27.3, 25.3. HRMS (ESI): calcd for C<sub>14</sub>H<sub>15</sub>BrNO<sub>2</sub><sup>+</sup> (MH<sup>+</sup>) 308.0281, found 308.0280.</p></sec><sec id="sec4.1.10.4"><title>2-((3-(Furan-2-yl)propyl)amino)nicotinaldehyde
(<bold>60</bold>)</title><p>(1) (2-((3-(Furan-2-yl)propyl)amino)pyridin-3-yl)methanol
was prepared following the general procedure for reductive amination
from 0.28 g (2.25 mmol) of 2-amino-3-pyridinemethanol with a yield
of 0.29 g (55%) and used without further purification in the next
step. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): &#x003b4; 8.12
(dd, <italic>J</italic> = 5.1, 1.8 Hz, 1H), 7.33 (dd, <italic>J</italic> = 1.8, 0.8 Hz, 1H), 7.26 (dd, <italic>J</italic> = 7.1, 1.8 Hz,
1H), 6.54 (dd, <italic>J</italic> = 7.1, 5.1 Hz, 1H), 6.31 (dd, <italic>J</italic> = 3.1, 1.9 Hz, 1H), 6.05 (m, 1H), 5.41 (s, 1H), 4.61 (s,
2H), 3.56 (t, <italic>J</italic> = 7.0 Hz, 2H), 2.78 (t, <italic>J</italic> = 7.5 Hz, 2H), 2.04 (p, <italic>J</italic> = 7.3 Hz, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): &#x003b4; 157.6, 155.7, 147.8, 140.9,
135.9, 118.5, 111.7, 110.1, 105.0, 64.0, 40.7, 28.0, 25.7.</p><p>(2)
Following the general procedure for benzylic alcohol oxidation from
0.15 g (0.65 mmol) of (2-((2-(furan-2-yl)benzyl)amino)pyridin-3-yl)methanol,
0.12 g (81%) of the title compound was obtained. <sup>1</sup>H NMR
(500 MHz, CDCl<sub>3</sub>): &#x003b4; 9.82 (s, 1H), 8.49 (s, 1H), 8.35
(dd, <italic>J</italic> = 4.8, 1.9 Hz, 1H), 7.76 (dd, <italic>J</italic> = 7.5, 2.0 Hz, 1H), 7.33 (m, 1H), 6.66 (dd, <italic>J</italic> =
7.5, 4.8 Hz, 1H), 6.30 (dd, <italic>J</italic> = 3.0, 1.9 Hz, 1H),
6.06 (m, 1H), 3.64 (m, 2H), 2.77 (t, <italic>J</italic> = 7.5 Hz,
2H), 2.05 (p, <italic>J</italic> = 7.3 Hz, 2H). <sup>13</sup>C NMR
(126 MHz, CDCl<sub>3</sub>): &#x003b4; 192.8, 157.8, 155.3, 155.0, 144.6,
141.0, 113.7, 111.4, 110.1, 105.1, 40.0, 27.8, 25.5. HRMS (ESI): calcd
for C<sub>13</sub>H<sub>15</sub>N<sub>2</sub>O<sub>2</sub><sup>+</sup> (MH<sup>+</sup>) 231.1129, found 231.1128.</p></sec><sec id="sec4.1.10.5"><title>2-((2-(Furan-2-yl)benzyl)amino)nicotinaldehyde
(<bold>63</bold>)</title><p>(1) (2-((2-(Furan-2-yl)benzyl)amino)pyridin-3-yl)methanol
was prepared following the general procedure for reductive amination
from 0.28 g (2.25 mmol) of 2-amino-3-pyridinemethanol with a yield
of 0.33 g (52%) and used without further purification in the next
step. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): &#x003b4; 8.06
(m, 1H), 7.69 (dd, <italic>J</italic> = 7.7, 1.3 Hz, 1H), 7.49 (m,
2H), 7.33 (td, <italic>J</italic> = 7.6, 1.2 Hz, 1H), 7.27 (td, <italic>J</italic> = 7.8, 1.4 Hz, 1H), 7.22 (d, <italic>J</italic> = 7.1
Hz, 1H), 6.60 (d, <italic>J</italic> = 3.4 Hz, 1H), 6.52 (m, 1H),
6.46 (dd, <italic>J</italic> = 3.3, 1.8 Hz, 1H), 5.71 (t, <italic>J</italic> = 5.5 Hz, 1H), 4.83 (d, <italic>J</italic> = 5.4 Hz, 2H),
4.50 (s, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): &#x003b4;
157.3, 153.0, 147.5, 142.2, 136.0, 135.8, 130.1, 129.7, 127.9, 127.9,
127.4, 118.9, 112.1, 111.5, 108.7, 63.5, 44.3.</p><p>(2) Following
the general procedure for benzylic alcohol oxidation from 0.33 g (1.17
mmol) of (2-((2-(furan-2-yl)benzyl)amino)pyridin-3-yl)methanol, 0.13
g (40%) of the title compound was obtained. <sup>1</sup>H NMR (500
MHz, CDCl<sub>3</sub>): &#x003b4; 9.83 (s, 1H), 8.83 (s, 1H), 8.37 (dd, <italic>J</italic> = 4.8, 1.9 Hz, 1H), 7.78 (dd, <italic>J</italic> = 7.5,
2.0 Hz, 1H), 7.67 (dd, <italic>J</italic> = 7.7, 1.4 Hz, 1H), 7.60
(d, <italic>J</italic> = 1.2 Hz, 1H), 7.51 (d, <italic>J</italic> =
7.6 Hz, 1H), 7.38&#x02013;7.30 (m, 2H), 6.69 (dd, <italic>J</italic> = 7.5, 4.8 Hz, 1H), 6.61 (d, <italic>J</italic> = 3.3 Hz, 1H), 6.53
(dd, <italic>J</italic> = 3.3, 1.8 Hz, 1H), 5.01 (d, <italic>J</italic> = 5.9 Hz, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): &#x003b4;
192.7, 155.0, 153.2, 144.6, 142.4, 135.3, 130.0, 129.3, 128.0, 128.0,
127.4, 113.8, 111.7, 111.4, 108.6, 43.2, 29.7. HRMS (ESI): calcd for
C<sub>17</sub>H<sub>15</sub>N<sub>2</sub>O<sub>2</sub><sup>+</sup> (MH<sup>+</sup>) 279.1128, found 279.1131.</p></sec><sec id="sec4.1.10.6"><title>2-((3-(5-Methylfuran-2-yl)butyl)amino)benzaldehyde
(<bold>61</bold>)</title><p>(1) (2-((3-(5-Methylfuran-2-yl)butyl)amino)phenyl)methanol
was prepared following general procedure A for reductive amination
from 0.52 g (3.48 mmol) of 3-(5-methyl-2-furyl)butanal and 0.28 g
(2.32 mmol) of 2-aminophenylmethanol with a yield of 0.60 g (90%)
and used in the oxidation step without further purification. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): &#x003b4; 7.23 (td, <italic>J</italic> = 7.9, 1.6, 1H), 7.08 (m, 1H), 6.67 (m, 2H), 5.91 (d, <italic>J</italic> = 3.0, 1H), 5.88 (dd, <italic>J</italic> = 2.9, 1.0, 1H),
4.66 (s, 2H), 3.18 (m, 2H), 2.96 (h, <italic>J</italic> = 6.9, 1H),
2.29 (s, 3H), 2.02 (m, 1H), 1.90 (ddt, <italic>J</italic> = 13.4,
8.0, 6.6, 1H), 1.31 (d, <italic>J</italic> = 7.0, 3H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): &#x003b4; 157.9, 150.3, 147.6, 129.6,
129.1, 124.2, 116.2, 110.5, 105.7, 104.5, 64.8, 41.4, 35.4, 31.2,
19.5, 13.5.</p><p>(2) Following the general procedure for benzilic
alcohol oxidation from 0.60 g (2.32 mmol) of (2-((3-(5-methylfuran-2-yl)butyl)amino)phenyl)methanol,
0.42 g (70%) of the title compound was obtained. <sup>1</sup>H NMR
(500 MHz, CDCl<sub>3</sub>): &#x003b4; 9.83 (s, 1H), 8.34 (s, 1H), 7.48
(dd, <italic>J</italic> = 7.7, 1.6 Hz, 1H), 7.39 (ddd, <italic>J</italic> = 8.5, 7.2, 1.2 Hz, 1H), 6.68 (m, 2H), 5.92 (d, <italic>J</italic> = 3.0 Hz, 1H), 5.88 (m, 1H), 3.24 (m, 2H), 2.95 (h, <italic>J</italic> = 6.9 Hz, 1H), 2.29 (s, 3H), 2.04 (dtd, <italic>J</italic> = 14.0,
8.2, 5.9 Hz, 1H), 1.92 (ddt, <italic>J</italic> = 13.4, 8.4, 6.6 Hz,
1H), 1.31 (d, <italic>J</italic> = 7.0 Hz, 3H). <sup>13</sup>C NMR
(126 MHz, CDCl<sub>3</sub>): &#x003b4; 193.9, 157.4, 150.8, 150.4, 136.7,
135.8, 118.3, 114.6, 110.8, 105.7, 104.7, 40.4, 35.0, 31.1, 19.5,
13.5. HRMS (ESI): calcd for C<sub>16</sub>H<sub>20</sub>NO<sub>2</sub><sup>+</sup> (MH<sup>+</sup>) 258.1489, found 258.1486.</p></sec><sec id="sec4.1.10.7"><title>8-((3-(Furan-2-yl)propyl)amino)-3,4-dihydronaphthalen-1(2<italic>H</italic>)-one (<bold>62</bold>)</title><p>Following the general
procedure for reductive amination from 0.40 g (2.48 mmol) of 8-amino-1-tetralone,
0.38 g (57%) of the title compound was obtained. <sup>1</sup>H NMR
(500 MHz, CDCl<sub>3</sub>): &#x003b4; 9.34 (s, 1H), 7.34 (dd, <italic>J</italic> = 1.8, 0.8 Hz, 1H), 7.26 (m, 1H), 6.54 (d, <italic>J</italic> = 8.5 Hz, 1H), 6.42 (dd, <italic>J</italic> = 7.2, 0.9 Hz, 1H),
6.31 (dd, <italic>J</italic> = 3.1, 1.9 Hz, 1H), 6.06 (m, 1H), 3.27
(m, 2H), 2.89 (m, 2H), 2.80 (t, <italic>J</italic> = 7.4 Hz, 2H),
2.65 (m, 2H), 2.05 (m, 4H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): &#x003b4; 201.3, 155.2, 151.9, 146.7, 141.0, 134.9, 114.7,
114.3, 110.1, 109.1, 105.3, 41.8, 40.5, 31.3, 27.4, 25.5, 23.0. HRMS
(ESI): calcd for C<sub>17</sub>H<sub>20</sub>NO<sub>2</sub><sup>+</sup> (MH<sup>+</sup>) 270.1489, found 270.1492.</p></sec><sec id="sec4.1.10.8"><title>8-((2-(Furan-2-yl)benzyl)amino)-3,4-dihydronaphthalen-1(2<italic>H</italic>)-one (<bold>64</bold>)</title><p>Following the general
procedure for reductive amination from 0.36 g (2.32 mmol) of 8-amino-1-tetralone,
0.45 g (61%) of the title compound was obtained. <sup>1</sup>H NMR
(500 MHz, CDCl<sub>3</sub>): &#x003b4; 9.69 (s, 1H), 7.71 (dd, <italic>J</italic> = 7.7, 1.3 Hz, 1H), 7.57 (d, <italic>J</italic> = 1.7
Hz, 1H), 7.47 (d, <italic>J</italic> = 7.6 Hz, 1H), 7.35 (td, <italic>J</italic> = 7.5, 1.3 Hz, 1H), 7.29 (m, 1H), 7.19 (m, 1H), 6.57 (d, <italic>J</italic> = 3.3 Hz, 1H), 6.53 (dd, <italic>J</italic> = 3.3, 1.8
Hz, 1H), 6.44 (m, 2H), 4.65 (d, <italic>J</italic> = 5.7 Hz, 2H),
2.92 (m, 2H), 2.67 (m, 2H), 2.08 (p, <italic>J</italic> = 6.4 Hz,
2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): &#x003b4; 201.38,
152.93, 151.66, 146.61, 142.27, 135.08, 134.90, 129.60, 128.08, 128.06,
127.93, 127.24, 115.05, 114.88, 111.48, 109.64, 108.81, 45.50, 40.49,
31.25, 23.01. HRMS (ESI): calcd for C<sub>21</sub>H<sub>20</sub>NO<sub>2</sub><sup>+</sup> (MH<sup>+</sup>) 318.1489, found 318.1482.</p></sec><sec id="sec4.1.10.9"><title>7-((3-(Furan-2-yl)propyl)amino)-2,3-dihydro-1<italic>H</italic>-inden-1-one
(<bold>73</bold>)</title><p>Following the general procedure for reductive
amination from 0.32 g (2.32 mmol) of 7-amino-indan-1-one, 0.29 g (45%)
of the title compound was obtained. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): &#x003b4; 7.36 (m, 3H), 6.61 (d, <italic>J</italic> = 7.3
Hz, 1H), 6.44 (d, <italic>J</italic> = 8.3 Hz, 1H), 6.31 (dd, <italic>J</italic> = 3.1, 1.9 Hz, 1H), 6.06 (m, 1H), 3.29 (m, 2H), 3.03 (m,
2H), 2.78 (m, 2H), 2.66 (m, 2H), 2.03 (m, 2H). <sup>13</sup>C NMR
(126 MHz, CDCl<sub>3</sub>): &#x003b4; 208.0, 156.9, 155.1, 148.6, 141.0,
136.8, 119.9, 112.1, 110.1, 107.0, 105.3, 41.5, 36.2, 27.5, 25.5,
25.4. HRMS (ESI): calcd for C<sub>16</sub>H<sub>18</sub>NO<sub>2</sub><sup>+</sup> (MH<sup>+</sup>) 256.1333, found 256.1338.</p></sec><sec id="sec70"><title>1-(2-Aminophenyl)-2-(furan-2-ylmethylthio)ethanone
(<bold>52</bold>)</title><p>A 2.24 g portion of 2-bromo-2&#x02032;-nitroacetophenone
(<bold>51</bold>; 9.2 mmol) was dissolved in 30 mL of dichloromethane
along with 1.08 g of 2-furylmercaptan (9.2 mmol) and 1.48 g of dry
pyridine (18.4 mmol), and the reaction mixture was stirred for 1 h
before it was quenched with 5% HCl solution (10 mL). The aqueous layer
was then extracted with dichloromethane (2 &#x000d7; 20 mL), and the
organic layers were combined and dried over anhydrous sodium sulfate.
The organic layer was then concentrated to give 2.50 g (98%) of 1-(2-nitrophenyl)-2-(furan-2-ylmethylthio)ethanone.
This was then dissolved in 100 mL of ethanol along with 5.23 g of
tin(II) chloride (27.0 mmol) and heated to 70 &#x000b0;C under a nitrogen
atmosphere for 2 h. Saturated sodium bicarbonate solution was added
slowly until the solution reached pH 8, giving a thick milky white
emulsion. This was filtered through a pad of Celite, and the filtrate
was extracted with EtOAc (3 &#x000d7; 100 mL). The organic phase was
washed with brine (2 &#x000d7; 50 mL) and then dried over anhydrous sodium
sulfate. The solvent was removed under reduced pressure, and the crude
product was purified by flash chromatography to give 1.76 g (78%)
of the title compound. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): &#x003b4; 7.67 (dd, <italic>J</italic> = 8.2, 1.0 Hz, 1H), 7.40
(dd, <italic>J</italic> = 1.8, 0.7 Hz, 1H) 7.30 (dt <italic>J</italic> = 8.4, 1.3 Hz 1H), 6.69 (d, <italic>J</italic> = 8.4 Hz, 1H), 6.15
(dt <italic>J</italic> = 8.2, 1.0, 1H) 6.37&#x02013;6.26 (m, 4H), 3.85
(s, 2H), 3.83 (s, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): &#x003b4; 196.7, 151.1, 150.7, 142.4, 134.8, 131.4, 117.5, 116.3,
115.8, 110.4, 108.4, 37.6, 28.5. HRMS (ESI): calcd for C<sub>13</sub>H<sub>14</sub>NO<sub>2</sub>S<sup>+</sup> (MH+) 248.0740, found 248.0743.</p></sec></sec><sec id="sec4.1.11"><title>General Procedure for Photochemical Reactions</title><p>A 4 mmol
portion of the photoprecursor was dissolved in 200 mL of methanol,
and the solution was degassed and irradiated with RPR-3500 until the
reaction was complete.</p><sec id="sec4.1.11.1"><title>Diethyl 2-(8b-Hydroxy-4,8b,9,10-tetrahydro-3<italic>H</italic>-3,14b-epoxybenzo[<italic>b</italic>]naphtho[2,1-<italic>d</italic>]azocin-10-yl)malonate (<bold>33</bold>)</title><p>From
0.27 g (0.53 mmol) of <bold>7</bold>, following the general procedure
for the photochemical reaction, 0.15 g (56%) of the title compound
was obtained upon chromatography. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): &#x003b4; 7.77 (dd, <italic>J</italic> = 8.1, 1.4, 1H), 7.31
(m, 3H), 7.23 (m, 1H), 7.10 (m, 1H), 6.89 (m, 1H), 6.63 (dd, <italic>J</italic> = 8.0, 1.1 Hz, 1H), 6.55 (d, <italic>J</italic> = 5.8
Hz, 1H), 5.94 (d, <italic>J</italic> = 2.8 Hz, 1H), 5.90 (dd, <italic>J</italic> = 5.8, 1.5 Hz, 1H), 4.73 (d, <italic>J</italic> = 3.5
Hz, 1H), 4.09 (m, 6H), 2.73 (dd, <italic>J</italic> = 14.1, 9.6 Hz,
1H), 2.10 (dd, <italic>J</italic> = 14.1, 7.2 Hz, 1H), 1.82 (s, 1H),
1.18 (t, <italic>J</italic> = 7.1 Hz, 3H), 1.09 (t, <italic>J</italic> = 7.1 Hz, 3H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): &#x003b4;
168.8, 168.0, 139.1, 136.8, 136.6, 134.4, 132.8, 129.3, 128.7, 128.5,
128.3, 128.1, 127.1, 127.0, 120.2, 120.0, 89.8, 88.5, 82.8, 61.4,
61.1, 56.8, 37.1, 35.2, 14.0, 13.9. HRMS (ESI): calcd for C<sub>26</sub>H<sub>27</sub>NaNO<sub>6</sub><sup>+</sup> (MNa<sup>+</sup>) 472.1731,
found 472.1737.</p></sec><sec id="sec4.1.11.2"><title>10-Phenyl-4,8b,9,10-tetrahydro-3<italic>H</italic>-3,14b-epoxybenzo[<italic>b</italic>]naphtho[2,1-<italic>d</italic>]azocin-8b-ol (<bold>32</bold>)</title><p>From 0.17 g (0.46 mmol)
of <bold>6</bold>, following the general procedure for the photochemical
reaction, 0.13 g (76%) of the title compound was obtained upon chromatography. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): &#x003b4; 7.87 (dd, <italic>J</italic> = 8.2, 1.5 Hz, 1H), 7.40 (dd, <italic>J</italic> = 7.6,
1.6 Hz, 1H), 7.26 (m, 7H), 7.12 (ddd, <italic>J</italic> = 8.1, 7.1,
1.6 Hz, 1H), 6.98 (d, <italic>J</italic> = 7.5 Hz, 1H), 6.92 (ddd, <italic>J</italic> = 8.3, 7.1, 1.3 Hz, 1H), 6.68 (d, <italic>J</italic> =
5.7 Hz, 1H), 6.64 (dd, <italic>J</italic> = 8.0, 1.2, Hz 1H), 6.01
(s, 1H), 5.99 (dd, <italic>J</italic> = 5.7, 1.5 Hz, 1H), 4.79 (s,
1H), 4.49 (dd, <italic>J</italic> = 11.4, 6.6 Hz, 1H), 2.70 (ddd, <italic>J</italic> = 14.1, 11.6, 0.8 Hz, 2H), 2.28 (dd, <italic>J</italic> = 14.2, 6.6 Hz, 1H), 2.08 (m, 1H). <sup>13</sup>C NMR (126 MHz,
CDCl<sub>3</sub>): &#x003b4; 146.1, 140.1, 138.9, 136.1, 134.6, 132.5,
129.8, 129.6, 129.0, 128.5, 128.5, 128.2, 128.1, 126.7, 126.3, 120.1,
120.0, 89.8, 88.6, 83.1, 77.2, 44.1, 42.9. HRMS (ESI): calcd for C<sub>25</sub>H<sub>22</sub>NO<sub>2</sub><sup>+</sup> (MH<sup>+</sup>)
368.1645, found 368.1649.</p></sec><sec id="sec4.1.11.3"><title>10-(Nitromethyl)-4,8b,9,10-tetrahydro-3<italic>H</italic>-3,14b-epoxybenzo[<italic>b</italic>]naphtho[2,1-<italic>d</italic>]azocin-8b-ol (<bold>34</bold>)</title><p>From 0.18 g (0.51
mmol) of <bold>8</bold>, following the general procedure for the photochemical
reaction, 0.10 g (56%) of the title compound was obtained upon chromatography. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): &#x003b4; 7.79 (dd, <italic>J</italic> = 8.1, 1.3, 1H), 7.41 (m, 2H), 7.34 (dd, <italic>J</italic> = 13.4, 6.9, 2H), 7.16 (m, 1H), 6.95 (m, 1H), 6.68 (m, 1H), 6.60
(d, <italic>J</italic> = 5.4, 1H), 5.95 (m, 2H), 4.83 (dd, <italic>J</italic> = 12.4, 4.8, 1H), 4.79 (s, 1H), 4.55 (dd, <italic>J</italic> = 12.4, 9.8, 1H), 4.10 (m, 1H), 2.40 (dd, <italic>J</italic> = 13.8,
8.8, 1H), 2.17 (dd, <italic>J</italic> = 14.2, 7.6, 1H), 1.86 (s,
1H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): &#x003b4; 138.9,
136.6, 134.5, 133.6, 132.1, 129.2, 128.9, 128.7, 128.7, 128.5, 127.9,
127.4, 120.3, 120.2, 89.9, 88.3, 82.2, 81.7, 37.7, 34.3. HRMS (ESI):
calcd for C<sub>20</sub>H<sub>19</sub>N<sub>2</sub>O<sub>4</sub><sup>+</sup> (MH<sup>+</sup>) 351.1339, found 351.1342.</p></sec><sec id="sec4.1.11.4"><title>14-(Nitromethyl)-8,12b,13,14-tetrahydro-7<italic>H</italic>-4b,7-epoxybenzo[2,3]azocino[4,5-<italic>h</italic>]quinolin-12b-ol
(<bold>35</bold>)</title><p>From 0.15 g (0.43 mmol) of <bold>15</bold>, following the general procedure for the photochemical reaction,
0.04 g (27%) of the title compound was obtained upon chromatography. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): &#x003b4; 8.61 (d, <italic>J</italic> = 3.9, 1H), 7.78 (dd, <italic>J</italic> = 8.1, 1.5 Hz,
1H), 7.65 (d, <italic>J</italic> = 7.9 Hz, 1H), 7.34 (dd, <italic>J</italic> = 7.9, 4.7 Hz, 1H), 7.18 (m, 1H), 6.96 (m, 1H), 6.73 (d, <italic>J</italic> = 5.8 Hz, 1H), 6.69 (dd, <italic>J</italic> = 8.0, 1.2
Hz, 1H), 6.03 (m, 1H), 5.96 (dd, <italic>J</italic> = 5.8, 1.6 Hz,
1H), 4.85 (br s, 1H), 4.79 (dd, <italic>J</italic> = 12.5, 5.2 Hz,
1H), 4.56 (dd, <italic>J</italic> = 12.5, 9.0 Hz, 1H), 4.13 (m, 1H),
2.43 (dd, <italic>J</italic> = 14.2, 9.3 Hz, 1H), 2.21 (dd, <italic>J</italic> = 14.1, 7.3 Hz, 1H), 1.91 (s, 1H). <sup>13</sup>C NMR
(126 MHz, CDCl<sub>3</sub>): &#x003b4; 155.7, 148.9, 139.1, 135.1, 133.4,
131.8, 130.7, 128.8, 128.6, 127.7, 123.8, 120.3, 120.3, 90.3, 89.6,
82.7, 80.7, 37.2, 33.7. HRMS (ESI): calcd for C<sub>19</sub>H<sub>17</sub>NaN<sub>3</sub>O<sub>4</sub><sup>+</sup> (MNa<sup>+</sup>) 374.1111, found 374.1111.</p></sec><sec id="sec4.1.11.5"><title>13-(Nitromethyl)-7,11b,12,13-tetrahydro-6<italic>H</italic>-3b,6-epoxybenzo[<italic>b</italic>]thieno [3&#x02032;,2&#x02032;:3,4]benzo[1,2-<italic>d</italic>]azocin-11b-ol (<bold>36</bold>)</title><p>From 0.19 g (0.53
mmol) of <bold>16</bold>, following the general procedure for the
photochemical reaction, 0.04 g (21%) of the title compound was obtained
upon chromatography. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>):
&#x003b4; 7.81 (dd, <italic>J</italic> = 8.2, 1.4 Hz, 1H), 7.30 (m,
1H), 7.16 (m, 1H), 6.94 (m, 2H), 6.66 (dd, <italic>J</italic> = 8.1,
1.1 Hz, 1H), 6.56 (d, <italic>J</italic> = 5.8 Hz, 1H), 5.99 (dd, <italic>J</italic> = 5.8, 1.6 Hz, 1H), 5.94 (dd, <italic>J</italic> = 4.4,
1.4 Hz, 1H), 4.82 (s, 1H), 4.81 (dd, <italic>J</italic> = 12.7, 5.5
Hz, 1H), 4.48 (dd, <italic>J</italic> = 12.7, 8.9 Hz, 1H), 4.22 (m,
1H), 2.39 (ddd, <italic>J</italic> = 13.5, 10.5, 1.3 Hz, 1H), 2.27
(dd, <italic>J</italic> = 13.6, 6.0 Hz, 1H), 1.99 (d, <italic>J</italic> = 1.3 Hz, 1H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): &#x003b4;
138.9, 137.3, 137.1, 133.2, 130.7, 130.2, 129.1, 128.8, 126.6, 124.9,
120.3, 120.2, 89.3, 86.2, 83.1, 80.2, 39.3, 32.9. HRMS (ESI): calcd
for C<sub>18</sub>H<sub>17</sub>N<sub>2</sub>O<sub>4</sub>S<sup>+</sup> (MH<sup>+</sup>) 357.0904, found 357.0907.</p></sec><sec id="sec4.1.11.6"><title>10-(Nitromethyl)-3,4,8b,9,10,11,12,13-octahydro-3,13b-epoxybenzo[<italic>b</italic>]indeno[5,4-<italic>d</italic>]azocin-8b-ol (<bold>37</bold>)</title><p>From 0.68 g (2.00 mmol) of <bold>29</bold>, following
the general procedure for the photochemical reaction, 0.23 g (34%)
of the title compound was obtained. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): &#x003b4; 7.75 (dd, <italic>J</italic> = 8.1, 1.3 Hz, 1H),
7.13 (m, 1H), 6.91 (m, 1H), 6.63 (m, 1H), 6.44 (d, <italic>J</italic> = 5.5 Hz, 1H), 5.85 (m, 2H), 4.80 (d, <italic>J</italic> = 3.7 Hz
1H), 4.64 (dd, <italic>J</italic> = 12.3, 5.6 Hz, 1H), 4.25 (dd, <italic>J</italic> = 12.2, 8.9 Hz, 1H), 3.41 (m, 1H), 2.47 (m, 3H), 2.32
(m, 1H), 2.09 (m, 2H), 2.00 (m, 2H), 1.96 (s, 1H). <sup>13</sup>C
NMR (126 MHz, CDCl<sub>3</sub>): &#x003b4; 138.9, 137.9, 137.2, 133.2,
130.9, 130.4, 128.5, 128.3, 120.2, 120.0, 88.9, 86.3, 83.3, 78.5,
39.0, 33.5, 33.3, 31.9, 21.9. HRMS (ESI): calcd for C<sub>19</sub>H<sub>21</sub>N<sub>2</sub>O<sub>4</sub><sup>+</sup> (MH<sup>+</sup>) 341.1501, found 341.1500.</p></sec><sec id="sec4.1.11.7"><title>10-(Nitromethyl)-4,8b,9,10,11,12,13,14-octahydro-3<italic>H</italic>-3,14b-epoxybenzo[<italic>b</italic>]naphtho[2,1-<italic>d</italic>]azocin-8b-ol (<bold>38</bold>)</title><p>From 0.39 g (1.10
mmol) of <bold>30</bold>, following the general procedure for the
photochemical reaction, 0.21 g (54%) of the title compound was obtained. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): &#x003b4; 7.73 (dd, <italic>J</italic> = 8.2, 1.5 Hz, 1H), 7.11 (m, 1H), 6.89 (ddd, <italic>J</italic> = 8.3, 7.1, 1.3 Hz, 1H), 6.61 (dd, <italic>J</italic> = 8.0, 1.2
Hz, 1H), 6.40 (m, 1H), 5.83 (m, 1H), 5.77 (dd, <italic>J</italic> =
5.8, 1.6 Hz, 1H), 4.77 (d, <italic>J</italic> = 4.3 Hz, 1H), 4.68
(dd, <italic>J</italic> = 11.9, 4.6 Hz, 1H), 4.26 (dd, <italic>J</italic> = 11.9, 9.5 Hz, 1H), 3.25 (m, 1H), 2.15 (dd, <italic>J</italic> =
13.9, 10.3 Hz, 1H), 2.07 (m, 4H), 1.95 (dd, <italic>J</italic> = 13.8,
6.2 Hz, 1H), 1.88 (m, 3H), 1.49 (m, 2H). <sup>13</sup>C NMR (126 MHz,
CDCl<sub>3</sub>): &#x003b4; 138.8, 133.6, 131.7, 131.4, 131.3, 129.8,
128.3, 127.7, 120.1, 120.0, 89.1, 88.2, 81.9, 78.8, 38.1, 37.0, 27.9,
26.2, 22.6, 22.4. HRMS (ESI): calcd for C<sub>20</sub>H<sub>23</sub>N<sub>2</sub>O<sub>4</sub><sup>+</sup> (MH<sup>+</sup>) 355.1652,
found 355.1657.</p></sec><sec id="sec4.1.11.8"><title>10-(Nitromethyl)-3,4,8b,9,10,11,12,13,14,15-decahydro-3,15b-epoxybenzo[<italic>b</italic>]cyclohepta[3,4]benzo[1,2-<italic>d</italic>]azocin-8b-ol
(<bold>39</bold>)</title><p>From 0.17 g (0.46 mmol) of <bold>31</bold>, following the general procedure for the photochemical reaction,
0.10 g (59%) of the title compound was obtained. <sup>1</sup>H NMR
(500 MHz, CDCl<sub>3</sub>): &#x003b4; 7.73 (dd, <italic>J</italic> =
8.2, 1.5 Hz, 1H), 7.11 (ddd, <italic>J</italic> = 8.1, 7.1, 1.6 Hz,
1H), 6.90 (ddd, <italic>J</italic> = 8.3, 7.1, 1.3 Hz, 1H), 6.62 (dd, <italic>J</italic> = 8.0, 1.2 Hz, 1H), 6.41 (dd, <italic>J</italic> = 5.8,
0.5 Hz, 1H), 5.85 (s, 1H), 5.75 (dd, <italic>J</italic> = 5.8, 1.6
Hz, 1H), 4.76 (m, 1H), 4.68 (dd, <italic>J</italic> = 12.1, 3.7 Hz,
1H), 4.24 (dd, <italic>J</italic> = 12.0, 10.2 Hz, 1H), 3.26 (m, 1H),
2.32 (m, 2H), 2.25 (m, 2H), 2.12 (dd, <italic>J</italic> = 14.0, 9.3
Hz, 1H), 2.03 (s, 1H), 1.99 (dd, <italic>J</italic> = 14.0, 6.9 Hz,
1H), 1.82 (m, 2H), 1.62 (m, 2H), 1.51 (m, 2H). <sup>13</sup>C NMR
(126 MHz, CDCl<sub>3</sub>): &#x003b4; 138.8, 137.6, 137.6, 134.5, 131.8,
129.7, 128.2, 127.2, 120.1, 120.1, 89.2, 89.2, 81.7, 79.5, 38.2, 38.0,
32.1, 31.8, 30.1, 26.5, 26.2. HRMS (ESI): calcd for C<sub>21</sub>H<sub>25</sub>N<sub>2</sub>O<sub>4</sub><sup>+</sup> (MH<sup>+</sup>) 369.1809, found 369.1811.</p></sec><sec id="sec4.1.11.9"><title>6-(Nitromethyl)-5,5a,5a1,6,13,14-hexahydro-4<italic>H</italic>-10b,13-epoxytetrapheno[1,12-<italic>bcd</italic>]azocin-5a1-ol
(<bold>49</bold>)</title><p>From 0.11 g (0.29 mmol) of <bold>48</bold>, following the general procedure for the photochemical reaction,
0.03 g (27%) of the title compound and 0.04 g (36%) of <bold>50</bold> were obtained. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): &#x003b4;
7.61 (dd, <italic>J</italic> = 7.4, 1.6 Hz, 1H), 7.32 (m, 2H), 7.08
(m, 2H), 6.75 (d, <italic>J</italic> = 7.0 Hz, 1H), 6.68 (d, <italic>J</italic> = 7.6 Hz, 1H), 6.34 (dd, <italic>J</italic> = 5.6, 1.3
Hz, 1H), 6.11 (d, <italic>J</italic> = 5.7 Hz, 1H), 5.77 (m, 1H),
5.24 (s, 1H), 5.21 (dd, <italic>J</italic> = 13.1, 8.1 Hz, 1H), 4.84
(dd, <italic>J</italic> = 13.1, 6.8 Hz, 1H), 4.12 (m, 2H), 2.76 (ddd, <italic>J</italic> = 16.6, 12.7, 4.4 Hz, 1H), 2.67 (dt, <italic>J</italic> = 16.7, 4.6 Hz, 2.3 Hz, 1H), 2.25 (dt, <italic>J</italic> = 13.9,
2.5 Hz, 1H), 1.34 (m, 2H), 0.80 (qd, <italic>J</italic> = 13.3, 4.7
Hz, 1H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): &#x003b4; 141.9,
137.3, 136.8, 136.7, 134.3, 132.5, 128.2, 128.1, 127.8, 127.3, 125.4,
123.2, 122.7, 118.3, 91.7, 88.3, 82.7, 76.3, 46.0, 37.2, 29.0, 21.0.
HRMS (ESI): calcd for C<sub>22</sub>H<sub>21</sub>N<sub>2</sub>O<sub>4</sub><sup>+</sup> (MH<sup>+</sup>) 377.1496, found 377.1496.</p></sec><sec id="sec4.1.11.10"><title>10-(Nitromethyl)-4,8,9,9a,9a1,10-hexahydro-3a<italic>H</italic>-dibenzo[<italic>i</italic>,<italic>lmn</italic>]furo[3,2-<italic>g</italic>]phenanthridin-9a1-ol
(<bold>50</bold>)</title><p>From 0.11 g (0.29 mmol) of <bold>48</bold>, following the general procedure for the photochemical reaction,
0.04 g (36%) of the title compound and 0.03 g (27%) of <bold>49</bold> were obtained. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): &#x003b4;
7.53 (m, 1H), 7.40 (m, 2H), 7.30 (m, 1H), 7.10 (t, <italic>J</italic> = 7.7 Hz, 1H), 6.74 (m, 1H), 6.62 (d, <italic>J</italic> = 7.7 Hz,
1H), 6.24 (dd, <italic>J</italic> = 2.7, 0.9 Hz, 1H), 5.40 (m, 1H),
5.10 (t, <italic>J</italic> = 2.6 Hz, 1H), 4.96 (dd, <italic>J</italic> = 12.5, 6.0 Hz, 1H), 4.62 (dd, <italic>J</italic> = 12.5, 8.5 Hz,
1H), 4.38 (m, 1H), 4.04 (s, 1H), 3.98 (s, 1H), 2.89 (m, 3H), 2.05
(dq, <italic>J</italic> = 11.5, 3.6 Hz, 1H), 1.81 (m, 1H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): &#x003b4; 146.9, 143.5, 139.2, 137.1,
135.8, 129.4, 129.1, 128.4, 127.7, 125.6, 125.3, 120.8, 114.7, 103.5,
90.9, 81.0, 70.8, 60.6, 42.2, 40.0, 29.5, 26.9. HRMS (ESI): calcd
for C<sub>22</sub>H<sub>21</sub>N<sub>2</sub>O<sub>4</sub><sup>+</sup> (MH<sup>+</sup>) 377.1496, found 377.1495.</p></sec><sec id="sec4.1.11.11"><title>9-Aza-10,11-benzo-5-hydroxy-2-oxa-3-thiatricyclo[6.3.1.0<sup>4,12</sup>]dodeca-6,10-diene (<bold>54</bold>)</title><p>A 0.31 g
portion of <bold>52</bold> was dissolved in 50 mL of acetonitrile
(5% H<sub>2</sub>O by volume) and irradiated in a Pyrex reaction vessel
in a Rayonet reactor equipped with RPR-3500 UV lamps (broad-band 300&#x02013;400
nm UV source with peak emission at 350 nm) for 2 h. The solution was
concentrated under reduced pressure and purified via flash chromatography,
with a yield of 0.28 g (89%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): &#x003b4; 8.32 (dd, <italic>J</italic> = 8.1, 1.3 Hz, 1H),
7.24, (dt, <italic>J</italic> = 8.1, 1.5 Hz, 1H), 6.97 (dt, <italic>J</italic> = 8.1, 1.3 Hz, 1H), 6.76, (dd, <italic>J</italic> = 8.0,
1.2 Hz, 1H), 6.31 (d, <italic>J</italic> = 9.8 Hz, 1H), 5.63 (dd, <italic>J</italic> = 9.8, 3.2 Hz, 1H), 5.50 (ddd, <italic>J</italic> = 5.0,
3.4, 0.6 Hz, 1H), 4.60&#x02013;4.55 (m, 1H), 3.38 (d, <italic>J</italic> = 9.8 Hz, 1H), 3.07 (m, 2H), 2.91 (d, <italic>J</italic> = 9.8 Hz,
1H), 2.85 (t, <italic>J</italic> = 1.4 Hz, 1H). <sup>13</sup>C NMR
(126 MHz, CDCl<sub>3</sub>): &#x003b4; 196.7, 151.1, 150.7, 142.4, 134.8,
131.4, 117.5, 116.3, 115.8, 110.4, 108.4, 37.6, 28.5. HRMS (ESI):
calcd for C<sub>13</sub>H<sub>14</sub>NO<sub>2</sub>S (MH<sup>+</sup>) 248.0740, found 248.0739.</p></sec></sec><sec id="sec4.1.12"><title>General Procedure for Acid-Induced
Rearrangemen</title><p>The photoproducts were dissolved in 5 mL of
dichloromethane, 0.05 mL of trifluoroacetic was added, and the reaction
mixture was stirred until the reaction was complete. The reaction
mixture was then concentrated and purified by flash chromatography.
Yields are summarized in Table <xref rid="tbl1" ref-type="other">1</xref>.</p><sec id="sec4.1.12.1"><title>2-(14b-Hydroxy-4,9,10,14b-tetrahydro-3<italic>H</italic>-3,8b-epoxybenzo[<italic>b</italic>]naphtho[2,1-<italic>d</italic>]azocin-10-yl)malonate (<bold>41</bold>)</title><p>From
47 mg (0.105 mmol) of <bold>33</bold>, 34 mg (72%) of the title compound
was obtained. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): &#x003b4;
7.53 (m, 1H), 7.45 (dd, <italic>J</italic> = 7.9, 1.3 Hz, 1H), 7.28
(m, 3H), 7.20 (m, 1H), 6.94 (td, <italic>J</italic> = 7.8, 1.3 Hz,
1H), 6.79 (dd, <italic>J</italic> = 8.0, 1.2 Hz, 1H), 6.48 (d, <italic>J</italic> = 10.1 Hz, 1H), 5.59 (dd, <italic>J</italic> = 10.0, 3.2
Hz, 1H), 5.17 (d, <italic>J</italic> = 3.1 Hz, 1H), 4.27 (d, <italic>J</italic> = 5.0 Hz, 1H), 4.26 (dq, <italic>J</italic> = 10.7, 7.2
Hz, 1H), 4.19(dq, <italic>J</italic> = 10.7, 7.2 Hz, 1H), 4.11 (dq, <italic>J</italic> = 10.7, 7.2 Hz, 1H), 4.09 (dq, <italic>J</italic> = 10.7,
7.2 Hz, 1H), 4.02 (m, 1H), 3.58 (s, 1H), 3.28 (dd, <italic>J</italic> = 13.9, 11.3 Hz, 1H), 1.94 (dd, <italic>J</italic> = 13.8, 6.4 Hz,
1H), 1.27 (t, <italic>J</italic> = 7.1 Hz, 3H), 1.14 (t, <italic>J</italic> = 7.1 Hz, 3H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): &#x003b4;
168.6, 168.5, 140.5, 139.1, 135.2, 134.8, 129.0, 128.3, 128.1, 127.7,
127.1, 126.8, 125.5, 124.5, 120.2, 118.7, 75.5, 74.9, 69.5, 61.7,
61.2, 55.1, 34.6, 32.0, 14.1, 13.9.</p></sec><sec id="sec4.1.12.2"><title>10-Phenyl-4,9,10,14b-tetrahydro-3<italic>H</italic>-3,8b-epoxybenzo[<italic>b</italic>]naphtho[2,1-<italic>d</italic>]azocin-14b-ol (<bold>40</bold>)</title><p>From 120 mg (0.327
mmol) of <bold>32</bold>, 90 mg (75%) of the title compound was obtained. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): &#x003b4; 7.59 (dd, <italic>J</italic> = 7.9, 1.1 Hz, 1H), 7.37 (m, 3H), 7.29 (m, 4H), 7.20 (m,
2H), 6.90 (m, 2H), 6.81 (dd, <italic>J</italic> = 8.0, 1.1 Hz, 1H),
6.49 (d, <italic>J</italic> = 10.0 Hz, 1H), 5.68 (dd, <italic>J</italic> = 10.0, 3.4 Hz, 1H), 5.29 (d, <italic>J</italic> = 3.3 Hz, 1H),
4.55 (dd, <italic>J</italic> = 12.4, 5.0 Hz, 1H), 3.34 (s, 1H), 2.93
(m, 1H), 2.16 (dd, <italic>J</italic> = 13.6, 5.0 Hz, 1H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): &#x003b4; 145.8, 139.2, 139.1, 138.7,
134.7, 129.4, 129.2, 128.6, 128.4, 128.3, 127.8, 127.5, 126.6, 126.5,
126.1, 124.7, 120.1, 118.7, 75.1, 74.9, 69.6, 42.5, 40.4. HRMS (ESI):
calcd for C<sub>25</sub>H<sub>22</sub>NO<sub>2</sub><sup>+</sup> (MH<sup>+</sup>) 368.1645, found 368.1648.</p></sec><sec id="sec4.1.12.3"><title>10-(Nitromethyl)-4,9,10,14b-tetrahydro-3<italic>H</italic>-3,8b-epoxybenzo[<italic>b</italic>]naphtho[2,1-<italic>d</italic>]azocin-14b-ol (<bold>42</bold>)</title><p>From 80 mg (0.228
mmol) of <bold>34</bold>, 47 mg (59%) of the title compound was obtained. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): &#x003b4; 7.60 (dd, <italic>J</italic> = 7.3, 2.2, 1H), 7.35 (m, 3H), 7.25 (m, 2H), 6.96 (m,
1H), 6.83 (m, 1H), 6.40 (d, <italic>J</italic> = 10.0 Hz, 1H), 5.66
(dd, <italic>J</italic> = 10.0, 3.4 Hz, 1H), 5.22 (d, <italic>J</italic> = 3.3, 1H), 5.05 (dd, <italic>J</italic> = 12.5 Hz, 4.8, 1H), 4.60
(dd, <italic>J</italic> = 12.5, 8.7 Hz, 1H), 4.19 (m, 1H), 2.86 (s,
1H), 2.72 (m, 1H), 2.06 (dd, <italic>J</italic> = 13.2, 5.0 Hz, 1H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): &#x003b4; 139.3, 139.0,
134.2, 133.1, 129.6, 128.7, 128.2, 127.7, 127.5, 125.6, 125.2, 125.0,
120.4, 119.0, 80.1, 75.0, 74.0, 69.4, 34.6, 33.8. HRMS (ESI): calcd
for C<sub>20</sub>H<sub>19</sub>N<sub>2</sub>O<sub>4</sub><sup>+</sup> (MH<sup>+</sup>) 351.1339, found 351.1341.</p></sec><sec id="sec4.1.12.4"><title>14-(Nitromethyl)-7,8,13,14-tetrahydro-4b<italic>H</italic>-7,12b-epoxybenzo[2,3]azocino[4,5-<italic>h</italic>]quinolin-4b-ol
(<bold>43</bold>)</title><p>Following the general procedure for rearrangement,
from 35 mg (0.099 mmol) of <bold>35</bold> 20 mg (57%) of the title
compound was obtained upon chromatography. <sup>1</sup>H NMR (500
MHz, CDCl<sub>3</sub>): &#x003b4; 8.63 (d, <italic>J</italic> = 4.7,
1H), 7.80 (d, <italic>J</italic> = 8.0, 1H), 7.43 (dd, <italic>J</italic> = 8.1, 4.9 Hz, 1H), 7.39 (m, 1H), 7.24 (m, 1H), 6.95 (td, <italic>J</italic> = 7.8, 1.2 Hz, 1H), 6.81 (dd, <italic>J</italic> = 8.0,
1.0 Hz, 1H), 6.64 (d, <italic>J</italic> = 10.0 Hz, 1H), 5.74 (dd, <italic>J</italic> = 10.0, 3.4, 1H), 5.22 (d, <italic>J</italic> = 3.3 Hz,
1H), 4.94 (s, 1H), 4.92 (dd, <italic>J</italic> = 12.9, 5.2 Hz, 1H),
4.71 (m, 1H), 4.23 (dq, <italic>J</italic> = 12.0, 5.4 Hz, 1H), 2.82
(m, 1H), 2.14 (dd, <italic>J</italic> = 13.3, 5.1 Hz, 1H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): &#x003b4; 158.1, 146.8, 138.5, 136.1,
133.1, 130.4, 128.6, 128.2, 125.8, 125.1, 123.3, 120.3, 118.7, 79.0,
75.3, 73.6, 70.3, 34.1, 33.2. HRMS (ESI): calcd for C<sub>19</sub>H<sub>18</sub>N<sub>3</sub>O<sub>4</sub><sup>+</sup> (MH<sup>+</sup>) 352.1292, found 352.1302.</p></sec><sec id="sec4.1.12.5"><title>13-(Nitromethyl)-6,7,12,13-tetrahydro-3b<italic>H</italic>-6,11b-epoxybenzo[<italic>b</italic>]thieno[3&#x02032;,2&#x02032;:3,4]benzo[1,2-<italic>d</italic>]azocin-3b-ol (<bold>44</bold>)</title><p>From 40 mg (0.112
mmol) of <bold>36</bold>, 23 mg (58%) of the title compound was obtained. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): &#x003b4; 7.32 (m, 2H), 7.30
(m, 1H), 7.25 (m, 1H), 7.12 (d, <italic>J</italic> = 5.2 Hz, 1H),
6.95 (m, 1H), 6.83 (dd, <italic>J</italic> = 8.0, 1.0 Hz, 1H), 6.24
(d, <italic>J</italic> = 10.0 Hz, 1H), 5.24 (d, <italic>J</italic> = 3.5 Hz, 1H), 4.90 (dd, <italic>J</italic> = 12.6, 5.2 Hz, 1H),
4.55 (dd, <italic>J</italic> = 12.6, 9.1 Hz, 1H), 4.17 (m, 1H), 2.70
(br s, 1H),2.64 (dd, <italic>J</italic> = 13.0, 11.3 Hz, 1H), 2.15
(dd, <italic>J</italic> = 13.1, 4.8 Hz, 1H). <sup>13</sup>C NMR (126
MHz, CDCl<sub>3</sub>): &#x003b4; 139.0, 138.4, 135.2, 132.7, 128.8,
127.5, 126.4, 125.7, 124.8, 124.7, 120.3, 119.0, 79.8, 74.9, 74.8,
68.7, 35.9, 32.9. HRMS (ESI): calcd for C<sub>18</sub>H<sub>17</sub>N<sub>2</sub>O<sub>4</sub>S<sup>+</sup> (MH<sup>+</sup>) 357.0904,
found 357.0906.</p></sec><sec id="sec4.1.12.6"><title>10-(Nitromethyl)-3,4,9,10,11,12,13,13b-octahydro-3,8b-epoxybenzo[<italic>b</italic>]indeno[5,4-<italic>d</italic>]azocin-13b-ol (<bold>45</bold>)</title><p>From 180 mg (0.529 mmol) of <bold>37</bold>, 130 mg (72%)
of the title compound was obtained. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): &#x003b4; 7.28 (m, 1H), 7.20 (m, 1H), 6.91 (m, 1H), 6.79
(dd, <italic>J</italic> = 8.0, 1.1 Hz, 1H), 5.93 (d, <italic>J</italic> = 10.0 Hz, 1H), 5.69 (dd, <italic>J</italic> = 10.0, 3.5 Hz, 1H),
5.25 (d, <italic>J</italic> = 3.5 Hz, 1H), 4.67 (dd, <italic>J</italic> = 12.2, 5.5 Hz, 1H), 4.34 (dd, <italic>J</italic> = 12.2, 8.8 Hz,
1H), 3.39 (m, 1H), 2.94 (s, 1H), 2.61 (dddd, <italic>J</italic> =
11.9, 9.0, 6.1, 3.9 Hz, 1H), 2.41 (m, 4H), 1.95 (m, 2H), 1.90 (dd, <italic>J</italic> = 13.2, 4.9 Hz, 1H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): &#x003b4; 138.9, 138.1, 135.0, 132.4, 128.5, 127.6, 126.3,
125.3, 120.1, 118.9, 78.6, 75.2, 74.9, 68.9, 35.0, 33.3, 32.8, 31.1,
22.0. HRMS (ESI): calcd for C<sub>19</sub>H<sub>21</sub>N<sub>2</sub>O<sub>4</sub><sup>+</sup> (MH<sup>+</sup>) 341.1496, found 341.1500.</p></sec><sec id="sec4.1.12.7"><title>10-(Nitromethyl)-4,9,10,11,12,13,14,14b-octahydro-3<italic>H</italic>-3,8b-epoxybenzo[<italic>b</italic>]naphtho[2,1-<italic>d</italic>]azocin-14b-ol (<bold>46</bold>)</title><p>From 180 mg (0.508 mmol)
of <bold>38</bold>, 110 mg (61%) of the title compound was obtained. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): &#x003b4; 7.28 (m, 1H), 7.18
(td, <italic>J</italic> = 8.1, 1.4 Hz, 1H), 6.89 (td, <italic>J</italic> = 7.8, 1.2 Hz, 1H), 6.75 (dd, <italic>J</italic> = 8.0, 1.0 Hz,
1H), 5.99 (d, <italic>J</italic> = 10.1 Hz, 1H), 5.63 (dd, <italic>J</italic> = 10.1, 3.3 Hz, 1H), 5.23 (d, <italic>J</italic> = 3.2
Hz, 1H), 4.73 (dd, <italic>J</italic> = 12.0, 4.6 Hz, 1H), 4.34 (dd, <italic>J</italic> = 12.0, 9.2 Hz, 1H), 3.23 (m, 1H), 3.20 (s, 1H), 2.42
(m, 2H), 2.06 (m, 3H), 1.87 (m, 2H), 1.79 (dd, <italic>J</italic> =
13.2, 5.0 Hz, 1H), 1.45 (m, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): &#x003b4; 139.0, 133.2, 133.1, 128.4, 128.0, 127.7, 126.1,
125.9, 120.1, 118.8, 78.6, 75.0, 74.2, 69.9, 36.6, 33.9, 27.5, 25.3,
22.5, 22.4. HRMS (ESI): calcd for C<sub>20</sub>H<sub>23</sub>N<sub>2</sub>O<sub>4</sub><sup>+</sup> (MH<sup>+</sup>) 355.1652, found
355.1659.</p></sec><sec id="sec4.1.12.8"><title>10-(Nitromethyl)-3,4,9,10,11,12,13,14,15,15b-decahydro-3,8b-epoxybenzo[<italic>b</italic>]cyclohepta[3,4]benzo[1,2-<italic>d</italic>]azocin-15b-ol
(<bold>47</bold>)</title><p>From 90 mg (0.244 mmol) of <bold>39</bold>, 50 mg (56%) of the title compound was obtained. <sup>1</sup>H NMR
(500 MHz, CDCl<sub>3</sub>): &#x003b4; 7.30 (m, 2H), 7.19 (m, 1H), 6.91
(m, 2H), 6.76 (m, 1H), 6.03 (d, <italic>J</italic> = 10.1, 1H), 5.65
(dd, <italic>J</italic> = 10.1, 3.3 Hz, 1H), 5.23 (d, <italic>J</italic> = 3.2 Hz, 1H), 4.77 (dd, <italic>J</italic> = 12.0, 3.8 Hz, 1H),
4.33 (dd, <italic>J</italic> = 12.0, 9.6 Hz, 1H), 3.33 (dq, <italic>J</italic> = 10.0, 4.9 Hz, 1H), 2.40 (m, 2H), 2.28 (m, 3H), 1.87
(dd, <italic>J</italic> = 13.3, 5.4, 1H), 1.78 (m, 2H), 1.52 (m, 4H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): &#x003b4; 139.0, 138.4,
134.7, 132.9, 128.4, 127.6, 126.4, 126.0, 120.1, 118.8, 79.4, 74.9,
74.2, 70.5, 37.3, 34.5, 31.9, 30.7, 29.0, 26.8, 25.9 HRMS (ESI): calcd
for C<sub>21</sub>H<sub>25</sub>N<sub>2</sub>O<sub>4</sub><sup>+</sup> (MH<sup>+</sup>) 369.1809, found 369.1816.</p></sec></sec><sec id="sec4.1.13"><title>General
Procedure for the Irradiation of Amines</title><p>An approximately
0.1&#x02013;0.3 M solution of the photoprecursors in acetonitrile was
irradiated in Pyrex or glass reaction vessels in a Rayonet reactor
equipped with RPR-3500 UV lamps (broad-band 300&#x02013;400 nm UV source
with peak emission at 350 nm) until the reaction was complete.</p><sec id="sec4.1.13.1"><title><italic>syn</italic>-2,3,6,7-Tetrahydro-1<italic>H</italic>-3a,7-epoxybenzo[<italic>g</italic>]pyrrolo[1,2-<italic>a</italic>]azocin-6-ol (<bold>65a</bold>)</title><p>From 150 mg (0.44 mmol) of <bold>57</bold>, following
the general procedure for irradiation of amines 60 mg (40%) of the
title compound was obtained upon chromatography. <sup>1</sup>H NMR
(500 MHz, CDCl<sub>3</sub>): &#x003b4; 7.23 (m, 1H), 7.10 (m, 1H), 6.85
(td, <italic>J</italic> = 7.5, 1.1 Hz, 1H), 6.80 (d, <italic>J</italic> = 8.1 Hz, 1H), 5.99 (ddd, <italic>J</italic> = 9.8, 5.2 Hz, 1.1,
1H), 5.71 (d, <italic>J</italic> = 9.8 Hz, 1H), 5.08 (s, 1H), 3.97
(ddd, <italic>J</italic> = 10.6, 5.2, 1.3 Hz, 1H), 3.77 (ddd, <italic>J</italic> = 8.9, 7.4, 4.6 Hz, 1H), 3.43 (dt, <italic>J</italic> =
8.8, 7.2 Hz, 1H), 2.25 (m, 3H), 2.16 (m, 1H), 2.05 (dtd, <italic>J</italic> = 15.3, 7.5, 4.7 Hz, 1H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): &#x003b4; 141.0, 132.1, 128.3, 125.9, 125.2, 121.4, 118.5,
116.9, 87.1, 77.7, 66.8, 50.3, 38.1, 22.5.</p></sec><sec id="sec4.1.13.2"><title><italic>anti</italic>-2,3,6,7-Tetrahydro-1<italic>H</italic>-3a,7-epoxybenzo[<italic>g</italic>]pyrrolo[1,2-<italic>a</italic>]azocin-6-ol (<bold>65b</bold>)</title><p>From 150 mg (0.44 mmol) of <bold>57</bold>, following
the general procedure for irradiation of amines 10 mg (7%) of the
title compound was obtained upon chromatography. <sup>1</sup>H NMR
(500 MHz, CDCl<sub>3</sub>): &#x003b4; 7.27 (m, 1H), 7.20 (d, <italic>J</italic> = 7.5 Hz, 1H), 6.83 (m, 2H), 5.81 (dt, <italic>J</italic> = 10.0, 1.4 Hz, 1H), 5.56 (dd, <italic>J</italic> = 10.0, 2.2 Hz,
1H), 4.98 (d, <italic>J</italic> = 5.9 Hz, 1H), 4.67 (ddt, <italic>J</italic> = 9.9, 6.0, 2.0 Hz, 1H), 3.76 (ddd, <italic>J</italic> = 9.0, 7.5, 4.0 Hz, 1H), 3.36 (m, 1H), 2.27 (m, 1H), 2.16 (m, 2H),
2.04 (ddt, <italic>J</italic> = 11.4, 7.6, 4.0 Hz, 1H), 1.50 (d, <italic>J</italic> = 11.9, 1H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): &#x003b4; 142.2, 130.2, 129.2, 128.7, 127.9, 117.8, 116.7, 87.2,
77.6, 73.9, 67.1, 50.4, 38.1, 22.7.</p></sec><sec id="sec4.1.13.3"><title>9-Chloro-2,3,6,7-tetrahydro-1<italic>H</italic>-3a,7-epoxybenzo[<italic>g</italic>]pyrrolo[1,2-<italic>a</italic>]azocin-6-ol (<bold>66</bold>)</title><p>From 115 mg (0.44
mmol) of <bold>58</bold>, following the general procedure for irradiation
of amines 65 mg (57%) of the title compound was obtained upon chromatography. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): &#x003b4; 7.17 (dd, <italic>J</italic> = 8.6, 2.4 Hz, 1H), 7.07 (d, <italic>J</italic> = 2.3
Hz, 1H), 6.71 (d, <italic>J</italic> = 8.6 Hz, 1H), 6.00 (ddd, <italic>J</italic> = 9.8, 5.2, 1.0 Hz, 1H), 5.69 (d, <italic>J</italic> =
9.8 Hz, 1H), 5.03 (s, 1H), 3.94 (ddd, <italic>J</italic> = 10.6, 5.2,
1.3 Hz, 1H), 3.73 (ddd, <italic>J</italic> = 8.8, 7.4, 4.5 Hz, 1H),
3.39 (dt, <italic>J</italic> = 8.8, 7.2 Hz, 1H), 2.25 (m, 2H), 2.17
(m, 2H), 2.05 (m, 1H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): &#x003b4; 139.6, 131.9, 128.3, 125.6, 125.1, 123.5, 122.8, 118.0,
87.1, 77.4, 66.6, 50.3, 37.9, 22.5. HRMS (ESI): calcd for C<sub>14</sub>H<sub>15</sub>ClNO<sub>2</sub><sup>+</sup> (MH<sup>+</sup>) 264.0786,
found 264.0790.</p></sec><sec id="sec4.1.13.4"><title>9-Bromo-2,3,6,7-tetrahydro-1<italic>H</italic>-3a,7-epoxybenzo[<italic>g</italic>]pyrrolo[1,2-<italic>a</italic>]azocin-6-ol (<bold>67</bold>)</title><p>From 124 mg (0.44 mmol) of <bold>59</bold>, following the general procedure for irradiation of amines
53 mg (43%) of the title compound was obtained upon chromatography. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): &#x003b4; 7.30 (dd, <italic>J</italic> = 8.7, 2.4 Hz, 1H), 7.21 (d, <italic>J</italic> = 1.9
Hz, 1H), 6.66 (d, <italic>J</italic> = 8.6, 1H), 6.00 (ddd, <italic>J</italic> = 9.8, 5.2, 1.0 Hz, 1H), 5.69 (d, <italic>J</italic> =
9. Hz 8, 1H), 5.03 (s, 1H), 3.94 (ddd, <italic>J</italic> = 10.6,
5.2, 1.3 Hz, 1H), 3.72 (ddd, <italic>J</italic> = 8.8, 7.4, 4.5 Hz,
1H), 3.39 (dt, <italic>J</italic> = 8.8, 7.2 Hz, 1H), 2.24 (m, 2H),
2.17 (m, 2H), 2.05 (m, 1H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): &#x003b4; 140.0, 131.8, 131.2, 128.5, 125.1, 123.2, 118.3,
110.6, 87.0, 77.3, 66.6, 50.1, 37.9, 22.5. HRMS (ESI): calcd for C<sub>14</sub>H<sub>15</sub>BrNO<sub>2</sub><sup>+</sup> (MH<sup>+</sup>) 308.0281, found 308.0287.</p></sec><sec id="sec4.1.13.5"><title>6,9,10,11-Tetrahydro-5<italic>H</italic>-5,8a-epoxypyrido[3,2-<italic>g</italic>]pyrrolo[1,2-<italic>a</italic>]azocin-6-ol (<bold>68</bold>)</title><p>From 210 mg (0.91
mmol) of <bold>60</bold>, following the general procedure for irradiation
of amines 130 mg (62%) of the title compound was obtained upon chromatography. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): &#x003b4; 8.19 (dd, <italic>J</italic> = 5.0, 1.8 Hz, 1H), 7.32 (ddd, <italic>J</italic> = 7.4,
1.7, 0.6 Hz, 1H), 6.71 (dd, <italic>J</italic> = 7.4, 5.0 Hz, 1H),
6.00 (ddd, <italic>J</italic> = 9.8, 5.1, 1.0 Hz, 1H), 5.74 (d, <italic>J</italic> = 9.8 Hz, 1H), 5.09 (s, 1H), 3.93 (s, 1H), 3.89 (ddd, <italic>J</italic> = 10.1, 7.6, 4.4 Hz, 1H), 3.72 (dt, <italic>J</italic> = 10.1, 7.3 Hz, 1H), 2.69 (s, 1H), 2.26 (m, 2H), 2.15 (m, 1H), 2.04
(m, 1H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): &#x003b4; 151.4,
148.1, 133.5, 131.8, 125.0, 115.4, 113.4, 87.2, 77.5, 66.7, 47.3,
37.8, 22.1. HRMS (ESI): calcd for C<sub>13</sub>H<sub>15</sub>N<sub>2</sub>O<sub>2</sub><sup>+</sup> (MH<sup>+</sup>) 231.1129, found
231.1127.</p></sec><sec id="sec4.1.13.6"><title><italic>syn</italic>-3,6-Dimethyl-2,3,6,7-tetrahydro-1<italic>H</italic>-3a,7-epoxybenzo[<italic>g</italic>]pyrrolo[1,2-<italic>a</italic>]azocin-6-ol (<bold>69a</bold>)</title><p>From 165 mg (0.64
mmol) of <bold>61</bold>, following the general procedure for irradiation
of amines 55 mg (33%) of the title compound was obtained upon chromatography
together with 60 mg (36%) of <bold>69b</bold>. <sup>1</sup>H NMR (500
MHz, CDCl<sub>3</sub>): &#x003b4; 7.23 (m, 1H), 7.10 (m, 1H), 6.83 (td, <italic>J</italic> = 7.5, 1.2 Hz, 1H), 6.76 (dd, <italic>J</italic> = 8.1,
1.0 Hz, 1H), 5.88 (dd, <italic>J</italic> = 9.8, 1.2 Hz, 1H), 5.48
(d, <italic>J</italic> = 9.8 Hz, 1H), 4.77 (s, 1H), 3.75 (td, <italic>J</italic> = 9.3, 7.0 Hz, 1H), 3.41 (td, <italic>J</italic> = 9.1,
2.6 Hz, 1H), 2.78 (d, <italic>J</italic> = 1.0 Hz, 1H), 2.40 (dp, <italic>J</italic> = 11.1, 6.8 Hz, 1H), 2.05 (dtd, <italic>J</italic> = 12.0,
6.8, 2.6 Hz, 1H), 1.90 (m, 1H), 1.41 (d, <italic>J</italic> = 1.0
Hz, 3H), 1.17 (d, <italic>J</italic> = 6.9 Hz, 3H). <sup>13</sup>C
NMR (126 MHz, CDCl<sub>3</sub>): &#x003b4; 142.8, 133.7, 130.0, 128.2,
127.9, 121.4, 118.2, 117.8, 88.0, 80.5, 68.4, 51.9, 43.4, 30.6, 23.1,
12.4.</p></sec><sec id="sec4.1.13.7"><title><italic>anti-</italic>3,6-Dimethyl-2,3,6,7-tetrahydro-1<italic>H</italic>-3a,7-epoxybenzo[<italic>g</italic>]pyrrolo[1,2-<italic>a</italic>]azocin-6-ol (<bold>69b</bold>)</title><p>From 165 mg (0.64
mmol) of <bold>61</bold> ,following the general procedure for irradiation
of amines 60 mg (36%) of the title compound was obtained upon chromatography
together with 55 mg (33%) of <bold>69a</bold>.<sup>&#x000a0;1</sup>H NMR (500
MHz, CDCl<sub>3</sub>): &#x003b4; 7.22 (td, <italic>J</italic> = 8.1,
1.4 Hz, 1H), 7.12 (d, <italic>J</italic> = 6.3 Hz, 1H), 6.75 (td, <italic>J</italic> = 7.5, 1.1 Hz, 1H), 6.67 (d, <italic>J</italic> = 8.1
Hz, 1H), 5.85 (m, 1H), 5.52 (d, <italic>J</italic> = 10.0 Hz, 1H),
4.83 (s, 1H), 3.66 (t, <italic>J</italic> = 7.8 Hz, 1H), 3.32 (ddd, <italic>J</italic> = 10.3, 8.7, 6.2 Hz, 1H), 2.76 (s, 1H), 2.40 (m, 1H),
2.24 (m, 1H), 1.79 (tdd, <italic>J</italic> = 12.3, 10.3, 7.9 Hz,
1H), 1.40 (s, 3H), 1.19 (d, <italic>J</italic> = 7.0, 3H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): &#x003b4; 140.4, 131.5, 128.5, 128.3,
126.5, 118.9,116.5, 113.6, 88.4, 81.9, 68.7, 46.3, 42.9, 30.4, 23.5,
13.6.</p></sec><sec id="sec4.1.13.8"><title>2,3,8,9,10,11-Hexahydro-1<italic>H</italic>-10a,13a-epoxynaphtho[1,8-<italic>fg</italic>]pyrrolo[1,2-<italic>a</italic>]azocin-11-ol (<bold>70</bold>)</title><p>From 360 mg (1.34
mmol) of <bold>62</bold>, following the general procedure for irradiation
of amines 170 mg (47%) of the title compound was obtained upon chromatography. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): &#x003b4; 7.14 (t, <italic>J</italic> = 7.8 Hz, 1H), 6.63 (m, 1H), 6.57 (d, <italic>J</italic> = 8.0 Hz, 1H), 6.06 (ddd, <italic>J</italic> = 9.7, 5.3, 0.6 Hz,
1H), 5.75 (d, <italic>J</italic> = 9.7 Hz, 1H), 3.87 (dd, <italic>J</italic> = 11.0, 5.3 Hz, 1H), 3.72 (ddd, <italic>J</italic> = 8.9,
7.6, 4.0 Hz, 1H), 3.38 (dt, <italic>J</italic> = 8.8, 7.2 Hz, 1H),
2.94 (ddd, <italic>J</italic> = 15.9, 10.6, 5.0 Hz, 1H), 2.84 (ddd, <italic>J</italic> = 17.4, 9.9, 5.4 Hz, 1H), 2.50 (ddd, <italic>J</italic> = 12.1, 6.6, 2.2 Hz, 1H), 2.24 (m, 1H), 2.11 (m, 4H), 1.95 (m, 1H),
1.75 (d, <italic>J</italic> = 11.1 Hz, 1H), 1.42 (td, <italic>J</italic> = 12.4, 7.6 Hz, 1H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): &#x003b4; 139.8, 136.3, 131.5, 127.9, 126.2, 123.5, 118.6, 113.1,
87.4, 76.6, 64.5, 50.1, 38.0, 30.0, 26.3, 22.2, 16.0. HRMS (ESI):
calcd for C<sub>17</sub>H<sub>20</sub>NO<sub>2</sub><sup>+</sup> (MH<sup>+</sup>) 270.1489, found 270.1491.</p></sec><sec id="sec4.1.13.9"><title>6,13-Dihydro-5<italic>H</italic>-5,8a-epoxypyrido[3&#x02032;,2&#x02032;:7,8]azocino[2,1-<italic>a</italic>]isoindol-6-ol (<bold>71</bold>)</title><p>From 130 mg (0.46 mmol)
of <bold>63</bold>, following the general procedure for irradiation
of amines 80 mg (62%) of the title compound was obtained upon chromatography. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): &#x003b4; 8.30 (dd, <italic>J</italic> = 4.9, 1.7 Hz, 1H), 7.45 (m, 5H), 6.83 (m, 1H), 6.19 (ddd, <italic>J</italic> = 9.8, 5.2, 1.0 Hz, 1H), 5.84 (d, <italic>J</italic> =
9.8 Hz, 1H), 5.23 (s, 1H), 5.10 (d, <italic>J</italic> = 14.4 Hz,
1H), 4.95 (d, <italic>J</italic> = 14.4 Hz, 1H), 4.07 (d, <italic>J</italic> = 5.3 Hz, 1H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): &#x003b4; 151.0, 148.4, 139.3, 138.4, 133.8, 131.4, 129.9, 128.0,
126.2, 123.4, 123.2, 116.0, 114.4, 89.7, 77.6, 66.4, 53.0. HRMS (ESI):
calcd for C<sub>17</sub>H<sub>15</sub>N<sub>2</sub>O<sub>2</sub><sup>+</sup> (MH<sup>+</sup>) 279.1128, found 279.1133.</p></sec><sec id="sec4.1.13.10"><title>2,3,4,11-Tetrahydro-1<italic>H</italic>-3a,6a-epoxynaphtho[1&#x02032;,8&#x02032;:6,7,8]azocino[2,1-<italic>a</italic>]isoindol-4-ol (<bold>72</bold>)</title><p>From 400 mg (1.26
mmol) of <bold>64</bold> following the general procedure for irradiation
of amines 140 mg (35%) of the title compound was obtained upon chromatography. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): &#x003b4; 8.20 (d, <italic>J</italic> = 8.0 Hz, 1H), 7.94 (dt, <italic>J</italic> = 7.5, 0.9
Hz, 1H), 7.70 (td, <italic>J</italic> = 7.4, 1.1 Hz, 1H), 7.65 (dt, <italic>J</italic> = 7.6, 1.1 Hz, 1H), 7.62 (td, <italic>J</italic> = 7.4,
1.2 Hz, 1H), 7.37 (t, <italic>J</italic> = 7.9 Hz, 1H), 7.04 (m, 1H),
6.04 (dd, <italic>J</italic> = 9.8, 1.9 Hz, 1H), 5.66 (dd, <italic>J</italic> = 9.8, 1.9 Hz, 1H), 4.68 (dt, <italic>J</italic> = 12.0,
2.0 Hz, 1H), 3.11 (ddd, <italic>J</italic> = 17.6, 9.2, 3.1 Hz, 1H),
2.81 (dt, <italic>J</italic> = 17.5, 7.7 Hz, 1H), 2.45 (m, 2H), 2.23
(ddd, <italic>J</italic> = 12.5, 5.9, 2.9 Hz, 1H), 1.91 (m, 3H), 1.26
(d, <italic>J</italic> = 12.0 Hz, 1H). <sup>13</sup>C NMR (126 MHz,
CDCl<sub>3</sub>): &#x003b4; 165.0, 143.9, 139.5, 133.2, 133.1, 132.4,
132.2, 130.5, 128.3, 127.2, 124.8, 124.2, 122.8, 120.4, 117.3, 85.1,
73.6, 35.2, 27.6, 17.5.</p></sec><sec id="sec4.1.13.11"><title>3,6,7,8-Tetrahydro-1<italic>H</italic>-3,5a-epoxyindeno[1,7-<italic>fg</italic>]pyrrolo[1,2-<italic>a</italic>]azocine (<bold>75</bold>)</title><p>From 203 mg (1.34 mmol)
of <bold>73</bold>, following the general procedure for irradiation
of amines 120 mg (67%) of the title compound was obtained upon chromatography. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): &#x003b4; 7.11 (m, 1H), 6.88
(m, 1H), 6.56 (d, <italic>J</italic> = 8.2 Hz, 1H), 6.10 (dd, <italic>J</italic> = 5.6, 2.0 Hz, 1H), 6.04 (t, <italic>J</italic> = 2.1
Hz, 1H), 5.75 (dd, <italic>J</italic> = 5.6, 1.2 Hz, 1H), 5.62 (s,
1H), 3.68 (m, 1H), 3.52 (m, 1H), 3.37 (m, 2H), 2.39 (m, 2H), 2.17
(m, 1H), 2.01 (m, 1H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): &#x003b4; 148.6, 146.5, 139.6, 134.5, 129.4, 128.9, 126.2, 121.7,
113.8, 113.6, 105.0, 80.9, 50.1, 38.7, 37.5, 22.1. HRMS (ESI): calcd
for C<sub>16</sub>H<sub>16</sub>NO<sup>+</sup> (MH<sup>+</sup>) 238.1226,
found 238.1232.</p></sec></sec><sec id="sec4.1.14"><title>General Procedure for the Rearrangement of
Amides</title><p>A solution of the photoproduct in DCM (15 mL) was
treated with 0.5 mL of TFA; when the reaction was complete as monitored
by NMR, the reaction mixture was concentrated and purified using flash
chromatography.</p><sec id="sec4.1.14.1"><title>6-Hydroxy-2,3,6,7-tetrahydro-1<italic>H</italic>-3a,7-epoxybenzo[<italic>g</italic>]pyrrolo[1,2-<italic>a</italic>]azocin-1-one (<bold>79</bold>)</title><p>From 12 mg of <bold>76</bold> following the general procedure for the rearrangement of amides
10 mg (83%) of the title compound was obtained. <sup>1</sup>H NMR
(500 MHz, CDCl<sub>3</sub>): &#x003b4; 8.33 (d, <italic>J</italic> =
8.2, 1H), 7.36 (m, 1H), 7.19 (m, 2H), 6.11 (ddd, <italic>J</italic> = 9.6, 5.2, 0.8, 1H), 5.86 (d, <italic>J</italic> = 9.8, 1H), 5.20
(s, 1H), 4.37 (s, 1H), 3.98 (dd, <italic>J</italic> = 5.2, 1.1, 1H),
2.77 (m, 2H), 2.40 (m, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): &#x003b4; 171.8, 132.4, 129.4, 128.6, 127.2, 125.4, 124.5,
123.4, 120.2, 86.4, 78.0, 66.8, 30.3, 29.8. HRMS (ESI): calcd for
C<sub>14</sub>H<sub>14</sub>NO<sub>3</sub><sup>+</sup> (MH<sup>+</sup>) 244.0969, found 244.0974.</p></sec><sec id="sec4.1.14.2"><title>6-Hydroxy-7-methyl-2,3,6,7-tetrahydro-1<italic>H</italic>-3a,7-epoxybenzo[<italic>g</italic>]pyrrolo[1,2-<italic>a</italic>]azocin-1-one</title><p>From 10 mg of <bold>77</bold>, following
the general procedure for the rearrangement of amides 9 mg (90%) of
the title compound was obtained. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): &#x003b4; 8.26 (d, <italic>J</italic> = 8.1 Hz, 1H), 7.33
(ddd, <italic>J</italic> = 8.4, 5.9, 3.1 Hz, 1H), 7.17 (m, 2H), 6.13
(dd, <italic>J</italic> = 9.7, 5.3 Hz, 1H), 5.78 (d, <italic>J</italic> = 9.7 Hz, 1H), 3.79 (d, <italic>J</italic> = 5.3 Hz, 1H), 3.42 (s,
1H), 2.74 (dd, <italic>J</italic> = 9.1, 7.3 Hz, 2H), 2.36 (m, 2H),
1.67 (s, 3H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): &#x003b4;
171.6, 132.0, 129.2, 129.1, 128.8, 128.2, 125.1, 124.5, 120.3, 86.9,
78.7, 68.5, 30.3, 29.8, 23.5. HRMS (ESI): calcd for C<sub>15</sub>H<sub>16</sub>NO<sub>3</sub><sup>+</sup> (MH<sup>+</sup>) 258.1125,
found 258.1126.</p></sec><sec id="sec4.1.14.3"><title>11-Hydroxy-8,9,10,11-tetrahydro-1<italic>H</italic>-10a,13a-epoxynaphtho[1,8-<italic>fg</italic>]pyrrolo[1,2-<italic>a</italic>]azocin-3(2<italic>H</italic>)-one (<bold>81</bold>)</title><p>From 10 mg of <bold>78</bold>, following the general procedure
for the rearrangement of amides 9 mg (90%) of the title compound was
obtained. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): &#x003b4; 8.19
(d, <italic>J</italic> = 8.2, 1H), 7.27 (m, 1H), 6.96 (d, <italic>J</italic> = 7.5 Hz, 1H), 6.16 (dd, <italic>J</italic> = 9.6, 5.3
Hz, 1H), 5.88 (d, <italic>J</italic> = 9.7 Hz, 1H), 3.82 (d, <italic>J</italic> = 5.4 Hz, 1H), 2.92 (m, 2H), 2.71 (m, 2H), 2.50 (ddd, <italic>J</italic> = 12.2, 6.7, 2.3 Hz, 1H), 2.40 (ddd, <italic>J</italic> = 12.6, 8.4, 4.0 Hz, 1H), 2.31 (dt, <italic>J</italic> = 13.3, 10.1
Hz, 1H), 2.12 (m, 1H), 1.98 (m, 1H), 1.56 (td, <italic>J</italic> =
12.3, 7.7 Hz, 1H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>):
&#x003b4; 171.0, 136.2, 131.3, 128.9, 128.3, 128.0, 125.0, 124.6, 116.8,
86.7, 77.4, 64.4, 30.5, 29.8, 29.3, 26.2, 15.9. HRMS (ESI): calcd
for C<sub>17</sub>H<sub>18</sub>NO<sub>3</sub><sup>+</sup> (MH<sup>+</sup>) 284.1282, found 284.1284.</p></sec><sec id="sec4.1.14.4"><title><italic>syn</italic>-10-Hydroxy-3-benzyl-7,8-benzo-13-oxa-3,6-diazatricyclo[7.3.1.0<sup>1,6</sup>]trideca-7,11-diene-2,5-dione (<bold>83</bold>)<italic>:</italic></title><p>Compound <bold>82</bold> (0.5 g, 1.38 mmol) was dissolved
in 5 mL of DMSO and heated to 150 &#x000b0;C for 44 h. The solvent was
removed under reduced pressure and purified by flash chromatography,
which afforded 0.41 g (82%) of the title compound. <sup>1</sup>H NMR
(500 MHz, CDCl<sub>3</sub>): &#x003b4; 8.17 (dd, <italic>J</italic> =
8.4, 1.2 Hz, 1H), 7.42&#x02013;7.27 (m, 6H), 7.20 (td, <italic>J</italic> = 7.5, 1.2 Hz, 1H), 7.13 (dd, <italic>J</italic> = 7.7, 1.6 Hz,
1H), 6.20 (ddd, <italic>J</italic> = 9.8, 5.7, 1.0 Hz, 1H), 5.81 (d, <italic>J</italic> = 9.8 Hz, 1H), 5.30 (s, 1H), 4.76 (d, <italic>J</italic> = 14.4 Hz, 1H), 4.64 (d, <italic>J</italic> = 14.4 Hz, 1H), 4.19
(d, <italic>J</italic> = 18.1 Hz, 1H), 4.03 (d, <italic>J</italic> = 18.1 Hz, 1H), 3.91 (dd, <italic>J</italic> = 5.7, 1.5 Hz, 1H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): &#x003b4; 162.17, 161.09,
134.3, 133.1, 129.3, 128.9, 128.9, 128.8, 128.7, 128.1, 126.6, 126.0,
125.7, 125.3, 124.2, 81.7, 66.6, 50.3, 49.4. HRMS (ESI): calcd for
C<sub>21</sub>H<sub>19</sub>N<sub>2</sub>O<sub>4</sub><sup>+</sup> (MH<sup>+</sup>) 363.1340, found 363.1334.</p></sec></sec></sec></body><back><notes id="notes-1" notes-type="si"><title>Supporting Information Available</title><p>Figures and CIF files giving 1D and 2D NMR data and X-ray data.
This material is available free of charge via the Internet at <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://pubs.acs.org">http://pubs.acs.org</uri>.</p></notes><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="sifile1"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jo5019848_si_001.pdf"><caption><p>jo5019848_si_001.pdf</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="sifile2"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jo5019848_si_002.cif"><caption><p>jo5019848_si_002.cif</p></caption></media></supplementary-material></sec><notes id="NOTES-d254e5529-autogenerated" notes-type="conflict-of-interest"><p>The authors declare no competing
financial interest.</p></notes><ack><title>Acknowledgments</title><p>Support of this work by the NIH (GM093930) is
gratefully acknowledged.</p></ack><ref-list><title>References</title><ref id="ref1"><mixed-citation publication-type="book" id="cit1"><person-group person-group-type="allauthors"><name><surname>Brown</surname><given-names>E. G.</given-names></name></person-group><source>Ring Nitrogen and
Key Biomolecules. The Biochemistry of N-Heterocycles</source>; <publisher-name>Kluwer Academic</publisher-name>: <publisher-loc>Dordrecht, The Netherlands</publisher-loc>, <year>1998</year>.</mixed-citation></ref><ref id="ref2"><mixed-citation publication-type="weblink" id="cit2a"><label>a</label><person-group person-group-type="allauthors"><name><surname>Bartholow</surname><given-names>M.</given-names></name></person-group> Pharmacy Times website, <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.pharmacytimes.com/publications/issue/2013/July2013/Top-200-Drugs-of-2012">http://www.pharmacytimes.com/publications/issue/2013/July2013/Top-200-Drugs-of-2012</uri>, <year>2013</year>.</mixed-citation><mixed-citation publication-type="journal" id="cit2b"><label>b</label><name><surname>McGrath</surname><given-names>N. A.</given-names></name>; <name><surname>Brichacek</surname><given-names>M.</given-names></name>; <name><surname>Njardarson</surname><given-names>J. T.</given-names></name>
<source>J. Chem. Educ.</source>
<year>2010</year>, <volume>87</volume>, <fpage>1348</fpage>.</mixed-citation></ref><ref id="ref3"><mixed-citation publication-type="book" id="cit3a"><label>a</label><person-group person-group-type="allauthors"><name><surname>Katritzky</surname><given-names>A. R.</given-names></name>; <name><surname>Pozharskii</surname><given-names>A. F.</given-names></name></person-group><source>Handbook of heterocyclic
chemistry</source>, <edition>2</edition>nd ed.; <publisher-name>Pergamon
Press</publisher-name>: <publisher-loc>Oxford, U.K.</publisher-loc>, <year>2000</year>.</mixed-citation><mixed-citation publication-type="book" id="cit3b"><label>b</label><person-group person-group-type="allauthors"><name><surname>Katritzky</surname><given-names>A. R.</given-names></name>; <name><surname>Ramsden</surname><given-names>C. A.</given-names></name>; <name><surname>Joule</surname><given-names>J. A.</given-names></name>; <name><surname>Zhdankin</surname><given-names>V. V.</given-names></name></person-group><source>Handbook of heterocyclic chemistry</source>, <edition>3</edition>rd ed.; <publisher-name>Elsevier</publisher-name>: <publisher-loc>Amsterdam</publisher-loc>, <year>2010</year>.</mixed-citation></ref><ref id="ref4"><mixed-citation publication-type="book" id="cit4"><person-group person-group-type="allauthors"><name><surname>Joule</surname><given-names>J. A.</given-names></name>, <name><surname>Mills</surname><given-names>K.</given-names></name></person-group><source>Heterocyclic chemistry</source>, <edition>5</edition>th ed.; <publisher-name>Wiley</publisher-name>: <publisher-loc>Hoboken, NJ</publisher-loc>, <year>2010</year>.</mixed-citation></ref><ref id="ref5"><mixed-citation publication-type="journal" id="cit5a"><name><surname>Young</surname><given-names>I. S.</given-names></name>; <name><surname>Kerr</surname><given-names>M. A.</given-names></name>
<source>J. Am. Chem. Soc.</source>
<year>2007</year>, <volume>129</volume>, <fpage>1465</fpage>.<pub-id pub-id-type="pmid">17263433</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit5b"><name><surname>Winkler</surname><given-names>J.
D.</given-names></name>; <name><surname>Axten</surname><given-names>J. M.</given-names></name>
<source>J. Am. Chem. Soc.</source>
<year>1998</year>, <volume>120</volume>, <fpage>6425</fpage>.<pub-id pub-id-type="pmid">25170173</pub-id></mixed-citation></ref><ref id="ref6"><mixed-citation publication-type="journal" id="cit6"><comment>For a review,
see:</comment><name><surname>Bass</surname><given-names>P.
D.</given-names></name>; <name><surname>Gubler</surname><given-names>D. A.</given-names></name>; <name><surname>Judd</surname><given-names>T. C.</given-names></name>; <name><surname>Williams</surname><given-names>R. M.</given-names></name>
<source>Chem. Rev.</source>
<year>2013</year>, <volume>113</volume>, <fpage>6816</fpage>&#x02013;<lpage>6863</lpage>.<pub-id pub-id-type="pmid">23654296</pub-id></mixed-citation></ref><ref id="ref7"><mixed-citation publication-type="journal" id="cit7a"><label>a</label><name><surname>Iyer</surname><given-names>V. N.</given-names></name>; <name><surname>Szybalski</surname><given-names>W.</given-names></name>
<source>Proc. Natl. Acad. Sci. U.S.A.</source>
<year>1963</year>, <volume>50</volume>, <fpage>355</fpage>.<pub-id pub-id-type="pmid">14060656</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit7b"><label> b</label><name><surname>Iyer</surname><given-names>V. N.</given-names></name>; <name><surname>Szybalski</surname><given-names>W.</given-names></name>
<source>Science</source>
<year>1964</year>, <volume>145</volume>, <fpage>55</fpage>.<pub-id pub-id-type="pmid">14162693</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit7c"><label> c</label><name><surname>Rajski</surname><given-names>S. R.</given-names></name>; <name><surname>Rollins</surname><given-names>S. B.</given-names></name>; <name><surname>Williams</surname><given-names>R. M.</given-names></name>
<source>J. Am. Chem. Soc.</source>
<year>1998</year>, <volume>120</volume>, <fpage>2192</fpage>.</mixed-citation><mixed-citation publication-type="journal" id="cit7d"><label> d</label><name><surname>Rajski</surname><given-names>S. R.</given-names></name>; <name><surname>Williams</surname><given-names>R. M.</given-names></name>
<source>Bioorg. Med. Chem.</source>
<year>2000</year>, <volume>8</volume>, <fpage>1331</fpage>.<pub-id pub-id-type="pmid">10896111</pub-id></mixed-citation></ref><ref id="ref8"><mixed-citation publication-type="journal" id="cit8"><name><surname>Wolkenberg</surname><given-names>S. E.</given-names></name>; <name><surname>Boger</surname><given-names>D. L.</given-names></name>
<source>Chem. Rev.</source>
<year>2002</year>, <volume>102</volume>, <fpage>2477</fpage>&#x02013;<lpage>2406</lpage>.<pub-id pub-id-type="pmid">12105933</pub-id></mixed-citation></ref><ref id="ref9"><mixed-citation publication-type="journal" id="cit9a"><label>a</label><name><surname>Mak</surname><given-names>X. Y.</given-names></name>; <name><surname>Crombie</surname><given-names>A. L.</given-names></name>; <name><surname>Danheiser</surname><given-names>R. L.</given-names></name>
<source>J. Org. Chem.</source>
<year>2011</year>, <volume>76</volume>, <fpage>1852</fpage>&#x02013;<lpage>1873</lpage>.<pub-id pub-id-type="pmid">21322545</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit9b"><label> b</label><name><surname>Papaioannou</surname><given-names>N.</given-names></name>; <name><surname>Blank</surname><given-names>J. T.</given-names></name>; <name><surname>Miller</surname><given-names>S. J.</given-names></name>
<source>J. Org. Chem.</source>
<year>2003</year>, <volume>26</volume>, <fpage>2728</fpage>&#x02013;<lpage>2734</lpage>.<pub-id pub-id-type="pmid">12662044</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit9c"><label> c</label><name><surname>Majumdar</surname><given-names>K. C.</given-names></name>; <name><surname>Samanta</surname><given-names>S.</given-names></name>; <name><surname>Chattodhyay</surname><given-names>B.</given-names></name>; <name><surname>Nandi</surname><given-names>R. K.</given-names></name>
<source>Synthesis</source>
<year>2010</year>, <fpage>863</fpage>&#x02013;<lpage>869</lpage>.</mixed-citation><mixed-citation publication-type="journal" id="cit9d"><label> d</label><name><surname>Fujiwara</surname><given-names>T.</given-names></name>; <name><surname>Kato</surname><given-names>Y.</given-names></name>; <name><surname>Takeda</surname><given-names>T.</given-names></name>
<source>Heterocycles</source>
<year>2000</year>, <volume>52</volume>, <fpage>147</fpage>&#x02013;<lpage>150</lpage>.</mixed-citation></ref><ref id="ref10"><mixed-citation publication-type="journal" id="cit10a"><label>a</label><name><surname>Trost</surname><given-names>B. M.</given-names></name>; <name><surname>O&#x02019;Boyle</surname><given-names>B. M.</given-names></name>; <name><surname>Torres</surname><given-names>W.</given-names></name>; <name><surname>Ameriks</surname><given-names>M. K.</given-names></name>
<source>Chem. Eur. J.</source>
<year>2011</year>, <volume>17</volume>, <fpage>7890</fpage>&#x02013;<lpage>7903</lpage>.<pub-id pub-id-type="pmid">21618622</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit10b"><label> b</label><name><surname>Ayala</surname><given-names>S. L. G.</given-names></name>; <name><surname>Stashenko</surname><given-names>E.</given-names></name>; <name><surname>Palma</surname><given-names>A.</given-names></name>; <name><surname>Bahsas</surname><given-names>A.</given-names></name>; <name><surname>Amaro-Luis</surname><given-names>J. M.</given-names></name>
<source>Synlett</source>
<year>2006</year>, <volume>14</volume>, <fpage>2275</fpage>&#x02013;<lpage>2277</lpage>.</mixed-citation></ref><ref id="ref11"><mixed-citation publication-type="journal" id="cit11a"><label>a</label><name><surname>Voskressensky</surname><given-names>L. G.</given-names></name>; <name><surname>Borisova</surname><given-names>T. N.</given-names></name>; <name><surname>Listratova</surname><given-names>A. V.</given-names></name>; <name><surname>Kulikova</surname><given-names>L. N.</given-names></name>; <name><surname>Titov</surname><given-names>A. A.</given-names></name>; <name><surname>Varlamov</surname><given-names>A. V.</given-names></name>
<source>Tetrahedron Lett.</source>
<year>2006</year>, <volume>47</volume>, <fpage>4585</fpage>&#x02013;<lpage>4589</lpage>.</mixed-citation><mixed-citation publication-type="journal" id="cit11b"><label> b</label><name><surname>Anand</surname><given-names>A.</given-names></name>; <name><surname>Singh</surname><given-names>P.</given-names></name>; <name><surname>Mehra</surname><given-names>V.</given-names></name>; <name><surname>Amandeep</surname></name>; <name><surname>Kumar</surname><given-names>V.</given-names></name>; <name><surname>Mahajan</surname><given-names>M. P.</given-names></name>
<source>Tetrahedron Lett.</source>
<year>2012</year>, <volume>53</volume>, <fpage>2417</fpage>&#x02013;<lpage>2419</lpage>.</mixed-citation></ref><ref id="ref12"><mixed-citation publication-type="journal" id="cit12a"><label>a</label><name><surname>Aoki</surname><given-names>T.</given-names></name>; <name><surname>Koya</surname><given-names>S.</given-names></name>; <name><surname>Yamasaki</surname><given-names>R.</given-names></name>; <name><surname>Saito</surname><given-names>S.</given-names></name>
<source>Org.
Lett.</source>
<year>2012</year>, <volume>14</volume>, <fpage>4506</fpage>&#x02013;<lpage>4509</lpage>.<pub-id pub-id-type="pmid">22880846</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit12b"><label> b</label><name><surname>Ha</surname><given-names>H.-J.</given-names></name>; <name><surname>Choi</surname><given-names>C.-J.</given-names></name>; <name><surname>Ahn</surname><given-names>Y.-G.</given-names></name>; <name><surname>Yun</surname><given-names>H.</given-names></name>; <name><surname>Dong</surname><given-names>Y.</given-names></name>; <name><surname>Lee</surname><given-names>W. K.</given-names></name>
<source>J. Org. Chem.</source>
<year>2000</year>, <volume>65</volume>, <fpage>8384</fpage>&#x02013;<lpage>8386</lpage>.<pub-id pub-id-type="pmid">11101403</pub-id></mixed-citation></ref><ref id="ref13"><mixed-citation publication-type="journal" id="cit13"><name><surname>Seto</surname><given-names>M.</given-names></name>; <name><surname>Aikawa</surname><given-names>K.</given-names></name>; <name><surname>Miyamoto</surname><given-names>N.</given-names></name>; <name><surname>Aramaki</surname><given-names>Y.</given-names></name>; <name><surname>Kanzaki</surname><given-names>N.</given-names></name>; <name><surname>Takashima</surname><given-names>K.</given-names></name>; <name><surname>Kuze</surname><given-names>Y.</given-names></name>; <name><surname>Iizawa</surname><given-names>Y.</given-names></name>; <name><surname>Baba</surname><given-names>M.</given-names></name>; <name><surname>Shiraishi</surname><given-names>M.</given-names></name>
<source>J. Med. Chem.</source>
<year>2006</year>, <volume>49</volume>, <fpage>2037</fpage>&#x02013;<lpage>2048</lpage>.<pub-id pub-id-type="pmid">16539392</pub-id></mixed-citation></ref><ref id="ref14"><mixed-citation publication-type="journal" id="cit14"><comment>See:</comment><name><surname>Schmidtke</surname><given-names>S.</given-names></name>; <name><surname>Underwood</surname><given-names>D. F.</given-names></name>; <name><surname>Blank</surname><given-names>D. A.</given-names></name>
<source>J. Phys. Chem. A</source>
<year>2005</year>, <volume>109</volume>, <fpage>7033</fpage>&#x02013;<lpage>7045</lpage><comment>and references therein</comment>.<pub-id pub-id-type="pmid">16834066</pub-id></mixed-citation></ref><ref id="ref15"><note><p>For a review see:</p></note><mixed-citation publication-type="journal" id="cit15a"><label>a</label><name><surname>Wojciechowski</surname><given-names>K.</given-names></name>
<source>Eur. J. Org. Chem.</source>
<year>2001</year>, <fpage>3587</fpage>&#x02013;<lpage>3605</lpage>.</mixed-citation><note><p>For examples
see:</p></note><mixed-citation publication-type="journal" id="cit15b"><label> b</label><name><surname>Lancaster</surname><given-names>M.</given-names></name>; <name><surname>Smith</surname><given-names>D. J. H.</given-names></name>
<source>J. Chem. Soc., Chem. Commun.</source>
<year>1980</year>, <fpage>471</fpage>&#x02013;<lpage>472</lpage>.</mixed-citation><mixed-citation publication-type="journal" id="cit15c"><label> c</label><name><surname>Wojciechowski</surname><given-names>K.</given-names></name>
<source>Tetrahedron</source>
<year>1993</year>, <volume>49</volume>, <fpage>7277</fpage>&#x02013;<lpage>7286</lpage>.</mixed-citation><mixed-citation publication-type="journal" id="cit15d"><label> d</label><name><surname>Ito</surname><given-names>Y.</given-names></name>; <name><surname>Miyata</surname><given-names>S.</given-names></name>; <name><surname>Nakatsuka</surname><given-names>M.</given-names></name>; <name><surname>Saegusa</surname><given-names>T.</given-names></name>
<source>J. Am. Chem. Soc.</source>
<year>1981</year>, <volume>103</volume>, <fpage>5250</fpage>&#x02013;<lpage>5251</lpage>.</mixed-citation><mixed-citation publication-type="journal" id="cit15e"><label> e</label><name><surname>Bowen</surname><given-names>R. D.</given-names></name>; <name><surname>Davies</surname><given-names>D. E.</given-names></name>; <name><surname>Fishwick</surname><given-names>C. W. G.</given-names></name>; <name><surname>Glasbey</surname><given-names>T. O.</given-names></name>; <name><surname>Noyce</surname><given-names>S. J.</given-names></name>; <name><surname>Storr</surname><given-names>R. C.</given-names></name>
<source>Tetrahedron Lett.</source>
<year>1982</year>, <volume>23</volume>, <fpage>4501</fpage>&#x02013;<lpage>4504</lpage>.</mixed-citation><mixed-citation publication-type="journal" id="cit15f"><label> f</label><name><surname>Wiebe</surname><given-names>J. M.</given-names></name>; <name><surname>Caille</surname><given-names>A. S.</given-names></name>; <name><surname>Trimble</surname><given-names>&#x000c2;. L.</given-names></name>; <name><surname>Lau</surname><given-names>C. K.</given-names></name>
<source>Tetrahedron</source>
<year>1996</year>, <volume>52</volume>, <fpage>11705</fpage>&#x02013;<lpage>11724</lpage>.</mixed-citation></ref><ref id="ref16"><mixed-citation publication-type="journal" id="cit16"><name><surname>Steinhagen</surname><given-names>H.</given-names></name>; <name><surname>Corey</surname><given-names>E. J.</given-names></name>
<source>Angew. Chem.,
Int. Ed.</source>
<year>1999</year>, <volume>38</volume>, <fpage>1928</fpage>.</mixed-citation></ref><ref id="ref17"><mixed-citation publication-type="journal" id="cit17a"><label>a</label><name><surname>Mukhina</surname><given-names>O.
A.</given-names></name>; <name><surname>Kumar</surname><given-names>N. N. B.</given-names></name>; <name><surname>Arisco</surname><given-names>T. M.</given-names></name>; <name><surname>Valiulin</surname><given-names>R. A.</given-names></name>; <name><surname>Metzel</surname><given-names>G. A.</given-names></name>; <name><surname>Kutateladze</surname><given-names>A. G.</given-names></name>
<source>Angew. Chem.,
Int. Ed.</source>
<year>2011</year>, <volume>50</volume>, <fpage>9423</fpage>&#x02013;<lpage>9428</lpage>.</mixed-citation><mixed-citation publication-type="journal" id="cit17b"><label> b</label><name><surname>Nandurkar</surname><given-names>N. S.</given-names></name>; <name><surname>Kumar</surname><given-names>N. N. B.</given-names></name>; <name><surname>Mukhina</surname><given-names>O. A.</given-names></name>; <name><surname>Kutateladze</surname><given-names>A. G.</given-names></name>
<source>ACS Comb. Sci.</source>
<year>2013</year>, <volume>15</volume>, <fpage>73</fpage>.<pub-id pub-id-type="pmid">23157463</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit17c"><label> c</label><name><surname>Kumar</surname><given-names>N. N. B.</given-names></name>; <name><surname>Mukhina</surname><given-names>O. A.</given-names></name>; <name><surname>Kutateladze</surname><given-names>A. G.</given-names></name>
<source>J. Am. Chem. Soc.</source>
<year>2013</year>, <volume>135</volume>, <fpage>9608</fpage>&#x02013;<lpage>9611</lpage>.<pub-id pub-id-type="pmid">23789841</pub-id></mixed-citation></ref><ref id="ref18"><note><p>For a review, see:</p></note><mixed-citation publication-type="journal" id="cit18a"><label>a</label><name><surname>Kappe</surname><given-names>C. O.</given-names></name>; <name><surname>Murphree</surname><given-names>S. S.</given-names></name>; <name><surname>Padwa</surname><given-names>A.</given-names></name>
<source>Tetrahedron</source>
<year>1997</year>, <volume>53</volume>, <fpage>14179</fpage>&#x02013;<lpage>14233</lpage>.</mixed-citation><note><p>For recent examples in total synthesis, see:</p></note><mixed-citation publication-type="journal" id="cit18b"><label> b</label><name><surname>O&#x02019;Keefe</surname><given-names>B. M.</given-names></name>; <name><surname>Mans</surname><given-names>D. M.</given-names></name>; <name><surname>Kaelin</surname><given-names>D. E.</given-names></name>; <name><surname>Martin</surname><given-names>S. F.</given-names></name>
<source>J. Am. Chem. Soc.</source>
<year>2010</year>, <volume>132</volume>, <fpage>15528</fpage>.<pub-id pub-id-type="pmid">20958036</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit18c"><name><surname>Boonsompat</surname><given-names>J.</given-names></name>; <name><surname>Padwa</surname><given-names>A.</given-names></name>
<source>J. Org. Chem.</source>
<year>2011</year>, <volume>76</volume>, <fpage>2753</fpage>.<pub-id pub-id-type="pmid">21391623</pub-id></mixed-citation></ref><ref id="ref19"><mixed-citation publication-type="journal" id="cit19a"><label>a</label><name><surname>Matsuya</surname><given-names>Y.</given-names></name>; <name><surname>Sasaki</surname><given-names>K.</given-names></name>; <name><surname>Nagaoka</surname><given-names>M.</given-names></name>; <name><surname>Kakuda</surname><given-names>H.</given-names></name>; <name><surname>Toyooka</surname><given-names>N.</given-names></name>; <name><surname>Imanishi</surname><given-names>N.</given-names></name>; <name><surname>Ochiai</surname><given-names>H.</given-names></name>; <name><surname>Nemoto</surname><given-names>H.</given-names></name>
<source>J. Org. Chem.</source>
<year>2004</year>, <volume>69</volume>, <fpage>7989</fpage>&#x02013;<lpage>7993</lpage>.<pub-id pub-id-type="pmid">15527281</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit19b"><label> b</label><name><surname>Wenjert</surname><given-names>E.</given-names></name>; <name><surname>Peittre</surname><given-names>S. R.</given-names></name>
<source>J. Org. Chem.</source>
<year>1988</year>, <volume>53</volume>, <fpage>5850</fpage>&#x02013;<lpage>5853</lpage>.</mixed-citation><mixed-citation publication-type="journal" id="cit19c"><label> c</label><name><surname>Heller</surname><given-names>H. G.</given-names></name>; <name><surname>Hughes</surname><given-names>D. S.</given-names></name>; <name><surname>Hursthouse</surname><given-names>M. B.</given-names></name>; <name><surname>Levell</surname><given-names>J. R.</given-names></name>; <name><surname>Ottaway</surname><given-names>M. J.</given-names></name>
<source>J. Chem. Soc., Chem. Commun.</source>
<year>1995</year>, <fpage>837</fpage>&#x02013;<lpage>838</lpage>.</mixed-citation></ref><ref id="ref20"><note><p>Recent examples of theoretical studies on Diels&#x02013;Alder
reactions of furans:</p></note><mixed-citation publication-type="journal" id="cit20a"><label>a</label><name><surname>Dadwal</surname><given-names>M.</given-names></name>; <name><surname>Kesharwani</surname><given-names>M. K.</given-names></name>; <name><surname>Vaishalee</surname><given-names>D.</given-names></name>; <name><surname>Ganguly</surname><given-names>B.</given-names></name>; <name><surname>Mobin</surname><given-names>S. M.</given-names></name>; <name><surname>Muruganantham</surname><given-names>R.</given-names></name>; <name><surname>Namboothiri</surname><given-names>I. N. N.</given-names></name>
<source>Eur. J. Org. Chem.</source>
<year>2008</year>, <fpage>6106</fpage>&#x02013;<lpage>6118</lpage>.</mixed-citation><mixed-citation publication-type="journal" id="cit20b"><label> b</label><name><surname>Pieniazek</surname><given-names>S. N.</given-names></name>; <name><surname>Houk</surname><given-names>K. N.</given-names></name>
<source>Angew. Chem., Int. Ed.</source>
<year>2006</year>, <volume>45</volume>, <fpage>1442</fpage>&#x02013;<lpage>1445</lpage>.</mixed-citation><mixed-citation publication-type="journal" id="cit20c"><label> c</label><name><surname>Bouacha</surname><given-names>S.</given-names></name>; <name><surname>Nacereddine</surname><given-names>A. K.</given-names></name>; <name><surname>Djerourou</surname><given-names>A.</given-names></name>
<source>Tetrahedron Lett.</source>
<year>2013</year>, <volume>54</volume>, <fpage>4030</fpage>&#x02013;<lpage>4033</lpage>.</mixed-citation></ref><ref id="ref21"><mixed-citation publication-type="journal" id="cit21"><name><surname>Mukhina</surname><given-names>O. A.</given-names></name>; <name><surname>Cronk</surname><given-names>W. C.</given-names></name>; <name><surname>Kumar</surname><given-names>N. N. B.</given-names></name>; <name><surname>Sekhar</surname><given-names>M.</given-names></name>; <name><surname>Samanta</surname><given-names>A.</given-names></name>; <name><surname>Kutateladze</surname><given-names>A. G.</given-names></name>
<source>J. Phys. Chem.
A</source>
<year>2014</year>, <pub-id pub-id-type="doi">10.1021/jp504281y</pub-id>.</mixed-citation></ref><ref id="ref22"><mixed-citation publication-type="journal" id="cit22a"><label>a</label><name><surname>Heidebrecht</surname><given-names>R. W.</given-names><suffix>Jr.</suffix></name>; <name><surname>Mulrooney</surname><given-names>C.</given-names></name>; <name><surname>Austin</surname><given-names>C. P.</given-names></name>; <name><surname>Baker</surname><given-names>R. H.</given-names><suffix>Jr.</suffix></name>; <name><surname>Beaudoin</surname><given-names>J. A.</given-names></name>; <name><surname>Cheng</surname><given-names>K. C&#x02013;.C.</given-names></name>; <name><surname>Comer</surname><given-names>E.</given-names></name>; <name><surname>Dandapani</surname><given-names>S.</given-names></name>; <name><surname>Dick</surname><given-names>J.</given-names></name>; <name><surname>Duvall</surname><given-names>J. R.</given-names></name>; <name><surname>Ekland</surname><given-names>E. H.</given-names></name>; <name><surname>Fidock</surname><given-names>D. A.</given-names></name>; <name><surname>Fitzgerald</surname><given-names>M. E.</given-names></name>; <name><surname>Foley</surname><given-names>M.</given-names></name>; <name><surname>Guha</surname><given-names>R.</given-names></name>; <name><surname>Hinkson</surname><given-names>P.</given-names></name>; <name><surname>Kramer</surname><given-names>M.</given-names></name>; <name><surname>Lukens</surname><given-names>A. K.</given-names></name>; <name><surname>Masi</surname><given-names>D.</given-names></name>; <name><surname>Marcaurelle</surname><given-names>L. A.</given-names></name>; <name><surname>Su</surname><given-names>X.-Z.</given-names></name>; <name><surname>Thomas</surname><given-names>C. J.</given-names></name>; <name><surname>Weiwer</surname><given-names>M.</given-names></name>; <name><surname>Wiegand</surname><given-names>R. C.</given-names></name>; <name><surname>Wirth</surname><given-names>D.</given-names></name>; <name><surname>Xia</surname><given-names>M.</given-names></name>; <name><surname>Yuan</surname><given-names>J.</given-names></name>; <name><surname>Zhao</surname><given-names>J.</given-names></name>; <name><surname>Palmer</surname><given-names>M.</given-names></name>; <name><surname>Munoz</surname><given-names>B.</given-names></name>; <name><surname>Schreiber</surname><given-names>S. L.</given-names></name>
<source>ACS Med. Chem.
Lett.</source>
<year>2012</year>, <volume>3</volume>, <fpage>112</fpage>&#x02013;<lpage>117</lpage>.<pub-id pub-id-type="pmid">22328964</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit22b"><label> b</label><name><surname>Marcaurelle</surname><given-names>L. A.</given-names></name>; <name><surname>Comer</surname><given-names>E.</given-names></name>; <name><surname>Dandapani</surname><given-names>S.</given-names></name>; <name><surname>Duvall</surname><given-names>J. R.</given-names></name>; <name><surname>Gerard</surname><given-names>B.</given-names></name>; <name><surname>Kesavan</surname><given-names>S.</given-names></name>; <name><surname>Lee</surname><given-names>M. D.</given-names><suffix>IV</suffix></name>; <name><surname>Liu</surname><given-names>H.</given-names></name>; <name><surname>Lowe</surname><given-names>J. T.</given-names></name>; <name><surname>Marie</surname><given-names>J.-C.</given-names></name>; <name><surname>Mulrooney</surname><given-names>C. A.</given-names></name>; <name><surname>Pandya</surname><given-names>B. A.</given-names></name>; <name><surname>Rowley</surname><given-names>A.</given-names></name>; <name><surname>Ryba</surname><given-names>T. D.</given-names></name>; <name><surname>Suh</surname><given-names>B.-C.</given-names></name>; <name><surname>Wei</surname><given-names>J.</given-names></name>; <name><surname>Young</surname><given-names>D. W.</given-names></name>; <name><surname>Akella</surname><given-names>L. B.</given-names></name>; <name><surname>Ross</surname><given-names>N. T.</given-names></name>; <name><surname>Zhang</surname><given-names>Y.-L.</given-names></name>; <name><surname>Fass</surname><given-names>D. M.</given-names></name>; <name><surname>Reis</surname><given-names>S. A.</given-names></name>; <name><surname>Zhao</surname><given-names>W.&#x02013;N.</given-names></name>; <name><surname>Haggarty</surname><given-names>S. J.</given-names></name>; <name><surname>Palmer</surname><given-names>M.</given-names></name>; <name><surname>Foley</surname><given-names>M. A.</given-names></name>
<source>J. Am. Chem. Soc.</source>
<year>2010</year>, <volume>132</volume>, <fpage>16962</fpage>&#x02013;<lpage>16976</lpage>.<pub-id pub-id-type="pmid">21067169</pub-id></mixed-citation><mixed-citation publication-type="book" id="cit22c"><label>c</label><person-group person-group-type="allauthors"><name><surname>Dow</surname><given-names>M.</given-names></name>; <name><surname>Marchetti</surname><given-names>F.</given-names></name>; <name><surname>Nelson</surname><given-names>A.</given-names></name></person-group><article-title>Diversity-Oriented
Synthesis of Natural Product-Like Libraries</article-title>. In <source>Diversity-Oriented Synthesis: Basics and Applications in Organic
Synthesis, Drug Discovery, and Chemical Biology</source>; <person-group person-group-type="allauthors"><name><surname>Trabocchi</surname><given-names>A.</given-names></name></person-group>, Ed.; <publisher-name>Wiley</publisher-name>: <publisher-loc>Hoboken, NJ</publisher-loc>, <year>2013</year>.</mixed-citation></ref><ref id="ref23"><mixed-citation publication-type="journal" id="cit23"><name><surname>Ye</surname><given-names>F.</given-names></name>; <name><surname>Shi</surname><given-names>Y.</given-names></name>; <name><surname>Zhou</surname><given-names>L.</given-names></name>; <name><surname>Xiao</surname><given-names>Q.</given-names></name>; <name><surname>Zhang</surname><given-names>Y.</given-names></name>; <name><surname>Wang</surname><given-names>J.</given-names></name>
<source>Org.
Lett.</source>
<year>2011</year>, <volume>13</volume>, <fpage>5020</fpage>&#x02013;<lpage>5023</lpage>.<pub-id pub-id-type="pmid">21875127</pub-id></mixed-citation></ref><ref id="ref24"><mixed-citation publication-type="journal" id="cit24"><name><surname>Donnelly</surname><given-names>J.
A.</given-names></name>; <name><surname>Farrell</surname><given-names>D. F.</given-names></name>
<source>J. Org. Chem.</source>
<year>1990</year>, <volume>55</volume>, <fpage>1757</fpage>&#x02013;<lpage>1761</lpage>.</mixed-citation></ref><ref id="ref25"><mixed-citation publication-type="journal" id="cit25a"><label>a</label><name><surname>Oriyama</surname><given-names>T.</given-names></name>; <name><surname>Aoyagi</surname><given-names>M.</given-names></name>; <name><surname>Iwanami</surname><given-names>K.</given-names></name>
<source>Chem. Lett.</source>
<year>2007</year>, <volume>36</volume>, <fpage>612</fpage>.</mixed-citation><mixed-citation publication-type="journal" id="cit25b"><label> b</label><name><surname>Berger</surname><given-names>S. T. A.</given-names></name>; <name><surname>Seeliger</surname><given-names>F. H.</given-names></name>; <name><surname>Hofbauer</surname><given-names>F.</given-names></name>; <name><surname>Mayr</surname><given-names>H.</given-names></name>
<source>Org. Biomol. Chem.</source>
<year>2007</year>, <volume>5</volume>, <fpage>3020</fpage>&#x02013;<lpage>3026</lpage>.<pub-id pub-id-type="pmid">17728869</pub-id></mixed-citation></ref><ref id="ref26"><mixed-citation publication-type="journal" id="cit26"><name><surname>Murai</surname><given-names>K.</given-names></name>; <name><surname>Matsushita</surname><given-names>T.</given-names></name>; <name><surname>Nakamura</surname><given-names>A.</given-names></name>; <name><surname>Hyogo</surname><given-names>N.</given-names></name>; <name><surname>Nakajima</surname><given-names>J.</given-names></name>; <name><surname>Fujioka</surname><given-names>H.</given-names></name>
<source>Org. Lett.</source>
<year>2013</year>, <volume>15</volume>, <fpage>2526</fpage>.<pub-id pub-id-type="pmid">23650985</pub-id></mixed-citation></ref><ref id="ref27"><mixed-citation publication-type="journal" id="cit27"><name><surname>Yamamoto</surname><given-names>T.</given-names></name>; <name><surname>Iizuka</surname><given-names>M.</given-names></name>; <name><surname>Ohta</surname><given-names>T.</given-names></name>; <name><surname>Ito</surname><given-names>Y.</given-names></name>
<source>Chem. Lett.</source>
<year>2006</year>, <volume>35</volume>, <fpage>198</fpage>&#x02013;<lpage>199</lpage>.</mixed-citation></ref><ref id="ref28"><mixed-citation publication-type="journal" id="cit28"><name><surname>Harrowven</surname><given-names>D. C.</given-names></name>; <name><surname>Pascoe</surname><given-names>D. D.</given-names></name>; <name><surname>Guy</surname><given-names>I. L.</given-names></name>
<source>Angew. Chem.,
Int. Ed.</source>
<year>2007</year>, <volume>46</volume>, <fpage>425</fpage>&#x02013;<lpage>428</lpage>.</mixed-citation></ref><ref id="ref29"><mixed-citation publication-type="journal" id="cit29a"><label>a</label><name><surname>Padwa</surname><given-names>A.</given-names></name>; <name><surname>Brodney</surname><given-names>M. A.</given-names></name>; <name><surname>Dimitroff</surname><given-names>M.</given-names></name>
<source>J. Org. Chem.</source>
<year>1998</year>, <volume>63</volume>, <fpage>5304</fpage>&#x02013;<lpage>5305</lpage>.</mixed-citation><mixed-citation publication-type="journal" id="cit29b"><label> b</label><name><surname>Li</surname><given-names>G.</given-names></name>; <name><surname>Padwa</surname><given-names>A.</given-names></name>
<source>Org. Lett.</source>
<year>2011</year>, <volume>13</volume>, <fpage>3767</fpage>&#x02013;<lpage>3769</lpage>.<pub-id pub-id-type="pmid">21696195</pub-id></mixed-citation></ref><ref id="ref30"><mixed-citation publication-type="journal" id="cit30"><name><surname>Kutateladze</surname><given-names>A. G.</given-names></name>; <name><surname>Mukhina</surname><given-names>O. A.</given-names></name>
<source>J. Org. Chem.</source>
<year>2014</year>, <volume>79</volume>, <fpage>8397</fpage>&#x02013;<lpage>8406</lpage>.<pub-id pub-id-type="pmid">25158224</pub-id></mixed-citation></ref><ref id="ref31"><mixed-citation publication-type="journal" id="cit31"><name><surname>Cronk</surname><given-names>W. C.</given-names></name>; <name><surname>Mukhina</surname><given-names>O. A.</given-names></name>; <name><surname>Kutateladze</surname><given-names>A. G.</given-names></name>
<source>J. Org. Chem.</source>
<year>2014</year>, <volume>79</volume>, <fpage>1235</fpage>&#x02013;<lpage>1246</lpage>.<pub-id pub-id-type="pmid">24397435</pub-id></mixed-citation></ref><ref id="ref32"><mixed-citation publication-type="journal" id="cit32"><name><surname>Despotopoulou</surname><given-names>C.</given-names></name>; <name><surname>Bauer</surname><given-names>R. C.</given-names></name>; <name><surname>Krasovskiy</surname><given-names>A.</given-names></name>; <name><surname>Mayer</surname><given-names>P.</given-names></name>; <name><surname>Stryker</surname><given-names>J. M.</given-names></name>; <name><surname>Knochel</surname><given-names>P.</given-names></name>
<source>Chem. Eur. J.</source>
<year>2008</year>, <volume>14</volume>, <fpage>2499</fpage>&#x02013;<lpage>2506</lpage>.<pub-id pub-id-type="pmid">18232043</pub-id></mixed-citation></ref><ref id="ref33"><mixed-citation publication-type="journal" id="cit33"><name><surname>Park</surname><given-names>C.-M.</given-names></name>; <name><surname>Bruncko</surname><given-names>M.</given-names></name>; <name><surname>Adickes</surname><given-names>J.</given-names></name>; <name><surname>Bauch</surname><given-names>J.</given-names></name>; <name><surname>Ding</surname><given-names>H.</given-names></name>; <name><surname>Kunzer</surname><given-names>A.</given-names></name>; <name><surname>Marsh</surname><given-names>K. C.</given-names></name>; <name><surname>Nimmer</surname><given-names>P.</given-names></name>; <name><surname>Shoemaker</surname><given-names>A. R.</given-names></name>; <name><surname>Song</surname><given-names>X.</given-names></name>; <name><surname>Tahir</surname><given-names>S. K.</given-names></name>; <name><surname>Tse</surname><given-names>C.</given-names></name>; <name><surname>Wang</surname><given-names>X.</given-names></name>; <name><surname>Wendt</surname><given-names>M. D.</given-names></name>; <name><surname>Yang</surname><given-names>X.</given-names></name>; <name><surname>Zhang</surname><given-names>H.</given-names></name>; <name><surname>Fesik</surname><given-names>S. W.</given-names></name>; <name><surname>Rosenberg</surname><given-names>S. H.</given-names></name>; <name><surname>Elmore</surname><given-names>S. W.</given-names></name>
<source>J. Med. Chem.</source>
<year>2008</year>, <volume>51</volume>, <fpage>6902</fpage>&#x02013;<lpage>6915</lpage>.<pub-id pub-id-type="pmid">18841882</pub-id></mixed-citation></ref><ref id="ref34"><mixed-citation publication-type="journal" id="cit34"><name><surname>Samanta</surname><given-names>K.</given-names></name>; <name><surname>Kar</surname><given-names>G. K.</given-names></name>; <name><surname>Sarkar</surname><given-names>A. K.</given-names></name>
<source>Tetrahedron Lett.</source>
<year>2008</year>, <volume>49</volume>, <fpage>1461</fpage>&#x02013;<lpage>1464</lpage>.</mixed-citation></ref><ref id="ref35"><mixed-citation publication-type="journal" id="cit35"><name><surname>Platzer</surname><given-names>N.</given-names></name>; <name><surname>Ronzani</surname><given-names>N.</given-names></name>; <name><surname>Lang</surname><given-names>C.</given-names></name>; <name><surname>Lange</surname><given-names>C.</given-names></name>
<source>Org.
Magn. Reson.</source>
<year>1982</year>, <volume>18</volume>, <fpage>14</fpage>&#x02013;<lpage>19</lpage>.</mixed-citation></ref><ref id="ref36"><mixed-citation publication-type="patent" id="cit36"><person-group person-group-type="allauthors"><name><surname>Baldino</surname><given-names>C. M.</given-names></name>; <name><surname>Caserta</surname><given-names>J. L.</given-names></name>; <name><surname>Dumas</surname><given-names>S. A.</given-names></name>; <name><surname>Lee</surname><given-names>C.-S.</given-names></name>; <name><surname>Flanders</surname><given-names>Y. L.</given-names></name></person-group><source>Aminopiperidine Kinase
Inhibitors</source>. <patent>US 20120270892 A1</patent>, Oct. 25, <year>2012</year>.</mixed-citation></ref><ref id="ref37"><mixed-citation publication-type="journal" id="cit37"><name><surname>Shi</surname><given-names>Z.</given-names></name>; <name><surname>Devasagayaraj</surname><given-names>A.</given-names></name>; <name><surname>Gu</surname><given-names>K.</given-names></name>; <name><surname>Jin</surname><given-names>H.</given-names></name>; <name><surname>Marinelli</surname><given-names>B.</given-names></name>; <name><surname>Samala</surname><given-names>L.</given-names></name>; <name><surname>Scott</surname><given-names>S.</given-names></name>; <name><surname>Stouch</surname><given-names>T.</given-names></name>; <name><surname>Tunoori</surname><given-names>A.</given-names></name>; <name><surname>Wang</surname><given-names>Y.</given-names></name>; <name><surname>Zang</surname><given-names>Y.</given-names></name>; <name><surname>Zhang</surname><given-names>C.</given-names></name>; <name><surname>Kimball</surname><given-names>S. D.</given-names></name>; <name><surname>Main</surname><given-names>A. J.</given-names></name>; <name><surname>Yu</surname><given-names>X.</given-names></name>; <name><surname>Buxton</surname><given-names>E.</given-names></name>; <name><surname>Patel</surname><given-names>S.</given-names></name>; <name><surname>Nguyen</surname><given-names>N.</given-names></name>; <name><surname>Swaffield</surname><given-names>J.</given-names></name>; <name><surname>Powell</surname><given-names>D. R.</given-names></name>; <name><surname>Wilson</surname><given-names>A.</given-names></name>; <name><surname>Liu</surname><given-names>Q.</given-names></name>
<source>J. Med. Chem.</source>
<year>2008</year>, <volume>51</volume>, <fpage>3684</fpage>.<pub-id pub-id-type="pmid">18557609</pub-id></mixed-citation></ref><ref id="ref38"><mixed-citation publication-type="journal" id="cit38"><comment>Procedure adapted
from:</comment><name><surname>Abonia</surname><given-names>R.</given-names></name>; <name><surname>Cuervo</surname><given-names>P.</given-names></name>; <name><surname>Insuasty</surname><given-names>B.</given-names></name>; <name><surname>Quiroga</surname><given-names>J.</given-names></name>; <name><surname>Nogueras</surname><given-names>M.</given-names></name>; <name><surname>Cobo</surname><given-names>J.</given-names></name>; <name><surname>Meier</surname><given-names>H.</given-names></name>; <name><surname>Lotero</surname><given-names>E.</given-names></name>
<source>Open Org. Chem. J.</source>
<year>2008</year>, <volume>2</volume>, <fpage>26</fpage>&#x02013;<lpage>34</lpage>.</mixed-citation></ref></ref-list></back></article>
